2019 Annual Meeting | P5 - Poster Session 5

Date Thursday 05/09/19

Time 11:30 AM - 06:30 PM EDT Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type Scientific Poster Session

Topic(s) Practice, Policy, and Ethics, Aging, Dementia, and Behavioral Neurology, Cerebrovascular Disease and Interventional Neurology, Child Neurology and Developmental Neurology, Epilepsy/Clinical Neurophysiology (EEG), General Neurology, Headache, Movement Disorders, Multiple Sclerosis, Neuro Trauma, Critical Care, and Sports Neurology, Neuromuscular and Clinical Neurophysiology (EMG), Neuro-rehabilitation

CME Available 0.00 credit

Program Materials Program Evaluations

Event Timeline
05:30 PM - 06:30 PM EDT	Abstract	9-001 - Effect of Leukoaraiosis on Decline in Naming in Primary Progressive Aphasia
05:30 PM - 06:30 PM EDT	Abstract	9-002 - Anatomical Correlates of Verbal Fluency in Parkinson Disease Federico J. Rodriguez-Porcel, MD, FAAN
05:30 PM - 06:30 PM EDT	Abstract	9-003 - Network-Based Approach to the Role of the Inferior Frontal Gyrus in Word Retrieval and Selection Joely A. Mass
05:30 PM - 06:30 PM EDT	Abstract	9-004 - The Contribution of Residual Anatomical Brain Networks in Language Recovery in Post-Stroke Aphasia
05:30 PM - 06:30 PM EDT	Abstract	9-005 - Impaired Global Network Topology in Residual Connectomes in Stroke-induced Aphasia John D. Medaglia, PhD
05:30 PM - 06:30 PM EDT	Abstract	9-006 - Greater Relative White Matter Burden is a Distinct Feature of Tauopathies in Frontotemporal Degeneration Spectrum Lucia Giannini
05:30 PM - 06:30 PM EDT	Abstract	9-007 - Plasma neurofilament light chain predicts disease progression in asymptomatic genetic frontotemporal dementia Julio C. Rojas-Martinez, MD, PhD
05:30 PM - 06:30 PM EDT	Abstract	9-008 - Progress and Participant Characterization in the Advancing Research and Treatment in Frontotemporal Lobar Degeneration (ARTFL) Rare Disease Clinical Research Consortium Adam L. Boxer, MD, PhD
05:30 PM - 06:30 PM EDT	Abstract	9-009 - Characteristics and Progress on 369 Subjects in the Longitudinal Evaluation Familial Frontotemporal Dementia Subjects (LEFFTDS) Protocol Leah K. Forsberg, PhD
05:30 PM - 06:30 PM EDT	Abstract	9-010 - The Multidomain Impairment Rating (MIR) Scale: Initial Reliability Data on a Multidimensional Scale for FTLD Bradley F. Boeve, MD, FAAN
05:30 PM - 06:30 PM EDT	Abstract	9-011 - Brain glucose metabolism in Lewy Body Dementia: implications for diagnostic criteria
05:30 PM - 06:30 PM EDT	Abstract	9-012 - 18F-AV-1451 Tau Tracer Uptake Correlates with Medial Temporal Lobe Subregional Atrophy in Amyloid Negative Individuals
05:30 PM - 06:30 PM EDT	Abstract	9-013 - Abnormal neuropsychological memory testing and hippocampal volume in a clinical population. Robert Ruchinskas, PhD
05:30 PM - 06:30 PM EDT	Abstract	9-014 - Cholinergic-Related White Matter Lesion Load is Associated with Alzheimer’s Disease-Signature Cortical Thickness: The Northern Manhattan Study Michelle R. Caunca, MD, PhD
05:30 PM - 06:30 PM EDT	Abstract	9-015 - Periventricular Cerebral Blood Flow as a Biomarker for Cerebral Small Vessel Disease Sudipto Dolui, PhD
05:30 PM - 06:30 PM EDT	Abstract	9-016 - Associations Between Amyloid Burden, White Matter Hyperintensities and Cognition in Cognitively Normal Older Adults Benjamin Chapin, MD
05:30 PM - 06:30 PM EDT	Abstract	9-017 - Assessment of Deep Medullary Veins on 3T MRI in a Population-based Cohort Dong-Hui Ao
05:30 PM - 06:30 PM EDT	Abstract	9-018 - Optical Properties and Oximetry Parameters of Cerebral Atrophic and Normal Regions in Healthy Volunteers
05:30 PM - 06:30 PM EDT	Abstract	9-019 - Cognition predicted by brain biomarkers and demographic factors Angeliki Tsapanou, PhD
05:30 PM - 06:30 PM EDT	Abstract	9-020 - Increased Activity in Functional Brain Network among the Elderly with Youthful Memory in Superaging Min Young Chun, MD
05:30 PM - 06:30 PM EDT	Abstract	9-021 - The Neural Substrate of Memory Impairment in the Oldest old with Dementia; The 90+ Study S. Ahmad Sajjadi, MD, PhD, MRCP, FAAN
05:30 PM - 06:30 PM EDT	Abstract	9-022 - Multimodal Magnetic Resonance Imaging versus 18F-FDG-PET to Identify Mild Cognitive Impairment Sudipto Dolui, PhD
05:30 PM - 06:30 PM EDT	Abstract	9-023 - Clinical and Molecular PET Imaging Markers of Primary Progressive Aphasia due to Likely Alzheimer's Disease Pathology Emily Roll
05:30 PM - 06:30 PM EDT	Abstract	9-024 - The Relationship of Amyloid Beta in the Retina to that of the Brain is Burden-specific David P. Bissig, MD
05:30 PM - 06:30 PM EDT	Abstract	9-025 - Diffusion Tensor Imaging in pre-dementia risk states: white matter atrophy findings in Mild Behavioral Impairment Sascha Gill, MSc
05:30 PM - 06:30 PM EDT	Abstract	9-026 - Phenotypes and Biomarkers in Posterior Cortical Atrophy: Application of Consensus Clinical Diagnostic Criteria and the AT(N) Framework Scott McGinnis, MD
05:30 PM - 06:30 PM EDT	Abstract	9-027 - Correlates between functional connectivity and amyloid deposition in healthy controls Ricardo Bruña
05:30 PM - 06:30 PM EDT	Abstract	9-028 - Association of Cortical and Subcortical Aß Deposition with Depressive and Anxiety Symptoms: A Population-based Cross-sectional Study Janina Krell-Roesch, PhD
05:30 PM - 06:30 PM EDT	Abstract	9-029 - Functional brain connectome organization associated with atrophy and hypometabolism in posterior cortical atrophy Raffaella Migliaccio
05:30 PM - 06:30 PM EDT	Abstract	9-030 - Tracking Neurostructural Preclinical Predictors of Alzheimer’s Disease: Linking Clinical Markers to the Size of the Ventral Tegmental Area and Other Subcortical Nuclei Matteo De Marco, PhD
05:30 PM - 06:30 PM EDT	Abstract	9-031 - WMH Progression but not Regression is Associated with a Higher CSF tau/Aß and Temporal Amyloid Concentration in The Amyloid PET Scan Omar M. Al-Janabi, MD, PhD, MSc
05:30 PM - 06:30 PM EDT	Abstract	9-032 - Structural Brain Organization Associated with Gait in Mild Cognitive Impairment Subtypes Gilles Allali, MD, PhD
05:30 PM - 06:30 PM EDT	Abstract	15-001 - Longitudinal Measures of Radiographic Outcomes as Predictors of Clinical Disability in Multiple Sclerosis: A 12-Year Study Jenny J. Feng, MD
05:30 PM - 06:30 PM EDT	Abstract	15-002 - Dietary and Lifestyle Factors in Multiple Sclerosis Progression: Results from a 5-year Longitudinal MRI Study Jesper Hagemeier
05:30 PM - 06:30 PM EDT	Abstract	15-003 - Vitamin D and Tobacco Use and Long-Term Clinical and MRI Outcomes among CIS patients: 11-year Follow-up of BENEFIT.
05:30 PM - 06:30 PM EDT	Abstract	15-004 - Adjusting neurofilament light levels using an MRI-based estimate of total axonal bulk improves its prediction of MS progression Jonathan Phillips
05:30 PM - 06:30 PM EDT	Abstract	15-005 - A History of Migraine Headache is Associated with Worse Disability and Walking Speed in a Cohort of Patients with MS Anne D. Yacoub, MD
05:30 PM - 06:30 PM EDT	Abstract	15-006 - Serum Neurofilament Light Chain and Glial Fibrillary Acid Protein in Patients With Multiple Sclerosis Xavier Ayrignac
05:30 PM - 06:30 PM EDT	Abstract	15-007 - The association between serum neurofilament light chain, atrophied lesion volume and brain atrophy with disability progression in multiple sclerosis Eleonora Tavazzi, MD
05:30 PM - 06:30 PM EDT	Abstract	15-008 - HLA genotype as a marker of Multiple Sclerosis prognosis: results from a multicentric extension study Andreas Lysandropoulos
05:30 PM - 06:30 PM EDT	Abstract	15-009 - No Association Between Lymphocyte Pharmacodynamics and Disability Following Alemtuzumab Treatment in Patients With Relapsing-Remitting Multiple Sclerosis Sven G. Meuth
05:30 PM - 06:30 PM EDT	Abstract	15-010 - Predicting EDSS in MS through Imaging Biomarkers Using Artificial Neural Networks David Chaar, MD
05:30 PM - 06:30 PM EDT	Abstract	15-011 - Loss of Brain Iron is Linked to Disability in Multiple Sclerosis - The Difference Between Concentration and Mass of Iron Jesper Hagemeier
05:30 PM - 06:30 PM EDT	Abstract	15-012 - Unilateral Motor Progression in Multiple Sclerosis: Association with a Single Critical Corticospinal Tract Lesion Elia Sechi, MD
05:30 PM - 06:30 PM EDT	Abstract	15-013 - The neutrophil-to-lymphocyte and monocyte-to-lymphocyte ratios are independently associated with neurological disability and brain atrophy in multiple sclerosis Christopher Hemond, MD
05:30 PM - 06:30 PM EDT	Abstract	15-014 - Oligoclonal band number as a predictor of multiple sclerosis disease course Christopher Perrone, MD
05:30 PM - 06:30 PM EDT	Abstract	15-015 - Cognition as a Disability Progression Marker: Two-Years Follow-Up of People with Multiple Sclerosis
05:30 PM - 06:30 PM EDT	Abstract	15-016 - Baló Concentric Sclerosis: Benign Evolution in a Tunisian Population Oussama Landolsi
05:30 PM - 06:30 PM EDT	Abstract	15-017 - Serum GFAP Associates with Neurofilament Light and Disease Severity in Late Multiple Sclerosis Laura Airas, MD, PhD
05:30 PM - 06:30 PM EDT	Abstract	15-018 - Characterization of the Immunophenotype of Clinically Isolated Syndrome Patients Who Convert or Not To Multiple Sclerosis
05:30 PM - 06:30 PM EDT	Abstract	15-019 - Late onset MS is associated with more severe longitudinal development of central brain atrophy compared to adult onset MS Dora Dujmic
05:30 PM - 06:30 PM EDT	Abstract	15-020 - Clinical Profile and functional outcomes of idiopathic inflammatory demyelinating disorders of CNS in adults. Sankar P. Gorthi, MD, FAAN
05:30 PM - 06:30 PM EDT	Abstract	15-021 - Real Life Evidence for CSF Neurofilaments Light Chain in Clinical Practice.
05:30 PM - 06:30 PM EDT	Abstract	15-022 - Positive Predictive Value of Elevated Unique Cerebrospinal Fluid Oligoclonal Bands Casey F. Jeffreys, MD
05:30 PM - 06:30 PM EDT	Abstract	15-023 - Sex-specific Differences in Rim Appearance of Multiple Sclerosis Lesions on Quantitative Susceptibility Mapping Besher Tolaymat
05:30 PM - 06:30 PM EDT	Abstract	15-024 - Demyelination, Inflammation and Axonal Loss Explain Different Patterns of Fractional Anisotropy Abnormalities in MS Cortical Normal Appearing Gray Matter and Lesions Paolo Preziosa
05:30 PM - 06:30 PM EDT	Abstract	15-025 - 3D MR image synthesis using unsupervised deep learning algorithm in MS patients
05:30 PM - 06:30 PM EDT	Abstract	15-026 - A comparison of FLAIR and T1 maps from MP2RAGE at 7T for quantifying lesion volume and its correlation to disability in multiple sclerosis Margaret Spini
05:30 PM - 06:30 PM EDT	Abstract	15-027 - New/Enlarging Lesion Count: Man versus Machine Wim Van Hecke, PhD
05:30 PM - 06:30 PM EDT	Abstract	15-028 - Correlation Between Neurologic Challenge Task Performance and Lesion Localization of Sub-Threshold Lesions in Multiple Sclerosis Patients with EDSS Score of 0 Ali M. Antoine
05:30 PM - 06:30 PM EDT	Abstract	15-029 - Automatically segmented medulla oblongata volume as a surrogate for spinal cord atrophy in multiple sclerosis Niels Bergsland
05:30 PM - 06:30 PM EDT	Abstract	15-030 - Inflammatory activity associated with increased rate of brain and retinal neuro-axonal injury in early MS The aim of this study is to address the effect of local inflammatory activity in brain and retinal neuro-axonal injury along MS course. Irene Pulido Valdeolivas
05:30 PM - 06:30 PM EDT	Abstract	15-031 - Investigation into the Relationship between Digital Brain Volume and Computerized Screening Assessment of Cognitive Function in People with Multiple Sclerosis: Objective Analytics to Quantify Disease Impact – Cross Sectional Relationship Jared Srinivasan
05:30 PM - 06:30 PM EDT	Abstract	15-032 - Quantitative Spinal Cord MRI in MS patients with Sexual Dysfunction: A Cross-sectional Study. Isobel A. Hawes
05:30 PM - 06:30 PM EDT	Abstract	15-033 - Clinical and Conventional MRI Predictors of Cognitive Rehabilitation Efficacy in Multiple Sclerosis Tom Fuchs
05:30 PM - 06:30 PM EDT	Abstract	15-034 - Integration and Characterization of Brain MRI Data from the Italian Neuroimaging Network Initiative (INNI) for the Study of Multiple Sclerosis Loredana Storelli
05:30 PM - 06:30 PM EDT	Abstract	15-035 - Cognitive Impairment and Deep Grey Matter Lesions on 7T MRI in Multiple Sclerosis Christine Tomkinson, MD
05:30 PM - 06:30 PM EDT	Abstract	15-036 - Cerebellar Volume Loss in Radiologically Isolated Syndrome Ilena George, MD
05:30 PM - 06:30 PM EDT	Abstract	15-037 - Lower Total Cerebral Arterial Flow Contributes to Cognitive Performance in Multiple Sclerosis Patients Dejan Jakimovski, MD, PhD
05:30 PM - 06:30 PM EDT	Abstract	15-038 - Increased Iron Accumulation in Red Nucleus, Spelium, Putamen and Thalamus in Multiple Sclerosis and CIS: A 7 Tesla MRI Study Belgin Kocer
05:30 PM - 06:30 PM EDT	Abstract	15-039 - Loss of intrathalamic tissue integrity in pediatric-onset multiple sclerosis measured with DTI.
05:30 PM - 06:30 PM EDT	Abstract	15-040 - Impact of Cervical Stenosis on Multiple Sclerosis Lesion Distribution in the Spinal Cord Daniel Gratch
05:30 PM - 06:30 PM EDT	Abstract	15-041 - MS patients with low central vein sign frequency can be identified by FLAIR* MRi sequences
05:30 PM - 06:30 PM EDT	Abstract	15-042 - Instrumental, Clinical, and Patient Reported Sensorimotor Correlates of Spinal Cord Grey and Total Cord Areas Amber M. Alexander
05:30 PM - 06:30 PM EDT	Abstract	15-043 - Functional Connectivity with the Default Mode Network Predicts Efficacy of Cognitive Rehabilitation in People with Multiple Sclerosis Alexander Bartnik
05:30 PM - 06:30 PM EDT	Abstract	15-044 - Magnetization Transfer Saturation Reveals Subclinical Optic Nerve Demyelination in Pediatric Multiple Sclerosis Giulia Longoni, MD
05:30 PM - 06:30 PM EDT	Abstract	15-045 - Higher EBV response is associated with more severe gray matter and lesion pathology in relapsing multiple sclerosis patients: a case-controlled magnetization transfer ratio study Michael G. Dwyer III, MD, PhD
05:30 PM - 06:30 PM EDT	Abstract	15-046 - Correlation between Magnetization Transfer Ratio and Functional Status in Multiple Sclerosis patients Ali Ebrahim, MD
05:30 PM - 06:30 PM EDT	Abstract	15-047 - Dynamics of Pseudo-Atrophy in RRMS Patients Treated with Interferon beta-1a as Assessed by Monthly Brain MRI Nicola De Stefano, MD
05:30 PM - 06:30 PM EDT	Abstract	15-048 - Resting-state functional correlates of Social Cognition in Multiple Sclerosis Alvino Bisecco
05:30 PM - 06:30 PM EDT	Abstract	15-049 - Cortical Thickness, Subcortical Volumes and Disability in Multiple Sclerosis: A Prospective Longitudinal Study Mihir Kakara, MD
05:30 PM - 06:30 PM EDT	Abstract	15-050 - Nystagmus-associated imaging signatures in Multiple Sclerosis: evaluation of subcortical and infratentorial structures Peter Bede, MD, PhD
05:30 PM - 06:30 PM EDT	Abstract	15-051 - Spine atrophy and sensory-motor disability in African Americans with Multiple Sclerosis
05:30 PM - 06:30 PM EDT	Abstract	15-052 - Influence of T2-Hyperintense Lesions on Cervical Spinal Cord Atrophy and Disability in Patients with Multiple Sclerosis Maria A. Rocca
05:30 PM - 06:30 PM EDT	Abstract	15-053 - Changes in Brain Volume in Specific Regions could be related to Disability Progression in Primary Progressive Multiple Sclerosis Patients Francisco Perez Miralles, MD
05:30 PM - 06:30 PM EDT	Abstract	15-054 - Is there a relationship between Incidental Learning and Self-temporal Projection in relapsing remitting multiple sclerosis patients?
05:30 PM - 06:30 PM EDT	Abstract	15-055 - Resting State Network Functional Connectivity Abnormalities in Systemic Lupus Erythematosus: Correlations with Neuropsychological and Neuropsychiatric Variables
05:30 PM - 06:30 PM EDT	Abstract	15-056 - Gray Matter Volume Loss Is Increased in Younger Patients With Relapsing Multiple Sclerosis but Minimized by Ozanimod: Experience From the Ozanimod Phase 3 Program Sven Schippling
05:30 PM - 06:30 PM EDT	Abstract	15-057 - Deep learning enables thalamic atrophy measurement on clinical quality T2 FLAIR images Michael G. Dwyer III, MD, PhD
05:30 PM - 06:30 PM EDT	Abstract	15-058 - Brain Volume Loss and Cognition in Teriflunomide-Treated Patients in TEMSO Jens Wuerfel, MD
05:30 PM - 06:30 PM EDT	Abstract	15-059 - Effect of Treatment Naiveté on MRI Outcomes with Fingolimod or Injectable Disease-Modifying Therapies in Patients with Multiple Sclerosis: PREFERMS Samuel F. Hunter, MD, PhD
05:30 PM - 06:30 PM EDT	Abstract	15-060 - Magnetic Resonance Imaging Measures as Prognostic Parameters for Physical and Cognitive Outcomes up to 8 Years in Patients with Relapsing Forms of Multiple Sclerosis Timothy L. Vollmer, MD, FAAN
05:30 PM - 06:30 PM EDT	Abstract	15-061 - Regional Myelin-Specific MRI Abnormalities in Susac Syndrome Suggests Demyelination is a Pathologic Feature Poljanka Johnson
05:30 PM - 06:30 PM EDT	Abstract	15-062 - Long-Term Monitoring Of Brain Volume Loss In Multiple Sclerosis Mikolaj Pawlak, MD PhD
05:30 PM - 06:30 PM EDT	Abstract	15-063 - Atrophied T2 lesion volume and cognitive outcomes in multiple sclerosis Eleonora Tavazzi, MD
05:30 PM - 06:30 PM EDT	Abstract	15-064 - Global and regional brain atrophy in highly active MS-A biomarker for therapy switch Alaleh Raji, MD
05:30 PM - 06:30 PM EDT	Abstract	15-065 - Myelinating Proteins in MS are Linked to Volumetric Brain MRI changes Staley A. Brod, MD
05:30 PM - 06:30 PM EDT	Abstract	15-066 - Trigeminal nerve root enhancement in multiple sclerosis Lokesh A. Rukmangadachar, MD
05:30 PM - 06:30 PM EDT	Abstract	15-067 - Short-term MRI-based Prediction of Clinical MS Progression in a Real World Setting Wim Van Hecke, PhD
05:30 PM - 06:30 PM EDT	Abstract	15-068 - The Effect of Glitiramer Acetate 40mg TIW on Multiple Brain MRI Parameters over One Year Jacob C. Rube, MD
05:30 PM - 06:30 PM EDT	Abstract	15-069 - Thalamic nuclei volumes as markers of clinical disability and cognitive dysfunction in multiple sclerosis Niels Bergsland
05:30 PM - 06:30 PM EDT	Abstract	15-070 - Volume Loss in Deep Gray Matter and Thalamic Sub-Nuclei in Placebo-treated Patients with Multiple Sclerosis in the Phase 3 TEMSO Study Ludwig Kappos, MD, FAAN
05:30 PM - 06:30 PM EDT	Abstract	15-071 - Factors associated with headache in intravenous immunoglobulin treatment for neurological diseases. Jonas Graf
05:30 PM - 06:30 PM EDT	Abstract	15-072 - Naturally Occurring Anti-Neuronal Antibodies within IVIg Preparations: Importance in Clinical Practice Maria Dimitriadou
05:30 PM - 06:30 PM EDT	Abstract	15-073 - Isoagglutinin Reduction In IVIG By Specific Immunoaffinity Chromatography Reduces Spontaneous Reporting Rates Of Hemolytic Reactions Amgad Shebl, MD, MBBS, FAAN
05:30 PM - 06:30 PM EDT	Abstract	15-074 - Adrenal Insufficiency and Multiorgan Failure in a Patient Receiving Alemtuzumab Therapy Paul M. Miller
05:30 PM - 06:30 PM EDT	Abstract	15-075 - Long-term efficacy of intravenous immunoglobulin treatment in 49 patients with chronic inflammatory demyelinating polyradiculoneuropathy
05:30 PM - 06:30 PM EDT	Abstract	15-076 - Analysis of Relapse by MRC Sum Score in the PATH Study of Subcutaneous Immunoglobulin in CIDP Vera Bril, MD
05:30 PM - 06:30 PM EDT	Abstract	15-077 - The effect of oral Steriods in Chronic Demyelinating Polyneuropathy associated with Diabetes Mellitus Thangjam S. Singh, MD, MBBS
05:30 PM - 06:30 PM EDT	Abstract	15-078 - Treatment Satisfaction and Work Productivity in a Clinical Study of IgPro20 Maintenance Treatment of CIDP Hans-Peter Hartung, MD, FAAN
05:30 PM - 06:30 PM EDT	Abstract	15-079 - RVT-1401, A Novel Anti-FcRn Monoclonal Antibody, Is Well Tolerated in Healthy Subjects and Reduces Plasma IgG Following Subcutaneous or Intravenous Administration Jon W. Collins, PharmD
05:30 PM - 06:30 PM EDT	Abstract	15-080 - Changes in Concomitant Immunosuppressive Therapy Use During a Phase 3 Open-label Study of Eculizumab in Adults with Generalized Myasthenia Gravis: an Interim Analysis Richard J. Nowak, MD
05:30 PM - 06:30 PM EDT	Abstract	15-081 - Molecular Characterization of VEGF Secretion by MSC-NTF Cells (NurOwn®): Therapeutic Implications in ALS
05:30 PM - 06:30 PM EDT	Abstract	15-082 - Saturation of alpha4 integrin (CD49d) in patients undergoing treatment with natalizumab in extended interval dose.
05:30 PM - 06:30 PM EDT	Abstract	15-083 - Precision Therapy for Neuromyelitis Optica Spectrum Disorder: A Retrospective Analysis of the Use of Class-Switched Memory B-cells for Individualized Rituximab Dosing Schedules Benjamin P. Trewin, MBBS, PhD, FRACP
05:30 PM - 06:30 PM EDT	Abstract	15-084 - New Sensorineural Hearing Loss can be Associated with Disabling Autoimmune Disease Kimia Ghavami, MD
05:30 PM - 06:30 PM EDT	Abstract	15-085 - Long-term Effectiveness of 9-d-tetrahydrocannabinol:Cannabidiol Oromucosal Spray in Clinical Practice: results from a 18-months Multicenter Italian Study Francesco Patti, MD
05:30 PM - 06:30 PM EDT	Abstract	15-086 - Feasibility of Using Wearable Technology with a Social Cognitive Theory-based Physical Activity Promotion Program in Youth with Multiple Sclerosis Stephanie Grover, MSc, CCRP
05:30 PM - 06:30 PM EDT	Abstract	15-087 - INROADS: A Phase 3 Study to Assess the Efficacy and Safety of ADS-5102 (Amantadine) Extended Release Capsules in Multiple Sclerosis (MS) Patients with Walking Impairment Michelle Cameron, MD
05:30 PM - 06:30 PM EDT	Abstract	15-088 - Which treatments improve fatigue and quality of life in Multiple Sclerosis? Evidence appraisal and development of visual interactive evidence maps Amy Tsou, MD
05:30 PM - 06:30 PM EDT	Abstract	15-089 - Sexual Dysfunction in Multiple Sclerosis: A Systematic Review and Meta-Analysis of Prevalence David D. Kim, MD
05:30 PM - 06:30 PM EDT	Abstract	15-090 - Interoception as a neurocognitive mechanism underlying fatigue in Multiple Sclerosis
05:30 PM - 06:30 PM EDT	Abstract	15-091 - Origins of Fatigue in an Early Multiple Sclerosis Cohort Colleen Marino, PhD
05:30 PM - 06:30 PM EDT	Abstract	15-092 - A Survey of Cannabis-Based Product Use in Multiple Sclerosis Patients at the University of British Columbia Hospital Alice J. Schabas, MD
05:30 PM - 06:30 PM EDT	Abstract	15-093 - N-acetyl cysteine for fatigue in progressive multiple sclerosis: A pilot randomized double-blind placebo-controlled trial Kristen M. Krysko, MD
05:30 PM - 06:30 PM EDT	Abstract	15-094 - Telerehabilitation reduces travel cost and time: A survey of participants with multiple sclerosis in an urban treatment setting Pamela Best
05:30 PM - 06:30 PM EDT	Abstract	15-096 - The Extent of the Relationship between Sleep Disturbances and walking ability in People with Multiple Sclerosis Khalid I. El-Salem, MD, FAAN
05:30 PM - 06:30 PM EDT	Abstract	15-097 - A Novel Approach to Treatment of Trigeminal Neuralgia in Multiple Sclerosis Patients Using Minimally Invasive Trigeminal Ablation (MITA) Yasser Tajali, MD
05:30 PM - 06:30 PM EDT	Abstract	15-098 - Lacosamide Efficacy in Trigeminal Neuralgia and Other Neuropathic Pain Syndromes: A Case Series Scott M. Belliston, DO
05:30 PM - 06:30 PM EDT	Abstract	15-099 - Social anxiety among patients with multiple sclerosis: a population-based case-control study in Ecuador Joyce A. Jimenez Zambrano, MD
05:30 PM - 06:30 PM EDT	Abstract	15-100 - Cannabis Use in People with Multiple Sclerosis and Self-Reported Spasticity Lucinda L. Hugos, PT
05:30 PM - 06:30 PM EDT	Abstract	15-101 - Gait and Balance Outcomes in Adrenomyeloneuropathy (AMN) Reza Seyedsadjadi, MD
05:30 PM - 06:30 PM EDT	Abstract	15-102 - Processing speed of information deficit induces a lack of functional impulsivity in Multiple Sclerosis Heloise Joly
05:30 PM - 06:30 PM EDT	Abstract	15-103 - Arabic Modified Fatigue Impact Scale: Validity and Reliability in People with Multiple Sclerosis
05:30 PM - 06:30 PM EDT	Abstract	15-104 - Cognitive-motor interaction in Multiple Sclerosis: how it impacts on patient’s Quality of Life.
05:30 PM - 06:30 PM EDT	Abstract	15-105 - Immunophenotyping of Depression and Fatigue in Relapsing-Remitting Multiple Sclerosis (RRMS) Patients Treated with Dimethyl Fumarate
05:30 PM - 06:30 PM EDT	Abstract	15-106 - Multiple Sclerosis and Use of Medical Cannabis: A Retrospective Review Evaluating Symptom Outcomes Katelyn McCormack, NP
05:30 PM - 06:30 PM EDT	Abstract	15-107 - Evidence of early Central Nervous System degeneration in Multiple Sclerosis patients with impulsivity
05:30 PM - 06:30 PM EDT	Abstract	15-108 - Prevalence and Factors Associated with Anxiety in Argentinian Patients with Multiple Sclerosis Anibal Chertcoff
05:30 PM - 06:30 PM EDT	Abstract	15-109 - Demyelinating Disease Associated with Parkinsonism: A Case Report Zachary B. Jordan, MD
05:30 PM - 06:30 PM EDT	Abstract	15-110 - Long-Term Follow-Up and Results of Patients with MRI Negative Demyelinating Diseases
05:30 PM - 06:30 PM EDT	Abstract	15-111 - The "MS Hug": Definition, Characteristics, Course, and Misattribution Risk Dean M. Wingerchuk, MD, FAAN
05:30 PM - 06:30 PM EDT	Abstract	3-001 - Out with the Old and In with the New - Understanding Barriers and Facilitators in Obtaining "New" Blood Pressure Goal for Patients with Ischemic Stroke Jason J. Sico, MD, FAAN
05:30 PM - 06:30 PM EDT	Abstract	3-002 - Blood Pressure at Hospital Arrival Does Not Reliably Distinguish Hypertensive Intracerebral Hemorrhage Nasir Fakhri, MD
05:30 PM - 06:30 PM EDT	Abstract	3-003 - Low and steady: Evidence for target blood pressure 24 hrs post-thrombectomy Cheran Elangovan, MD
05:30 PM - 06:30 PM EDT	Abstract	3-004 - Sympathetic Nervous System Dysfunction Correlates with Increased Blood Pressure Variability after Acute Stroke Adam De Havenon, MD, FAAN
05:30 PM - 06:30 PM EDT	Abstract	3-005 - High In-Hospital Systolic Blood Pressure Variability and Poor Functional Outcomes in Primary Intracerebral Hemorrhage Patients Katie Alex
05:30 PM - 06:30 PM EDT	Abstract	3-006 - Blood Pressure Variability Post Mechanical Thrombectomy And Outcomes Phong T. Vu, MD
05:30 PM - 06:30 PM EDT	Abstract	3-007 - Patients with Parenchymal Hemorrhagic Transformation and Poor Functional Outcome Have Distinct Systolic Blood Pressure Trajectories 72 hours After Mechanical Thrombectomy Sreeja Kodali
05:30 PM - 06:30 PM EDT	Abstract	3-008 - Examining the Mortality Benefit of Various Post Ischemic Stroke/TIA Hypertension Goals – an VA-based Observational Study Jason J. Sico, MD, FAAN
05:30 PM - 06:30 PM EDT	Abstract	3-009 - Admission Blood Pressure and Outcome after Successful Recanalization: a collaborative pooled analysis Mohammad Anadani, MD
05:30 PM - 06:30 PM EDT	Abstract	3-010 - Cerebral venous thrombosis from thrombocytosis in a patient with thalassemia and splenectomy Sahar H. Osman, MD
05:30 PM - 06:30 PM EDT	Abstract	3-011 - Cerebral Venous Thrombosis In A Single Center Tertiary Hospital Of A South East Asian Country (CVSTS Study) – A Retrospective Study On The Clinical Profiles Of Patients with Cerebral Venous Thrombosis Miguela Marie A. Senga, MD
05:30 PM - 06:30 PM EDT	Abstract	3-012 - Novel Oral Anticoagulants (NOACs) vs. Warfarin in the Treatment of Cerebral Venous Sinus Thrombosis (CVST): A retrospective study of functional and radiographic outcomes among patients enrolled in BEAST (Biorepository to Establish the Aetiology of Sinovenous Thrombosis) at UVA. Jeremy D. Wells, MD
05:30 PM - 06:30 PM EDT	Abstract	3-013 - Study of the factors predicting clinical outcome in patients with Cerebral Venous Sinus Thrombosis Salma Suhana, MD
05:30 PM - 06:30 PM EDT	Abstract	3-014 - Cerebral Venous Thrombosis and Intracerebral Hemorrhage due to Pegaspargase Therapy for Acute Lymphoblastic Leukemia Monica Scarsella, MD
05:30 PM - 06:30 PM EDT	Abstract	3-015 - Reactive thrombocytosis related cerebral venous thrombosis: A rare complication of untreated iron deficiency anemia Aparna Vaddiparti, MD
05:30 PM - 06:30 PM EDT	Abstract	3-016 - Clinical course of seizures in patients with cerebral venous thrombosis
05:30 PM - 06:30 PM EDT	Abstract	3-017 - Safety and Effectiveness of Intravenous Recombinant Tissue Plasminogen Activator (rt-PA) in Patients with Concurrent Migraine Headaches and Focal Neurological Deficits.
05:30 PM - 06:30 PM EDT	Abstract	3-018 - Congestive Heart Failure is Strongly Associated with Hereditary Hemorrhagic Telangiectasia (HHT): Analysis of a Large National Database Mudassir Farooqui, MD
05:30 PM - 06:30 PM EDT	Abstract	3-019 - Life Expectancy in Familial Cerebral Cavernous Malformation: An Analysis of Prospective Database Nazeem Arsalan, MD
05:30 PM - 06:30 PM EDT	Abstract	3-021 - A Case of Dural A-V Fistula with Bilateral Thalamic Hyper-intensity
05:30 PM - 06:30 PM EDT	Abstract	3-022 - Rapidly Progressive Cognitive Decline from a Dural AV Fistula Sarah Berth, MD
05:30 PM - 06:30 PM EDT	Abstract	3-023 - Clinical and Radiographic Features of Multiple Intracranial Arteriovenous Malformations Shannon Y. Chiu, MD, MSc
05:30 PM - 06:30 PM EDT	Abstract	3-024 - Is There Any Pivotal Association Between Smoking and Alpha-1 Antitrypsin Level and Function in Aneurysmal Subarachnoid Hemorrhage? Saeed Ansari, MD
05:30 PM - 06:30 PM EDT	Abstract	3-025 - Dynamic Cerebral Autoregulation and Personalized Blood Pressure Monitoring in Patients with Aneurysmal Subarachnoid Hemorrhage (aSAH)
05:30 PM - 06:30 PM EDT	Abstract	3-026 - Endovascular Therapy Versus Clipping For Aneurysmal Subarachnoid Hemorrhage, 2004-2014 Trends Anand Venkatraman, MBBS
05:30 PM - 06:30 PM EDT	Abstract	3-027 - Early Elevation of Plasma Lipocalin-2/NGAL is Associated with Poor Neurofunctional Outcome in Subarachnoid Hemorrhage Patients Fang Yu, Jr., MD
05:30 PM - 06:30 PM EDT	Abstract	3-028 - Novel explanation of angular remodeling in stent assisted coiling (SAC) of bifurcation aneurysms: Is it the stent or the coils? Ahmed Saied
05:30 PM - 06:30 PM EDT	Abstract	3-029 - Systematic Review of the Angiographic Evoluation of Neck Residual (Class II) Aneurysms Alberto Maud, MD
05:30 PM - 06:30 PM EDT	Abstract	3-030 - Impact of daughter vessel selection for stent deployment on the recanalization rates of bifurcation aneurysms treated with single stent-assisted coiling (SAC) Ahmed Saied
05:30 PM - 06:30 PM EDT	Abstract	3-031 - Location of Intracerebral Hemorrhage and Cause of Death in the Longitudinal Follow-up of ICH Survivors in ERICH (ERICH-L) Study Ian Bakk
05:30 PM - 06:30 PM EDT	Abstract	3-032 - Predictors and Associated Outcomes with Unanticipated Surgical Evacuation in Patients with Intracerebral Hemorrhage: Post Hoc Analysis of ATACH 2 Trial Hamza I. Maqsood, MD
05:30 PM - 06:30 PM EDT	Abstract	3-033 - In-hospital Mortality, Resource Utilization and 30-Day Readmission among Patients with Intracerebral Hemorrhage Transferred to Centers with Higher Level of Care
05:30 PM - 06:30 PM EDT	Abstract	3-034 - A cross sectional analytical study of cognitive impairment in survivors of spontaneous intracranial hemorrhage (ICH). Sankar P. Gorthi, MD, FAAN
05:30 PM - 06:30 PM EDT	Abstract	3-035 - Hypervitaminosis E and a-tocopherol levels in Intracranial Hemorrhagic Stroke Nicole K. Le
05:30 PM - 06:30 PM EDT	Abstract	3-036 - Unusual intracerebral hemorrhagic (ICH) stroke presentation: Tumor to tumor metastasis. Alexis Alvarado Arias, MD
05:30 PM - 06:30 PM EDT	Abstract	3-037 - Simultaneous Ischemic stroke and Intracerebral Hemorrhage due to Amyloid Angiopathy presenting as a Therapeutic Challenge Moein Amin, MD
05:30 PM - 06:30 PM EDT	Abstract	3-038 - A Case of Cerebral Amyloid Angiopathy Associated Primary Progressive Aphasia Juan Pablo Pauta Martinez, MD
05:30 PM - 06:30 PM EDT	Abstract	3-039 - Similarities and Differences in Intracerebral Hemorrhage Risk Factors by Race/Ethnicity Steven J. Kittner, MD, MPH
05:30 PM - 06:30 PM EDT	Abstract	3-040 - Mortality and Long Term Outcome after Spontaneous Intracerebral Hemorrhage
05:30 PM - 06:30 PM EDT	Abstract	3-041 - Primary Occipital Lobar Hemorrhages Associated with Lower 1 Year Mortality Rachel W. Pan, MD
05:30 PM - 06:30 PM EDT	Abstract	3-042 - Role of Anti-Platelets & Anti-coagulants in Intracerebral hemorrhage: Analysis of a Large National Database Sajid Suriya, MD
05:30 PM - 06:30 PM EDT	Abstract	3-043 - Hemoglobin A1c in Intracerebral Hemorrhage: A Cross-sectional Analysis of a Large National Database. Mudassir Farooqui, MD
05:30 PM - 06:30 PM EDT	Abstract	3-044 - A Unique Case of Cavum Veli Interpositum Hemorrhage in an Adult Kavneet Kaur, MD
05:30 PM - 06:30 PM EDT	Abstract	3-045 - Validation of ICH and ICH-GS scores in cohort of Indian patients with Intracerebral hemorrhage
05:30 PM - 06:30 PM EDT	Abstract	3-046 - Early Ischemic Changes on Serial CT Imaging in Acute Ischemic Stroke Alexandra L. Czap, MD
05:30 PM - 06:30 PM EDT	Abstract	3-047 - The Absence of Collaterals is Associated with Larger Infarct Volume and Worse Outcome Eric Kimmel, MD
05:30 PM - 06:30 PM EDT	Abstract	3-048 - To CTA or Not to CTA: Should We Continue to Order CT Angiography of Head and Neck in Patients with TIA? Ivo Bach, MD
05:30 PM - 06:30 PM EDT	Abstract	3-049 - Tissue Based Selection for Large Vessel Occlusion Thrombectomy Leads to Similar Functional Outcomes in Conventional (0-6 hours) and Extended (>6 hours) Window Chantal Bhan, DO
05:30 PM - 06:30 PM EDT	Abstract	3-050 - Underestimation of Ischemic Core on Perfusion CT in Patients with Acute Large Vessel Occlusion: Results from the BEST Prospective Cohort Study James E. Siegler III, MD
05:30 PM - 06:30 PM EDT	Abstract	3-051 - Computed Tomography Perfusion Imaging in Evaluation of Patients With Acute Stroke is Not Associated With Increased Risk of Acute Kidney Injury Kelsey Satkowiak, MD
05:30 PM - 06:30 PM EDT	Abstract	3-052 - Computed Tomography Perfusion provides clinically relevant core infarct for thrombectomy selection Hussam Shaker, MD
05:30 PM - 06:30 PM EDT	Abstract	3-053 - Clinical and imaging features of contrast induced neurotoxicity after cerebral angiography – Case series
05:30 PM - 06:30 PM EDT	Abstract	3-054 - Ischemic Stroke Subtyping, Based on Vascular Imaging: A University Hospital Based Study Mohammad Shahidullah, MD, MBBS
05:30 PM - 06:30 PM EDT	Abstract	3-055 - Focal Parietal Lobe Atrophy in Antiphospholipid Syndrome: Retrospective Analysis Ka-Ho Wong
05:30 PM - 06:30 PM EDT	Abstract	3-056 - Hazy DWI Restriction in Pons on Hyperacute MRI: DWI 'Smog Sign’ Asad Ikram, MD, MBBS
05:30 PM - 06:30 PM EDT	Abstract	3-057 - Cardiovascular and metabolic risk factors for the development of cerebral small vessel disease: Longitudinal FLAIR imaging in the Mayo Clinic Study of Aging Eugene L. Scharf, MD
05:30 PM - 06:30 PM EDT	Abstract	3-058 - Imaging of angiogenesis in white matter hyperintensities using simultaneous 68Ga-NOTA-PRGD2 PET/MRI Lingling Ding
05:30 PM - 06:30 PM EDT	Abstract	3-059 - Case Report: Sonographic demonstration of a perfusion dependent stroke with negative MRI and a flow limiting stenosis
05:30 PM - 06:30 PM EDT	Abstract	3-060 - Transcranial Doppler-detected Microembolic Signals as a Predictor of New Brain Ischemic Lesion after Elective Coronary Intervention Roman Herzig, MD, PhD
05:30 PM - 06:30 PM EDT	Abstract	3-061 - Subclinical peripheral arterial disease in patients with acute ischemic stroke; study with an ultrasonography
05:30 PM - 06:30 PM EDT	Abstract	3-062 - The Perplexing Texting of Dystextia – Whynn th Mesrage Indcates Thar Is A Probm Taylor R. Anderson, MD
05:30 PM - 06:30 PM EDT	Abstract	3-063 - Acute anterior thalamic infarcts affecting Memory and Cognition- an important but less well known lacunar syndrome Deepmala Nandanwar, MD
05:30 PM - 06:30 PM EDT	Abstract	3-064 - Lesion Topography and Its Correlation with Etiology in Medullary Infarction: Analysis from a Multi-Center Stroke Study in China Yuehui Hong
05:30 PM - 06:30 PM EDT	Abstract	3-065 - Bilateral Medial Medullary Syndrome with Atypical Clinical Presentation and Brain MRI Findings
05:30 PM - 06:30 PM EDT	Abstract	3-066 - Floating Heads: An Occi-dental Discovery of Bálint Syndrome Anirudha S. Rathnam, MD
05:30 PM - 06:30 PM EDT	Abstract	3-067 - Novel Neuroimaging Pattern In A Patient With Cerebral Autosomal Dominant Arteriopathy With Subcortical Infarcts And Leukoencephalopathy Rodica Elena Petrea, MD
05:30 PM - 06:30 PM EDT	Abstract	3-068 - Transient Smartphone Blindness: An Unusual Cause of Vision Loss in the 21st Century Matthew William Rondeau, PA
05:30 PM - 06:30 PM EDT	Abstract	3-069 - Non-invasive Longitudinal Assessment of Cerebrovascular Reactivity after TBI using functional Near Infrared Spectroscopy
05:30 PM - 06:30 PM EDT	Abstract	12-001 - A novel TTN deletion causes Autosomal Dominant Limb-Girdle Muscular Dystrophy with Dilated Cardiomyopathy Kelly Rich, MS, CGC
05:30 PM - 06:30 PM EDT	Abstract	12-002 - Relationships between DMD mutations and neurodevelopment in dystrophinopathy Mathula Thangarajh, MD, PhD, FAAN
05:30 PM - 06:30 PM EDT	Abstract	12-003 - NEO1 and NEO-EXT Studies: Long-Term Safety of Repeat Avalglucosidase Alfa Dosing for 4.5 Years in Patients With Late-Onset Pompe Disease Mazen M. Dimachkie, MD, FAAN
05:30 PM - 06:30 PM EDT	Abstract	12-004 - GNE Myopathy Biomarkers: Essential for Diagnosis and Response to Therapy May Christine Malicdan
05:30 PM - 06:30 PM EDT	Abstract	12-005 - The IPANEMA Study: Top Line Results from an Investigator-Initiated Multi-site Late-onset Pompe Disease Prevalence Study Marie Wencel, CCRP
05:30 PM - 06:30 PM EDT	Abstract	12-006 - A Novel Homozygous TNNT1 Missense Mutation in a French-Canadian Kindred Causing a Unique Clinical and Pathological Phenotype of Congenital Nemaline Myopathy with Rods, Cores and Lobulated Fibers David Pellerin, MD
05:30 PM - 06:30 PM EDT	Abstract	12-007 - GNE Myopathy in Turkey: Clinical Features and Novel Mutations Hacer Durmus, MD
05:30 PM - 06:30 PM EDT	Abstract	12-008 - Long-Term Efficacy of Dichlorphenamide for the Treatment of Primary Periodic Paralysis (PPP) Nicholas E. Johnson, MD, FAAN
05:30 PM - 06:30 PM EDT	Abstract	12-009 - A Survey of Patient-Identified Symptom Themes and Attitudes Toward Clinical Trials in Facioscapulohumeral Muscular Dystrophy (FSHD) David A. Shirilla, DO
05:30 PM - 06:30 PM EDT	Abstract	12-010 - A novel frameshift mutation in DNA2 causes early onset myopathy with velopharyngeal weakness and cardiac arrhythmias
05:30 PM - 06:30 PM EDT	Abstract	12-011 - Carotid Artery Dissection in a Young Woman with Ullrich Congenital Muscular Dystrophy Sarita Said-Said, MD, FAAN
05:30 PM - 06:30 PM EDT	Abstract	12-012 - The Potential Role of Estrogen in Moderating Symptom Severity in Women with RYR1-Related Myopathy Lydia Sharp, MD
05:30 PM - 06:30 PM EDT	Abstract	12-013 - TTR Knockdown Therapy in Patients with hATTR Amyloidosis Who Have Disease Progression despite Liver Transplant Orly Moshe-Lilie, MD
05:30 PM - 06:30 PM EDT	Abstract	12-014 - Lack of Genotype-Phenotype Correlation in Individuals with DMPK Expansions Amanda S. Lindy, PhD
05:30 PM - 06:30 PM EDT	Abstract	12-015 - mRna Expression Genes Associated To Myofibrillar Myopathies – Preliminary Study Alzira A. Carvalho, MD
05:30 PM - 06:30 PM EDT	Abstract	12-016 - Transition to Adulthood in Duchenne/Becker Muscular Dystrophy Jeffrey Statland, MD
05:30 PM - 06:30 PM EDT	Abstract	12-017 - A Novel Case of Overlapping of Myotonic Dystrophy Type 2 and Bethlem Congenital Muscular Dystrophy Mayur Chalia, MD
05:30 PM - 06:30 PM EDT	Abstract	12-018 - X-Linked Myotubular Myopathy and Fragile X Syndrome in a Female Patient Dustin J. Paul, DO
05:30 PM - 06:30 PM EDT	Abstract	12-019 - PYGM mRNA Expression In Patients With McArdle Disease: Demographic, Clinical, Genetic And Morphological Correlations.
05:30 PM - 06:30 PM EDT	Abstract	12-020 - Thyrotoxic Periodic Paralysis: An Unusual Presentation of Hyperthyroidism in a 20 year-old Male
05:30 PM - 06:30 PM EDT	Abstract	12-021 - A NOVEL COMPOUND HETEROZYGOUS MUTATION IN TITIN LEADS TO CORE MYOPATHY WITH HEART DISEASE Ryan Castoro, DO
05:30 PM - 06:30 PM EDT	Abstract	12-022 - Diagnostic Challenges of Congenital Myopathies in the Adult Neuromuscular Clinic Stefan Nicolau, MD
05:30 PM - 06:30 PM EDT	Abstract	12-023 - Incidence and Predictors of readmission in patients with Myasthenia Gravis: A National population-based cohort study (2010-14). Tejinder Singh, MD
05:30 PM - 06:30 PM EDT	Abstract	12-024 - LEMS with Anti-VGCC Antibodies and Dermatomyositis with Anti-TIF1-Gamma Antibodies: A Unique Case Study of Concomitant Autoimmune Neuromuscular Conditions without Malignancy Michael Isfort, MD
05:30 PM - 06:30 PM EDT	Abstract	12-025 - Response Rates in Placebo arm of MG Clinical Trials Srikanth Muppidi, MD, FAAN
05:30 PM - 06:30 PM EDT	Abstract	12-026 - Congenital Myasthenic Syndrome with A Novel Agrin Gene Mutation Gema E. Giler, MD
05:30 PM - 06:30 PM EDT	Abstract	12-027 - The Diagnostic Yield of Repetitive Nerve Stimulation in Seropositive vs. Seronegative Tingting Hua
05:30 PM - 06:30 PM EDT	Abstract	12-028 - Efficacy and limitations of cyclophosphamide in refractory myasthenia gravis
05:30 PM - 06:30 PM EDT	Abstract	12-029 - Assessment of disease severity in patients with Myasthenia Gravis – Clinical Phenotype and Immunological Correlation Butchi Raju Garuda, MD, FAAN
05:30 PM - 06:30 PM EDT	Abstract	12-030 - Are the choices of Therapeutic options for the Management of Myasthenia Gravis Crisis with acute respiratory failure-Influenced by the patient’s Age. A New York State Planning and Research Cooperation System Database Analysis (1998-2014) Shuja Sheikh, MD
05:30 PM - 06:30 PM EDT	Abstract	12-031 - A case of hepatocellular carcinoma presenting with myasthenia gravis Steven Fussner, MD
05:30 PM - 06:30 PM EDT	Abstract	12-032 - Myasthenia Gravis Mimicking Stroke - Implications of Cognitive Errors and Clinical Factors Natalie Kukulka, MD
05:30 PM - 06:30 PM EDT	Abstract	12-033 - High Prevelance Of Osteoporosis And Osteopenia In Adult Myasthenia Gravis Patients-A Pilot Study From An Academic Institution In Central Pennsylvania Nadia N. Bowling, MD
05:30 PM - 06:30 PM EDT	Abstract	12-034 - Comparison of Clinical and Laboratory Features of Myasthenia Gravis in Different Ethnic, Gender and Age groups. Shabnam Pakneshan, MD
05:30 PM - 06:30 PM EDT	Abstract	12-035 - Successful Rituximab Desensitization In Two Patients With Myasthenia Gravis Joome Suh, MD
05:30 PM - 06:30 PM EDT	Abstract	12-036 - Volumetric Analysis and Densitiy of Extraocular Muscles in patients with Myasthenia Gravis Alejandro Kohler
05:30 PM - 06:30 PM EDT	Abstract	12-037 - Burden of Disease in Patients with Refractory Myasthenia Gravis Aditi Sharma, MBBS
05:30 PM - 06:30 PM EDT	Abstract	12-038 - Nocebo In Myasthenia Gravis: A Systematic Review And Meta-Analysis Of Randomized Placebo-Controlled Trials Adithya Varma, MSc
05:30 PM - 06:30 PM EDT	Abstract	12-039 - Retrospective longitudinal assessment of MG-ADL score with treatment of myasthenia gravis Matthew Varon, MD
05:30 PM - 06:30 PM EDT	Abstract	12-040 - Clinical and demographic features of LRP4 positive myasthenia gravis patients Siva P. Pesala, MD
05:30 PM - 06:30 PM EDT	Abstract	12-041 - Elevated Antiganglioside Antibodies in a Case of Paraneoplastic Neuromuscular Junction Disorder Noushin Jazebi, MD
05:30 PM - 06:30 PM EDT	Abstract	6-001 - Long-term Safety and Efficacy of Add-on Cannabidiol (CBD) Treatment in Patients with Lennox Gastaut Syndrome in an Open-label Extension Trial (GWPCARE5) Anup D. Patel, MD, FAAN
05:30 PM - 06:30 PM EDT	Abstract	6-002 - Evaluation of Withdrawal Seizures During Conversion from Antiepileptic Drug Regimens Containing Carbamazepine to Eslicarbazepine Acetate Monotherapy
05:30 PM - 06:30 PM EDT	Abstract	6-003 - Adherence to AED treatment for patients with focal seizure receiving monotherapy with eslicarbazepine acetate or prior generation generics: Evidence from a large US commercial claims database Darshan Mehta
05:30 PM - 06:30 PM EDT	Abstract	6-004 - Adjunctive Perampanel in Pediatric Patients with Epilepsy: Population Pharmacokinetic (PK) and Exposure-Response Analyses
05:30 PM - 06:30 PM EDT	Abstract	6-005 - Long-Term Safety and Efficacy of Add-on Cannabidiol (CBD) Treatment in Patients with Dravet Syndrome in an Open-Label Extension Trial Jonathan J. Halford, MD, FAAN
05:30 PM - 06:30 PM EDT	Abstract	6-006 - Efficacy and Tolerability of Adjunctive Brivaracetam in Adults With Focal Seizures by Antiepileptic Drug Treatment History: Post Hoc Analysis Pavel Klein, MD, FAAN
05:30 PM - 06:30 PM EDT	Abstract	6-007 - The proposed multimodal mechanism of action of cannabidiol (CBD) in epilepsy: modulation of intracellular calcium and adenosine-mediated signaling Kathryn Nichol, PhD
05:30 PM - 06:30 PM EDT	Abstract	6-008 - Perampanel in Real-World Clinical Care of Patients with Epilepsy: Retrospective Phase IV Study 506 – Second Interim Analysis Robert T. Wechsler, MD, PhD, FAAN
05:30 PM - 06:30 PM EDT	Abstract	6-009 - Study 506 – Second Interim Analysis of a Retrospective, Phase IV Study of Perampanel in Real-World Clinical Care of Patients with Epilepsy: Pediatric Subgroup (Aged <12 Years) Katherine Moretz, MD
05:30 PM - 06:30 PM EDT	Abstract	6-010 - Comparative Neuropsychological Effects of Carbamazepine and Eslicarbazepine Acetate Kimford J. Meador, MD, FAAN
05:30 PM - 06:30 PM EDT	Abstract	6-011 - Time Course of Efficacy and Tolerability Outcomes With Adjunctive Brivaracetam in Adults: A Post Hoc Analysis Kimford J. Meador, MD, FAAN
05:30 PM - 06:30 PM EDT	Abstract	6-012 - Long-term Retention on Adjunctive Brivaracetam in Adults With Focal Seizures Previously Exposed to Carbamazepine, Lamotrigine, Levetiracetam, or Topiramate: A Post Hoc Analysis Steve Chung, MD, FAAN
05:30 PM - 06:30 PM EDT	Abstract	6-013 - Experience with Eslicarbazepine Acetate Treatment at a Pediatric Epilepsy Center Ahmet Tanritanir, MD
05:30 PM - 06:30 PM EDT	Abstract	6-014 - Inpatient Hospitalization Risk in Medicaid Patients with Epilepsy Before and After Perampanel Treatment
05:30 PM - 06:30 PM EDT	Abstract	6-015 - Efficacy and Tolerability of Switching from Traditional Sodium Channel Blockers to Lacosamide in Epilepsy Patients Wonshik Kim, MD
05:30 PM - 06:30 PM EDT	Abstract	6-016 - Analysis of Patient Characteristics and Outcomes by Prior AED use: Data from Pooled Observational Studies of Routine Perampanel use across Europe Eugen Trinka
05:30 PM - 06:30 PM EDT	Abstract	6-017 - Study 506 – Second Interim Analysis of a Retrospective, Phase IV Study of Perampanel in Real-World Clinical Care of Patients with Epilepsy: Adolescent Subgroup (Aged 12 to <18 Years) Eric Segal, MD
05:30 PM - 06:30 PM EDT	Abstract	6-018 - Aura as a Predictor of Outcome after Epilepsy Surgery Scott Grossman, MD
05:30 PM - 06:30 PM EDT	Abstract	6-019 - Long-term Outcomes in Patients with Intractable Mesial Temporal Lobe Epilepsy who Undergo Laser Ablation. Akta Patel, DO
05:30 PM - 06:30 PM EDT	Abstract	6-020 - Level Four Epilepsy Center Experience With Stereo-electroencephalography Irina Podkorytova
05:30 PM - 06:30 PM EDT	Abstract	6-021 - Altered resting-state network topology in drug-naïve idiopathic generalized epilepsy Jung Bin Kim, MD
05:30 PM - 06:30 PM EDT	Abstract	6-022 - Epilepsy MRI Interpretations Outside Of Comprehensive Epilepsy Centers Often Miss Epileptogenic Lesions Gloria Ortiz-Guerrero
05:30 PM - 06:30 PM EDT	Abstract	6-023 - Epilepsy Surgery Outcomes in the setting of Encephalitis: A Case Series Elizabeth Spurgeon, MD
05:30 PM - 06:30 PM EDT	Abstract	6-024 - Hospital Readmissions After an Epilepsy Related Surgical Intervention in the Nationwide Readmissions Database
05:30 PM - 06:30 PM EDT	Abstract	6-025 - Epilepsy Surgery Trends In the United States, 2009–2014
05:30 PM - 06:30 PM EDT	Abstract	6-026 - Contralateral hippocampal atrophy after temporal lobe surgery: volumetric analysis of preoperative and long-term postoperative MRI
05:30 PM - 06:30 PM EDT	Abstract	6-027 - The Pathogenesis and A Novel Surgical Approach to Treating Drug-Resistant Status Epilepticus Associated with Neurocysticercosis Christina Law, NP
05:30 PM - 06:30 PM EDT	Abstract	6-028 - VNS therapy vs. discontinuation of VNS therapy: Long-term seizure outcome Sonia Gill, MD
05:30 PM - 06:30 PM EDT	Abstract	6-029 - Patient selection and outcomes of placement of the Neuropace Responsive Neurostimulator for the treatment of intractable epilepsy: a single center experience Mark Agostini, MD
05:30 PM - 06:30 PM EDT	Abstract	6-030 - Effects of Low- Frequency Stimulation of Anterior Piriform Cortex on Memory in Epileptic Rats Arezou Bayat, MD
05:30 PM - 06:30 PM EDT	Abstract	6-031 - Evaluating an Online Tool to Determine Appropriateness for Epilepsy Surgery Evaluation in Brazil
05:30 PM - 06:30 PM EDT	Abstract	6-032 - Early Use of Vagal Nerve Stimulation (VNS) in a Patient with New Onset Refractory Status Epilepticus (NORSE) Bonnie Wong, MD, MPH
05:30 PM - 06:30 PM EDT	Abstract	6-033 - Combined Treatment of Bilateral Periventricular Nodular Heterotopia with Laser Ablation and Neuropace Leads Placement after Stereo-EEG Evaluation Irina Podkorytova
05:30 PM - 06:30 PM EDT	Abstract	6-034 - Stereoelectroencephalography following grids and strips: case series of six patients Melissa Crowder, MD
05:30 PM - 06:30 PM EDT	Abstract	7-001 - Swallowing outcomes and discharge destinations in acute-stroke tube-feeding-dependent dysphagia patients treated with neuromuscular-electrical-stimulation during inpatient rehabilitation David S. Kushner, MD, FAAN
05:30 PM - 06:30 PM EDT	Abstract	7-002 - Functional anomaly mapping using BOLD time-courses reveals local and distant dysfunction caused by stroke Andrew T. DeMarco, PhD, CCC-SLP
05:30 PM - 06:30 PM EDT	Abstract	7-003 - Causes of interruption of acute rehabilitation and readmission after stroke
05:30 PM - 06:30 PM EDT	Abstract	7-004 - The Relationship of Neurologic Impairments to Post-Stroke Fatigue in an Urban, Minority Population Tracey Yee
05:30 PM - 06:30 PM EDT	Abstract	7-005 - Repetitive Transcranial Magnetic Stimulation in Improving Lower Extremity Function and Gait Among Stroke Patients: A Meta-analysis Alexandria E. Matic, MD
05:30 PM - 06:30 PM EDT	Abstract	7-006 - A Pilot Study of Right Cerebellar tDCS as a Therapeutic Adjuvant in Chronic Aphasia after Left-Hemisphere Stroke Elizabeth Dvorak
05:30 PM - 06:30 PM EDT	Abstract	7-007 - Effect of Training Eye Hand Coordination Using Emerging Natural User Interface Technologies for Improving Hand Function in Stroke Survivors- A Randomized Controlled Study Nikhil Choudhary, PT
05:30 PM - 06:30 PM EDT	Abstract	7-008 - Action Observation Training Increases Dynamic Functional Connectivity in Patients with Multiple Sclerosis Claudio Cordani
05:30 PM - 06:30 PM EDT	Abstract	7-009 - Remotely Supervised Transcranial Direct Current Stimulation (RS-tDCS) Paired with a Hand Exercise Program to Improve Manual Dexterity in Progressive Multiple Sclerosis: A Randomized Sham Controlled Trial
05:30 PM - 06:30 PM EDT	Abstract	7-010 - Clinical and fMRI Effects of Action Observation and Motor Imagery Training on Dual-Task Performances in Parkinson’s Disease Patients With Postural Instability and Gait Disorders Elisabetta Sarasso
05:30 PM - 06:30 PM EDT	Abstract	7-011 - Interventional First-Person Video Game Training Reduces Fall Risk in Parkinson’s Disease by Improving Gait, Contrast Sensitivity, Visual Acuity and Cognition Sonia Koul
05:30 PM - 06:30 PM EDT	Abstract	7-012 - Motor Function of Individuals with HNRNPH2-related Disorders. Rachel Salazar, PT
05:30 PM - 06:30 PM EDT	Abstract	7-013 - A Mixed-Methods Evaluation of Neurorehabilitation Resources for Pediatric Cerebral Malaria Survivors in Blantyre, Malawi Alexandra Boubour
05:30 PM - 06:30 PM EDT	Abstract	7-014 - Restoration of Barnes maze, Protein Kinase M? and MAP2 by Minocycline plus N-Acetylcysteine when first dosed 72 hours after experimental traumatic brain injury Syed Rahman
05:30 PM - 06:30 PM EDT	Abstract	7-015 - The cofilin/Limk1 pathway controls the rate of regenerating motor axons Alexandra L. Da Silva
05:30 PM - 06:30 PM EDT	Abstract	7-016 - Activity monitoring in neuromuscular disease: Successes, challenges, and a path forward Linda P. Lowes, PT PhD
05:30 PM - 06:30 PM EDT	Abstract	7-017 - New treatments, now what: A pilot study investigating the use of in-home body-weight support harness systems to maximize the therapeutic benefit of novel treatments for spinal muscular atrophy. Megan Iammarino, PT
05:30 PM - 06:30 PM EDT	Abstract	7-018 - AbobotulinumtoxinA, onabotulinumtoxinA and incobotulinumtoxinA neurotoxin content and activity: Potential implications for duration of efficacy in patients
05:30 PM - 06:30 PM EDT	Abstract	7-019 - Burden of Spasticity Among Patients and Caregivers: Results of a Multinational Survey Atul T. Patel
05:30 PM - 06:30 PM EDT	Abstract	7-020 - Economic evaluation of abobotulinumtoxinA vs onabotulinumtoxinA in real-life clinical management of post-stroke upper limb spasticity
05:30 PM - 06:30 PM EDT	Abstract	7-021 - A study on Affordable Rehabilitation Care in Developing Countries with Use of Low Cost Technologies Sachin M. Kokane
05:30 PM - 06:30 PM EDT	Abstract	7-022 - One Hundred Years of Innovation: Automatic Detection of Brain Ventricular Volume using Deep Learning in a Large-Scale Multi-Institutional Study Michelle Han, MD
05:30 PM - 06:30 PM EDT	Abstract	7-023 - Abnormal DWI Signals of Spine in a Sporadic Adult-Onset Leukoencephalopathy with Axonal Spheroids and Pigmented Glia caused by a novel c.1907T>A. Mutation in CSF1R Shanglin Li, MD
05:30 PM - 06:30 PM EDT	Abstract	7-024 - Clinical and Radiographic Characterization of Synthetic Cannabinoid-induced Toxic Leukoencephalopathy Jordan Amar, MD
05:30 PM - 06:30 PM EDT	Abstract	7-025 - Cocaine Use Associated with Bilateral Globus Pallidus Changes; Similar to Carbon Monoxide intoxication. Muhammad Azeem, MD
05:30 PM - 06:30 PM EDT	Abstract	7-026 - Capecitabine Induced Leukoencephalopathy: Is there a correlation with liver metastases? Faisal A. Ibrahim, MD
05:30 PM - 06:30 PM EDT	Abstract	7-027 - Tacrolimus Induced Osmotic Demyelination in Patient with Liver Transplantation Juan Pablo Pauta Martinez, MD
05:30 PM - 06:30 PM EDT	Abstract	7-028 - Is Acute Immunodeficiency Syndrome (AIDS) a risk factor for Central Pontine Myelinolysis (CPM). Muhammad Waleed Zeb, MD, MBBS
05:30 PM - 06:30 PM EDT	Abstract	7-029 - Post-Mortem Neuroimaging in Amyotrophic Lateral Sclerosis Abdullah Ishaque
05:30 PM - 06:30 PM EDT	Abstract	7-030 - Evolution of Magnetic Resonance Signal Characteristics in Inferior Olivary Nuclei in Patients Presenting with Palatal Myoclonus Syndrome – Cases Neil Manering, MD
05:30 PM - 06:30 PM EDT	Abstract	7-031 - Magnetic Resonance Imaging-Based Evaluation of the Etiology of Non-traumatic Myelopathies in Bangladesh: A Hospital-based Observational Cross-sectional Study from Two Tertiary Care Centers of Dhaka. Abul K. Shoab, MD, FAAN
05:30 PM - 06:30 PM EDT	Abstract	7-032 - Diagnostic utility of hypoglossal canal MRI in uncovering an unusual cause of Isolated hypoglossal nerve palsy. Appaji Rayi, MD, FAAN
05:30 PM - 06:30 PM EDT	Abstract	7-033 - Chronic Vestibular Syndrome Associated with Anterior Inferior Cerebellar Artery loop into the Internal Acoustic Meatus Temitope A. Lawal, MD
05:30 PM - 06:30 PM EDT	Abstract	7-034 - Cerebral Venous Sinus Thrombosis Associated with Electroconvulsive Therapy Resulting in Dural Arteriovenous Fistula Mohammed Al-Dulaimi, MD
05:30 PM - 06:30 PM EDT	Abstract	7-035 - Clinical and radiographic mismatch in fat embolism syndrome in hemoglobin SC disease Shahla Moghbel, MD
05:30 PM - 06:30 PM EDT	Abstract	7-036 - Brainstem Posterior Reversible Encephalopathy Syndrome Paul Sanmartin, MD
05:30 PM - 06:30 PM EDT	Abstract	7-037 - Creutzfeldt-Jakob Disease Associated Longitudinally Extensive Transverse Myelitis; a Rare Presentation Accompanied By Rapid Disease Progression Zachary B. Jordan, MD
05:30 PM - 06:30 PM EDT	Abstract	7-038 - Novel Mutation in ACSL4 Gene Leading to X-linked Intellectual Disability, Autism and ADHD Siddharth Gupta, MD
05:30 PM - 06:30 PM EDT	Abstract	7-039 - Evaluation of Dystonia and Dystonic Posturing in a cohort of patients with autism spectrum disorder (ASD) Carly N. Ray, MD
05:30 PM - 06:30 PM EDT	Abstract	7-040 - Genetic test results for 523 patients with ASD/ID: The diagnostic yield of multigene analysis (Autism/ID Xpanded test) is higher than conventional first-tier tests, such as FMR1 repeat analysis and chromosomal microarray Anita Shanmugham, MS, MPH
05:30 PM - 06:30 PM EDT	Abstract	7-041 - "Tell me with whom you walk, and I will tell you who you are”: A Social Network Analysis of Adolescents with ADHD Renato Arruda, MD
05:30 PM - 06:30 PM EDT	Abstract	7-042 - Methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism status does not predict serum folate and B12 in children with Attention-Deficit/Hyperactivity Disorder (ADHD) Sarah N. Silverstein
05:30 PM - 06:30 PM EDT	Abstract	7-043 - Methylenetetrahydrofolate Reductase (MTHFR) C677T polymorphism and associated vitamin D levels in children with Attention-Deficit/Hyperactivity Disorder (ADHD) Sarah N. Silverstein
05:30 PM - 06:30 PM EDT	Abstract	7-044 - A Prospective Open-label Trial of Long-Acting Liquid Methylphenidate for the Treatment of Attention Deficit/Hyperactivity Disorder in Intellectually Capable Adults with Autism Spectrum Disorder
05:30 PM - 06:30 PM EDT	Abstract	7-045 - Disparities in the Diagnosis and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents - a Nationwide Study Marco A. Arruda, MD, PhD
05:30 PM - 06:30 PM EDT	Abstract	7-046 - Novel Research Initiatives for Early Recognition and Comprehensive Management of Autism Spectrum Disorder to Empower Health Professionals and Health Care Providers: Two Decade Experience from a Tertiary Care Centre in India
05:30 PM - 06:30 PM EDT	Abstract	7-047 - Health Care Transition and Longitudinal Care for Adolescents and Young Adults with Hydrocephalus Michael A. Williams, MD, FAAN
05:30 PM - 06:30 PM EDT	Abstract	7-048 - Assessing Effectiveness of an ��ɫ��al Intervention on Gaps in Child Neurology Knowledge for Pediatric Residents Anisa Kelley, MD
05:30 PM - 06:30 PM EDT	Abstract	7-049 - In Silico Predictions of KCNQ Channel Variant Pathogenicity in Epilepsy David Ritter, MD, PhD
05:30 PM - 06:30 PM EDT	Abstract	7-050 - Correlations between genetic, biochemical, and clinical characteristics in glucose transporter 1 deficiency syndrome: a single-center study. Shin Nabatame
05:30 PM - 06:30 PM EDT	Abstract	7-051 - Clinical Decision Support to Promote SUDEP Discussions Stephen Downs
05:30 PM - 06:30 PM EDT	Abstract	7-052 - Evolution of Dietary Therapies in Treatment of Childhood Drug Resistant Epilepsy: an overview of nine studies including six randomized controlled trials accomplished over last twelve years in a tertiary care teaching hospital in North India
05:30 PM - 06:30 PM EDT	Abstract	7-053 - Safety ��ɫ�� by Frontline Providers in Pediatric Patients with Suspected Seizures Daniel Freedman, DO
05:30 PM - 06:30 PM EDT	Abstract	7-054 - Late-onset Rasmussen encephalitis: Diagnosis Difficulty
05:30 PM - 06:30 PM EDT	Abstract	7-055 - Mesenchymal Stem/Stromal Cell Therapy during Pediatric Cardiac Surgery on Neurogenesis in the Porcine Subventricular Zone Nisha Kapani
05:30 PM - 06:30 PM EDT	Abstract	7-056 - Novel In Vivo Model of Prenatal Hypoxic Injury and Genetic Mitochondrial Hyposufficiency Ana G. Cristancho, MD, PhD
05:30 PM - 06:30 PM EDT	Abstract	7-057 - Estrogen receptor GPR30 is participated in the long-term adverse effect of neonatal dexamethasone treatment in female rats Keiko Lo
05:30 PM - 06:30 PM EDT	Abstract	7-058 - Sleep Disturbances in Pediatric Intracranial Hypertension Alexandra B. Kornbluh, MD
05:30 PM - 06:30 PM EDT	Abstract	7-059 - Neurocognitive outcomes and their Diffusion Tensor Imaging (DTI) correlates in children with Mild Traumatic Brain Injury (mTBI) Priyanka Madaan
05:30 PM - 06:30 PM EDT	Abstract	7-060 - Neurologic Sequelae of Infective Endocarditis in Children
05:30 PM - 06:30 PM EDT	Abstract	7-061 - Favorable Outcome in Children and Adults with PRES despite Clinical and Radiological Differences Richard S. Young, MD, FAAN
05:30 PM - 06:30 PM EDT	Abstract	7-062 - Fetal Pain: A Review of Available Evidence Meaghan Berns, MD
05:30 PM - 06:30 PM EDT	Abstract	7-063 - Psychogenic Gait Disorder Complicating Recovery after Concussion: A Case Series Scott I. Otallah, MD
05:30 PM - 06:30 PM EDT	Abstract	7-064 - Kernicterus in the 21st Century: Bilirubin-Induced Brain Injury Due to Glucose-6-Phosphate Dehydrogenase Deficiency Denise F. Chen
05:30 PM - 06:30 PM EDT	Abstract	7-065 - Caffeine Augments Anesthesia Neurotoxicity in the Fetal Macaque Brain
05:30 PM - 06:30 PM EDT	Abstract	7-066 - Strengthening knowledge when data are scarce: the role of social media after AFM. Riley Bove, MD, FAAN
05:30 PM - 06:30 PM EDT	Abstract	7-067 - A Case of Rapidly Progressive Juvenile-Onset Amyotrophic Lateral Sclerosis with a rare SOD1 genetic variant Alejandro J. De La Torre Ribadeneira, MD
05:30 PM - 06:30 PM EDT	Abstract	7-068 - Stiff Person Syndrome: An Elusive Diagnosis in a Pediatric Patient Gabriela Tuttrup, MD
05:30 PM - 06:30 PM EDT	Abstract	7-069 - Early onset congenital myopathies and LGMD phenotype investigated by muscle MRI in two trasportinopathy families
05:30 PM - 06:30 PM EDT	Abstract	7-070 - Juvenile Myasthenia Gravis: Evaluation of presentation and treatment outcomes in a large cohort Jason S. Gill, MD, PhD
05:30 PM - 06:30 PM EDT	Abstract	1-001 - Medial temporal lobe subfield volumes are spared in non-amnestic Alzheimer's disease Jeffrey S. Phillips, PhD
05:30 PM - 06:30 PM EDT	Abstract	1-002 - Synergistic neuropathology resulting from co-expression of TDP-43 and tau protein in vivo Alexander J. Moszczynski, MD, PhD
05:30 PM - 06:30 PM EDT	Abstract	1-003 - Predicting Clinical Course in Persons with Mild Cognitive Impairment using structural MRI. Ali Ezzati, MD
05:30 PM - 06:30 PM EDT	Abstract	1-004 - Preliminary neuropathological findings in porcine brains following hypobaric exposure Melissa Cook, MD
05:30 PM - 06:30 PM EDT	Abstract	1-005 - Connectomics in Brain Aging and Dementia
05:30 PM - 06:30 PM EDT	Abstract	1-006 - A Care Pathway for Post-Stroke Spatial Neglect: Initial Analysis of a Practice-Based Rehabilitation Research Network A. M. Barrett, MD, FAAN
05:30 PM - 06:30 PM EDT	Abstract	1-007 - Machine Learning of Quantified Volumetric MR Imaging for Diagnostic Delineation of Alzheimer’s Dementia and Mild Cognitive Impairment in the Alzheimer's Disease Neuroimaging Initiative Cyrus A. Raji, MD, PhD
05:30 PM - 06:30 PM EDT	Abstract	1-008 - Creutzfeldt-Jakob Disease (CJD) Presenting as Epilepsia Partialis Continua: An Uncommon Presentation Shadi Milani, DO
05:30 PM - 06:30 PM EDT	Abstract	1-009 - Young-onset Creutzfeldt-Jakob disease with neuropsychiatric presentation and prolonged disease course Roshan Dhanapalaratnam, MBBS
05:30 PM - 06:30 PM EDT	Abstract	1-010 - A case of Lymphomatosis Cerebri: a diagnostic challenge Sen Sheng, MD
05:30 PM - 06:30 PM EDT	Abstract	10-001 - Striatal Acetylcholine and Dopamine are Necessary for Motor Function in Parkinsonism Nigel S. Bamford, MD
05:30 PM - 06:30 PM EDT	Abstract	10-002 - L-Dopa-Induced Dyskinesias are Reduced by Propranolol in Parkinsonian Mice Nigel S. Bamford, MD
05:30 PM - 06:30 PM EDT	Abstract	10-003 - Glial alpha-synuclein induces a unique transcriptional program in vivo Abby L. Olsen, MD
05:30 PM - 06:30 PM EDT	Abstract	10-004 - Over Expression of PERK Suppresses the Neurodegenerative Phenotypes in PINK1 Mutant Flies by Enhancing Mitochondrial Function Ying Cui
05:30 PM - 06:30 PM EDT	Abstract	10-005 - A kinome-wide Drosophila RNAi screen identifies glial adenylate kinases as modifiers of neuronal alpha-synuclein toxicity Abby L. Olsen, MD
05:30 PM - 06:30 PM EDT	Abstract	10-006 - PBT434 Prevents a-synuclein Aggregation, Neuron Loss, Motor Dysfunction and Reduces Glial Cell Inclusions in a Transgenic Mouse Model of Multiple System Atrophy David T. Finkelstein, MD
05:30 PM - 06:30 PM EDT	Abstract	10-007 - Dopaminergic Grafts Prevent Risk Of Secondary Parkinsonism In Cocaine Self-administering Rats
05:30 PM - 06:30 PM EDT	Abstract	10-008 - Study of Yerba Mate (Ilex Paraguariensis) as a Neuroprotective Agent of Dopaminergic Neurons in an Animal Model of Parkinson's Disease
05:30 PM - 06:30 PM EDT	Abstract	10-009 - Exploring the role of the basal ganglia in the control and learning of motor sequences in mice Tori Riccelli
05:30 PM - 06:30 PM EDT	Abstract	10-010 - Progression of Parkinson’s Disease: A Longitudinal MRI Study of Functional Brain Connectome in a Large Cohort of Patients Massimo Filippi, MD, FAAN
05:30 PM - 06:30 PM EDT	Abstract	10-011 - Different Patterns of Brain Activity During Lower Limb Movements in Parkinson’s Disease Patients With and Without Freezing of Gait Noemi Piramide, MSc
05:30 PM - 06:30 PM EDT	Abstract	10-012 - Functional Network Connectivity Predicts Spreading of Cortical Atrophy in Parkinson’s Disease Federica Agosta
05:30 PM - 06:30 PM EDT	Abstract	10-013 - Dual-Task in Parkinson’s Disease: A Gait Analysis and Functional MRI Study Elisabetta Sarasso
05:30 PM - 06:30 PM EDT	Abstract	10-014 - Microstructure alterations in the midbrain of Parkinson’s patients: a multishell diffusion MRI study
05:30 PM - 06:30 PM EDT	Abstract	10-015 - Impaired midbrain networks connectivity underlies freezing of gait in Parkinson’s disease
05:30 PM - 06:30 PM EDT	Abstract	10-016 - Tracking Cortical Changes Throughout Cognitive Decline in Parkinson’s Disease: A Longitudinal MRI Study Elisa Canu
05:30 PM - 06:30 PM EDT	Abstract	10-017 - Relationships Between Substantia Nigra Resting State Functional Connectivity and Uric Acid in REM Sleep Behavior Disorder and Parkinson’s Disease Timothy M. Ellmore, PhD
05:30 PM - 06:30 PM EDT	Abstract	10-018 - Longitudinal Evolution of White Matter Damage in Parkinson’s Disease
05:30 PM - 06:30 PM EDT	Abstract	10-019 - Gray Matter Atrophy in Parkinson’s Disease and Freezing of Gait Assessed Using Surface-Based Algorithm Petr Kanovsky, PhD
05:30 PM - 06:30 PM EDT	Abstract	10-020 - EEG-fNIRS Combined Neuroimaging Study on PD patients performing UPDRS Motor Tasks
05:30 PM - 06:30 PM EDT	Abstract	10-021 - Initial Long-term Treatment with Rotigotine Maintains Striatal Dopamine Transporter Binding in De Novo Patients with Parkinson Disease Ken Ikeda, MD, PhD
05:30 PM - 06:30 PM EDT	Abstract	10-022 - Quantifying iron deposition within the substantia nigra of Parkinson's disease by quantitative susceptibility mapping Dongya Huang, MD
05:30 PM - 06:30 PM EDT	Abstract	10-023 - Barriers and Characteristics of Caregiving Preparedness in Parkinson’s disease: a qualitative approach Chinwe Nwadiogbu
05:30 PM - 06:30 PM EDT	Abstract	10-024 - What Bothers Parkinson Patients: Clinical Curation of their Verbatim Reports Lakshmi Arbatti, NLP
05:30 PM - 06:30 PM EDT	Abstract	10-025 - A Closer Look at the Unmet Needs, Research and Care Priorities for Women with Parkinson's Megan Feeney, MPH
05:30 PM - 06:30 PM EDT	Abstract	10-026 - SNCA G51D Missense Mutation Causing Juvenile Onset Parkinson’s Disease Christa S. Cooper, PA
05:30 PM - 06:30 PM EDT	Abstract	10-027 - Levodopa Responsiveness Subtypes of Freezing of Gait: Results Using a Levodopa Test Stewart A. Factor, DO, FAAN
05:30 PM - 06:30 PM EDT	Abstract	10-028 - Altered Dopamine Transmission in Peripheral Mononuclear Cells in Parkinson's Disease Leila Saadatpour, MD
05:30 PM - 06:30 PM EDT	Abstract	10-029 - Incidence and Predictors of 30 days readmission associated with Parkinson’s disease: 5-year National estimate (2010-2014) Tejinder Singh, MD
05:30 PM - 06:30 PM EDT	Abstract	10-030 - G2019S mutation and motor complications of levodopa in Parkinson disease
05:30 PM - 06:30 PM EDT	Abstract	10-031 - Changes in Prescribing Practices of Dopaminergic Medications in Individuals with Parkinson's Disease by Expert Care Centers From 2010 to 2017: The Parkinson's Foundation Quality Improvement Initiative (PF-QII) Ornella M. Dubaz, MD
05:30 PM - 06:30 PM EDT	Abstract	10-032 - Survival in Parkinson disease, the Trondheim cohort Eldbjorg Hustad, MD, PhD
05:30 PM - 06:30 PM EDT	Abstract	10-033 - Levodopa doses and improvement in LRRK2 G2019S carriers compared to non-carriers
05:30 PM - 06:30 PM EDT	Abstract	10-034 - Trend in PEG placement in Parkinson's disease compared to Alzheimer dementia and ALS Duk Soo Kim, DO
05:30 PM - 06:30 PM EDT	Abstract	10-035 - Endemic parkinsonism associated with the rare haplotype of LRRK2 gene Katerina Mensikova
05:30 PM - 06:30 PM EDT	Abstract	10-036 - Case-based Medical ��ɫ�� Improves Neurologists’ Competence in Diagnosing and Managing Levodopa-induced Dyskinesia
05:30 PM - 06:30 PM EDT	Abstract	10-037 - Risk Factors in Essential Tremors for the Development of Parkinson’s Disease vs Parkinsonism Hsien Lee Lau, MD
05:30 PM - 06:30 PM EDT	Abstract	10-038 - Oral cavity disorders in Parkinson’s disease: more than meets the eye
05:30 PM - 06:30 PM EDT	Abstract	10-039 - MANAGE-PD: A clinician-reported tool to identify patients with Parkinson's Disease inadequately controlled on oral medications – Results from vignette-based validation Angelo Antonini, MD
05:30 PM - 06:30 PM EDT	Abstract	10-040 - Comorbidity and Polypharmacy in Parkinson's disease: comparative study with control group. Results from the COPPADIS Study Cohort. Asuncion Avila-Rivera, MD
05:30 PM - 06:30 PM EDT	Abstract	10-041 - Molecular and Genetic Characterization of Parkinson’s Disease: A Center-Wide Approach. Thomas F. Tropea, DO
05:30 PM - 06:30 PM EDT	Abstract	10-042 - Novel Assistive Dress Shoe & Footwear Needs Analysis for Patients with Parkinson's Disease Jamasb Sayadi
05:30 PM - 06:30 PM EDT	Abstract	10-043 - Parkinsonian patients experiences operating the computer with their eyes: the MAMEM project. Sevasti Bostantjopoulou-Kambouroglou, MD
05:30 PM - 06:30 PM EDT	Abstract	10-044 - Jumping as a Strategy to Overcome Freezing of Gait while Turning in Parkinson’s Disease Karlo J. Lizarraga, MD, MS, FAAN
05:30 PM - 06:30 PM EDT	Abstract	10-045 - Non-invasive Assessment of Dysphagia in Degenerative Disorder (Parkinson’s Disease)
05:30 PM - 06:30 PM EDT	Abstract	10-046 - Vitamin D Assessment in Veterans with Parkinson’s Disease Fariha Jamal
05:30 PM - 06:30 PM EDT	Abstract	10-047 - Impact of Parkinson’s Disease on Faith and Spirituality - a Comparative Study Dawit K. Worku, MD
05:30 PM - 06:30 PM EDT	Abstract	10-048 - Prevalence and clinical correlates of metabolic syndrome in patients with Parkinson’s disease.
05:30 PM - 06:30 PM EDT	Abstract	10-049 - Sporadic Parkinson's Disease and Amyotrophic Lateral Sclerosis: A New Syndrome? Sushant Puri, MBBS
05:30 PM - 06:30 PM EDT	Abstract	10-050 - Exploring the Experience of Wearing Off in Parkinson’s Disease: A Qualitative Research Approach Lana Chahine, MD, FAAN
05:30 PM - 06:30 PM EDT	Abstract	4-001 - Utility of whole body 18-FDG-PET in management of Tuberculous Meningitis: A preliminary study from a tertiary care institute of North India Manish Modi, MD
05:30 PM - 06:30 PM EDT	Abstract	4-002 - Prophylactic Palmitoylethanolamide Prolongs Survival and Decreases detrimental Inflammation in Aged Mice with Bacterial Meningitis
05:30 PM - 06:30 PM EDT	Abstract	4-003 - Nontraumatic Spontaneous Pneumocephalus in Clostridium Septicum Central Nervous System Infection – A Case Report Amputch Karukote, MD
05:30 PM - 06:30 PM EDT	Abstract	4-004 - Acute Disseminated Streptococcus Anginosus Abscesses in a Young Immunocompetent Patient Jane Khalife, MD
05:30 PM - 06:30 PM EDT	Abstract	4-005 - Listeria meningoencephalitis in an immunocompetent child Surabhi Kaul, MD
05:30 PM - 06:30 PM EDT	Abstract	4-006 - Late-Onset Austrian Syndrome in a Patient with Bacterial Meningitis Sara Shapouran, MD
05:30 PM - 06:30 PM EDT	Abstract	4-007 - Read Between the Lyme's: Case Series of Bannwarth Syndrome Phong T. Vu, MD
05:30 PM - 06:30 PM EDT	Abstract	4-008 - Microvessel Cerebral Vasculitis and Peripheral Neuropathy as Neurologic Manifestations in Rocky Mountain Spotted Fever Laura Danielson, MD
05:30 PM - 06:30 PM EDT	Abstract	4-009 - Eisenmenger Syndrome presenting as Focal Seizures Stephen W. English, MD
05:30 PM - 06:30 PM EDT	Abstract	4-010 - A Rare Case of Mucormycosis Clivus Osteomyelitis Presenting With Stroke-Like Symptoms Jessie Jacobson, DO
05:30 PM - 06:30 PM EDT	Abstract	4-011 - Cryptococcus Strikes Again: Recurrent Cryptococcal Meningitis in an Immunocompetent Host Catherine McDermott
05:30 PM - 06:30 PM EDT	Abstract	4-012 - Comparison of Lumbar and Ventricular Cerebrospinal Fluid for Diagnosis and Monitoring of Meningitis Bhavika Kakadia, DO
05:30 PM - 06:30 PM EDT	Abstract	4-013 - Acute Chorea associated with Group C Streptococcus Pharyngitis Maryamnaz Zaribaf, MD
05:30 PM - 06:30 PM EDT	Abstract	4-014 - A Case of Neurobrucellosis in a non-endemic area Yuri Bronstein, MD
05:30 PM - 06:30 PM EDT	Abstract	4-015 - Immunomodulating Biologics and sCJD Paula K. Lee, MD
05:30 PM - 06:30 PM EDT	Abstract	4-016 - Lyme Neuroborreliosis Initially Presenting as a Cavernous Sinus Syndrome: A Case Report Hannah N. Rinehardt
05:30 PM - 06:30 PM EDT	Abstract	4-017 - Bartonella Papillitis Mimicking Anti-MOG Optic Neuritis Peter Sguigna, MD
05:30 PM - 06:30 PM EDT	Abstract	4-018 - Diagnostic Challenge: Sporadic Creutzfeldt-Jakob Disease (sCJD) Presenting with Isolated Visual Symptoms Adeolu O. Morawo, MD
05:30 PM - 06:30 PM EDT	Abstract	4-019 - Sarcoidosis to Nocardiosis: An odyssey of doubt and agony Amit S. Singh, MD
05:30 PM - 06:30 PM EDT	Abstract	4-020 - Carbon Monoxide exposure, a red herring in a patient with rapidly progressive dementia, later diagnosed with Creutzfeldt-Jakob disease Haoming Pang, MD
05:30 PM - 06:30 PM EDT	Abstract	4-021 - Aortic Fungus Ball – An Unusual Cause of Paraplegia Prashant Natteru, MBBS
05:30 PM - 06:30 PM EDT	Abstract	4-022 - Leprosy presenting as orofacial pain: case report. Philippe J. Macedo, MD
05:30 PM - 06:30 PM EDT	Abstract	4-023 - The Mysterious Mold: A Case of Coccidioides Meningitis Diana E. Slawski, MD
05:30 PM - 06:30 PM EDT	Abstract	4-024 - Unilateral Periorbital and Facial Swelling with Multiple Unilateral Cranial Nerve Deficits in an Uncontrolled Diabetic Frank Dicken
05:30 PM - 06:30 PM EDT	Abstract	4-025 - Community-acquired Klebsiella pneumoniae meningitis. Questioning the demographic paradigm with new recommendations for diagnosis and effective treatment Nara Michaelson, MD
05:30 PM - 06:30 PM EDT	Abstract	4-026 - Pituitary Apoplexy Mimicking Meningoencephalitis: A Case Report and Literature Review Chun Chu, MD, PhD
05:30 PM - 06:30 PM EDT	Abstract	4-027 - Suboxone abuse with shared needle as a cause of Botulism in an IV drug user Shuvro Roy, MD
05:30 PM - 06:30 PM EDT	Abstract	4-028 - Lyme disease presenting as multiple small cerebral infarcts of undetermined source. Arthur Alcantara Lima, MD
05:30 PM - 06:30 PM EDT	Abstract	4-029 - Sudden Death from Rupture of Cerebral Abscess into Subarachnoid Space Courtney Curran, MD
05:30 PM - 06:30 PM EDT	Abstract	4-030 - Paradoxical reaction in non-HIV patients with CNS tuberculosis: what, when and how? Rogelio Dominguez-Moreno, MD
05:30 PM - 06:30 PM EDT	Abstract	4-031 - Intramedullary spinal neurocysticercosis Jacob Manske, MD
05:30 PM - 06:30 PM EDT	Abstract	4-032 - Neurocysticercosis in Qatar Yanal R. Shaheen, MD
05:30 PM - 06:30 PM EDT	Abstract	4-033 - Brain eating Balamuthia amoebic infection – A Case Report Varalakshmi Ballur Narayana Reddy, MD
05:30 PM - 06:30 PM EDT	Abstract	4-034 - Spinal Schistosomiasis masquerading as an Intramedullary Astrocytoma Alexandra Kvernland, MD
05:30 PM - 06:30 PM EDT	Abstract	4-035 - MRI findings and evolution of active or calcified cysts in treated and untreated patients with neurocysticercosis
05:30 PM - 06:30 PM EDT	Abstract	4-036 - Neurotoxoplasmosis in Immunocompetent Patients Mimicking Lymphoproliferative Disease Karlla Danielle Ferreira Lima
05:30 PM - 06:30 PM EDT	Abstract	4-037 - New Diagnosed Active Neurocysticercosis: Serial Image Findings and Corresponding Clinical Manifestations Asfi Rafiuddin, MD
05:30 PM - 06:30 PM EDT	Abstract	4-038 - An Unusual Radiographic Feature of Toxoplasma Encephalitis in Renal Transplant Recipient Paulus Sugianto, MD, FAAN
05:30 PM - 06:30 PM EDT	Abstract	4-039 - Validation of the original FRESH score in patients with subarachnoid hemorrhage Jens Witsch, MD
05:30 PM - 06:30 PM EDT	Abstract	4-040 - Role of Systemic Inflammatory Response Syndrome (SIRS) in Subarachnoid Hemorrhage (SAH) Outcome Yash K. Pandya
05:30 PM - 06:30 PM EDT	Abstract	4-041 - Early uptrending white blood cell count can be a predictor of poor outcome in patients with aneurysmal subarachnoid hemorrhage Aidan Azher, MD
05:30 PM - 06:30 PM EDT	Abstract	4-042 - Variability In Reported Physician Practices For Brain Death Determination Sherri A. Braksick, MD, FAAN
05:30 PM - 06:30 PM EDT	Abstract	4-043 - Prediction of QTc interval prolongation using aneurysm location and bleeding pattern in aneurysmal subarachnoid hemorrhage. Jay Kinariwala, MD
05:30 PM - 06:30 PM EDT	Abstract	4-044 - Radiological Severity Determines Glycemic Burden In Aneurysmal Subarachnoid Hemorrhage And Patient Outcome Syeda Dania Shujaat, MD, MBBS
05:30 PM - 06:30 PM EDT	Abstract	4-045 - Predictors of 30-day readmissions and in-hospital mortality amongst patients admitted with aneurysmal subarachnoid hemorrhage-Insights from National Database Sukriye Damla Kara, MD
05:30 PM - 06:30 PM EDT	Abstract	4-046 - Decreased Odds for Vasospasm Treatment in Patients with Aneurysmal Subarachnoid Hemorrhage After Transitioning from Neurosurgery-Led Care to a Neurology-Led Multidisciplinary Approach Russell E. Bartt, MD, FAAN
05:30 PM - 06:30 PM EDT	Abstract	4-047 - Role of Glycemic Burden and Glycemic Burden Variability in Determination of Temporary and Permanent Cerebrospinal Fluid diversion after Aneurysmal Subarachnoid Hemorrhage Syeda Maria Muzammil, MD
05:30 PM - 06:30 PM EDT	Abstract	4-048 - Lactococcus garvieae endocarditis with an initial presentation of subarachnoid hemorrhage Abinayaa Purushothaman Ravichandran, MBBS
05:30 PM - 06:30 PM EDT	Abstract	4-049 - Epidemiological Factors Influencing Organ Donation Following Brain Death Christopher Green, MD
05:30 PM - 06:30 PM EDT	Abstract	4-050 - Two Cases of Fulminant Acute Motor and Sensory Axonal Neuropathy Mimicking Brain Death Shashika Rodrigo, MD
05:30 PM - 06:30 PM EDT	Abstract	4-051 - Bobbing-Like Ocular Movements in a Patient with Brain Death Julie McDaniel, MD
05:30 PM - 06:30 PM EDT	Abstract	4-052 - End of Life Preferences: Medical Students’ Attitudes Toward Life Support Charlotte Zhong, DO
05:30 PM - 06:30 PM EDT	Abstract	4-053 - Outcomes in Neurologically Critically Ill Patients with Fixed Dilated Pupils: A Retrospective Cohort Study Alana Kornspun, MD
05:30 PM - 06:30 PM EDT	Abstract	4-054 - The Successful Implementation of a TBI Brain Donation Pathway Erika Silverman
05:30 PM - 06:30 PM EDT	Abstract	4-055 - Characterization of acute traumatic cerebral venous sinus thrombosis Daniel Schwartz
05:30 PM - 06:30 PM EDT	Abstract	4-056 - Implementation of Attending-Supervised IPASS Handoffs in the Neuro-ICU Laura Scholtz, MD
05:30 PM - 06:30 PM EDT	Abstract	4-057 - Utility of Digital Ophthalmoscope in Neurology Residency Jennifer Chima, MD
05:30 PM - 06:30 PM EDT	Abstract	4-058 - Does Non-automated Phone Call Notification Improve No-Show Rates in Neurology Resident Clinic? Abdullah Alshammaa, MD
05:30 PM - 06:30 PM EDT	Abstract	4-059 - Gender disparities in course speakers at the AAN Annual Meeting Morgan Figurelle, MD
05:30 PM - 06:30 PM EDT	Abstract	4-060 - Perception of Futile Provision of Care among Clinicians in the Neurointensive Care Unit Julio A. Chalela, MD
05:30 PM - 06:30 PM EDT	Abstract	4-061 - Impact of doing Echocardiogram and Brain Magnetic Resonance Imaging on Length of Stay and Hospital Charges in Transient Ischemic Attack Patients in United States: Analysis of Nationwide Inpatient Sample 2006-2014 Harathi Bandaru, MD
05:30 PM - 06:30 PM EDT	Abstract	4-062 - Regional Variation in Medicare Part D Drug Spending Amongst Neurologists Adam De Havenon, MD, FAAN
05:30 PM - 06:30 PM EDT	Abstract	4-063 - AAN Axon Registry: Limitation and Barriers to Optimal Participation and Performance at an Academic center Neeta Garg, MD
05:30 PM - 06:30 PM EDT	Abstract	4-064 - A Survey of Attitudes Towards Genetic Testing in Amyotrophic Lateral Sclerosis (ALS) Changrui Xiao, MD
05:30 PM - 06:30 PM EDT	Abstract	4-065 - Use of a Philadelphia Specific Spanish Toolkit in the neurology outpatient clinic in Temple University Hospital Mercedes P. Jacobson, MD
05:30 PM - 06:30 PM EDT	Abstract	4-067 - Transition of Care from Child to Adult Neurologists: Implementation and Financial Strategies for Child and Adult Neurologists Bruce H. Cohen, MD, FAAN
05:30 PM - 06:30 PM EDT	Abstract	4-068 - Challenges with the use of Prehospital Stroke Scales for early identification of Large Vessel Occlusion Strokes. Rahul H. Rahangdale, MD
05:30 PM - 06:30 PM EDT	Abstract	4-069 - Establishing a resident-led lumbar puncture clinic to improve resident satisfaction and skills during neurology residency Elie Sader, MD
05:30 PM - 06:30 PM EDT	Abstract	4-070 - Contribution towards Public Health Awareness Activities and Continuing Medical education for Empowering Health Care Professionals on Childhood Neurodevelopmental Disorders: Experience of a Tertiary Care Teaching Hospital in North India over the last decade-Going E-way
05:30 PM - 06:30 PM EDT	Abstract	4-071 - Perceptions of Preventive Stroke Care Received by Women in Different Primary Care Settings Caroline Atlas
05:30 PM - 06:30 PM EDT	Abstract	4-072 - Strategies to Decrease Post Hospital Discharge Negative Outcomes for Patients with Neurological Diseases. Erin Smith, MD
05:30 PM - 06:30 PM EDT	Abstract	4-073 - Quality Improvement in Laboratory Analysis of Paraneoplastic Panels Nikesh Bajaj, DO
05:30 PM - 06:30 PM EDT	Abstract	4-074 - Improving Patient Return to Residency Clinic using a Patient Portal: A Residency Quality Improvement Project Christina Catherine, MD
05:30 PM - 06:30 PM EDT	Abstract	4-075 - Evaluation of the Duke Neurology Advanced Practice Provider Training Program Joel C. Morgenlander, MD, FAAN
05:30 PM - 06:30 PM EDT	Abstract	4-076 - Effects of a novel practice model on medical team burnout in an academic neurology practice Drew S. Kern, MD, FAAN
05:30 PM - 06:30 PM EDT	Abstract	4-077 - Improving neurologists’ adherence to guidelines on prevention of possible complications of systemic corticosteroid therapy Verena C. Samara, MD
05:30 PM - 06:30 PM EDT	Abstract	4-078 - First Year Experience at SAC Health System, the First Federally Qualified Health Center (FQHC) Based Neurology Clinics Nancy Baker, MD
05:30 PM - 06:30 PM EDT	Abstract	13-001 - Undertreatment of Patients with Cluster Headache Anusha Mannava, MD
05:30 PM - 06:30 PM EDT	Abstract	13-002 - Acute Headache Diagnosis in the Emergency Department: Accuracy and Safety of an Artificial Intelligence System Julian Acosta, MD
05:30 PM - 06:30 PM EDT	Abstract	13-003 - Use of Traditional Medicine for Primary Headache Disorders in Kuwait. Fatemah Alshawaf, MD
05:30 PM - 06:30 PM EDT	Abstract	13-004 - Filling the Gap: CSF Fistula as a Presentation of Intracranial Hypertension Aimee Szewka, MD, FAAN
05:30 PM - 06:30 PM EDT	Abstract	13-005 - An Interdisciplinary Approach Between Neurology and Neurosurgery for the Treatment of Headaches in the Setting of Aqueductal Stenosis Virginia Baker, MD
05:30 PM - 06:30 PM EDT	Abstract	13-006 - Severity of Post-traumatic Headache in relation to Severity of TBI, PTSD and severe depression in Veterans of recent wars James R. Couch, Jr., MD, PhD, FAAN
05:30 PM - 06:30 PM EDT	Abstract	13-007 - One and Done: A Case Series of Large Volume Occipital Nerve Blocks for the Treatment of Occipital Neuralgia Paul G. Mathew, MD, DNBPAS, FAHS, FACSM, FAAN
05:30 PM - 06:30 PM EDT	Abstract	13-008 - Syndrome of Transient Headache and Neurological Deficits with Cerebrospinal Fluid Lymphocytosis (HaNDL): A Case Report with Newly Described Electroencephalography (EEG) findings, Symptomatic Treatment Strategies, and Literature Review Sam Hooshmand, DO
05:30 PM - 06:30 PM EDT	Abstract	13-009 - Quality of life in patients with cluster headache during the active periods Soo-Kyoung Kim
05:30 PM - 06:30 PM EDT	Abstract	13-010 - A Tale of two headaches – Use of Dynamic CT Myelogram to Localize Cerebrospinal Fluid Leak Jeffrey B. Schachter, MD
05:30 PM - 06:30 PM EDT	Abstract	13-011 - Features of episodic cluster headache in the real world setting: clinical characteristics from a large, multi-national, cross-sectional survey James Martinez
05:30 PM - 06:30 PM EDT	Abstract	13-012 - Trend of Cluster Headache Hospitalizations and their Associated Outcomes, a National Four Year Retrospective Review. Matthew Chung, MD
05:30 PM - 06:30 PM EDT	Abstract	13-013 - Intravenous Fosphenytoin as Rescue Treatment in Trigeminal Neuralgia Crisis
05:30 PM - 06:30 PM EDT	Abstract	13-014 - Assessment and Management of Patients with Headache Referred to a General Neurology Consultation Service Conor Fearon, MD
05:30 PM - 06:30 PM EDT	Abstract	13-015 - Acute and preventive treatment patterns in episodic cluster headache: findings from the United States, United Kingdom and Germany Russell Nichols
05:30 PM - 06:30 PM EDT	Abstract	13-016 - Idiopathic Orbital Inflammation Presenting as Hemicrania Continua Jaclyn Duvall, MD
05:30 PM - 06:30 PM EDT	Abstract	13-017 - Predictors of 30-Day Readmission Post Index Hospitalization for Cluster Headache: 5 Years National Estimate Grace Kim
05:30 PM - 06:30 PM EDT	Abstract	13-018 - Accuracy of Pre-Headache Clinic SUNCT Diagnosis: A Cautionary Tale Jennifer Wax, MD
05:30 PM - 06:30 PM EDT	Abstract	13-019 - Healthcare resource use and humanistic burden associated with attack frequency in episodic cluster headache J S. Andrews
05:30 PM - 06:30 PM EDT	Abstract	13-020 - Medical Cannabis Treatment in Patients with Trigeminal Neuralgia Laszlo Mechtler, MD, FEAN, FASN, FAHS, FAAN
05:30 PM - 06:30 PM EDT	Abstract	13-021 - Persistent Neurological Deficits in a Patient with Hemiplegic Migraine Revealing Diffuse Astrocytoma Aarushi Suneja, MD
05:30 PM - 06:30 PM EDT	Abstract	13-022 - Hypnic Headache: Characteristics and Treatment Modalities in An Academic Headache Center Jennifer Wax, MD
05:30 PM - 06:30 PM EDT	Abstract	13-023 - Sex-induced Headache Associated with Moyamoya Angiopathy: A Case Story and Literature Review ShuTing Chen
05:30 PM - 06:30 PM EDT	Abstract	13-024 - Diagnostic Delay in Patients Prior to Being Seen in Headache Clinic
05:30 PM - 06:30 PM EDT	Abstract	13-025 - One-Month Feasibility of Progressive Muscle Relaxation (PMR) via Smartphone Application for Post Traumatic Headache (PTH) Patients Saima Usmani, MD
05:30 PM - 06:30 PM EDT	Abstract	13-026 - Marijuana Use In Headache In a University–Based Headache Clinic Melissa Schorn, ARNP, DNP
05:30 PM - 06:30 PM EDT	Abstract	13-027 - A Survey Comparing Neurology and Internal Medicine Residents’ Approaches to Headache Management Vanessa Cooper, MD
05:30 PM - 06:30 PM EDT	Abstract	13-028 - Undertreatment of Headache Associated with Sexual Activity Ami Cuneo, MD

Faculty Disclosures
Daniel Kaufer, MD, FAAN	No disclosure on file
Jonathan L. Carter, MD	Dr. Carter has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck Pharmaceuticals A/S. The institution of Dr. Carter has received research support from MedDay Pharmaceuticals . The institution of Dr. Carter has received research support from Roche Pharmaceuticals.
Jennifer G. Goldman, MD, MS, FAAN	Dr. Goldman has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for Parkinson's Foundation Scientific Advisory Board. The institution of Dr. Goldman has received research support from Michael J. Fox Foundation. The institution of Dr. Goldman has received research support from Parkinson's Foundation.
Patrick Landazuri, MD, FAAN	Dr. Landazuri has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neuropace. Dr. Landazuri has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neuropace. Dr. Landazuri has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Federal Public Defender - District of Kansas. Dr. Landazuri has received publishing royalties from a publication relating to health care.
Amy K. Guzik, MD, FAAN	Dr. Guzik has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Local law firms, available by request.
Drew S. Kern, MD, FAAN	Dr. Kern has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medtronic. The institution of Dr. Kern has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Boston Scientific. The institution of Dr. Kern has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Kern has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbott. The institution of Dr. Kern has received research support from Boston Scientific. The institution of Dr. Kern has received research support from AbbVie Pharmaceticals. Dr. Kern has received research support from Medtronic.
Sven G. Meuth	Sven G. Meuth has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Merck. Sven G. Meuth has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Sven G. Meuth has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Almirall. Sven G. Meuth has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Celgene. Sven G. Meuth has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genzyme. Sven G. Meuth has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Sven G. Meuth has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TEVA. Sven G. Meuth has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche.
Bassem I. Yamout, MD, FAAN	Dr. Yamout has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Yamout has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Yamout has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Yamout has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Yamout has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi.
Christian Brandt, MD	Dr. Brandt has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Idorsia. Dr. Brandt has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for GW. Dr. Brandt has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Desitin. Dr. Brandt has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Arvelle. Dr. Brandt has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for UCB. Dr. Brandt has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Eisai. Dr. Brandt has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Zogenix. Dr. Brandt has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for GW. Dr. Brandt has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Arvelle. The institution of Dr. Brandt has received research support from Rubin-Stiftung. Dr. Brandt has received publishing royalties from a publication relating to health care.
	No disclosure on file
Ima M. Ebong, MD, FAAN	The institution of Dr. Ebong has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. The institution of Dr. Ebong has received research support from Ad Scientiam.
Silvia Basaia	Silvia Basaia has nothing to disclose.
Walter Kremers	The institution of Walter Kremers has received research support from NIH. The institution of an immediate family member of Walter Kremers has received research support from NIH.
Ingrid E. Scheffer, MBBS, PhD, FRACP, AO	Dr. Scheffer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biohaven Pharmaceuticals, Inc. Dr. Scheffer has received personal compensation in the range of $0-$499 for serving as a Consultant for Longboard Pharmaceuticals . Dr. Scheffer has received personal compensation in the range of $0-$499 for serving as a Consultant for UCB. Dr. Scheffer has received personal compensation in the range of $0-$499 for serving as a Consultant for Biocodex. Dr. Scheffer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bellberry Ltd. The institution of Dr. Scheffer has received research support from National Health and Medical Research Council, Australia. The institution of Dr. Scheffer has received research support from National Health and Medical Research Council, Australia. The institution of Dr. Scheffer has received research support from National Health and Medical Research Council, Australia. The institution of Dr. Scheffer has received research support from Medical Research Future Fund, Australia. The institution of Dr. Scheffer has received research support from Medical Research Future Fund, Australia. The institution of Dr. Scheffer has received research support from Medical Research Future Fund, Australia. The institution of Dr. Scheffer has received research support from Medical Research Future Fund, Australia. The institution of Dr. Scheffer has received research support from Medical Research Future Fund, Australia. The institution of Dr. Scheffer has received research support from Einstein Visiting Fellowship. The institution of Dr. Scheffer has received research support from National Health and Medical Research Council, Australia. Dr. Scheffer has received intellectual property interests from a discovery or technology relating to health care. Dr. Scheffer has received intellectual property interests from a discovery or technology relating to health care. Dr. Scheffer has received intellectual property interests from a discovery or technology relating to health care. Dr. Scheffer has received personal compensation in the range of $0-$499 for serving as a Speaker honoraria with Akumentis. Dr. Scheffer has received personal compensation in the range of $0-$499 for serving as a Speaker honoraria with Biocodex. Dr. Scheffer has received personal compensation in the range of $0-$499 for serving as a Speaker honoraria with Chiesi . Dr. Scheffer has received personal compensation in the range of $0-$499 for serving as a Travel/Conference/Speaker honoraria with Stoke Therapeutics. Dr. Scheffer has received personal compensation in the range of $0-$499 for serving as a Speaker honoraria with Zuellig Pharma Inc.. Dr. Scheffer has a non-compensated relationship as a Trial Investigator with Anavex Life Sciences that is relevant to AAN interests or activities. Dr. Scheffer has a non-compensated relationship as a Trial investigator with Cerebral Therapeutics that is relevant to AAN interests or activities. Dr. Scheffer has a non-compensated relationship as a Trial investigator with Cerecin that is relevant to AAN interests or activities. Dr. Scheffer has a non-compensated relationship as a Trial investigator with Cereval Therapeutics that is relevant to AAN interests or activities. Dr. Scheffer has a non-compensated relationship as a Trial investigator with Biohaven Ltd. that is relevant to AAN interests or activities. Dr. Scheffer has a non-compensated relationship as a Scientific Advisory Board, Trial investigator with Encoded Therapeutics that is relevant to AAN interests or activities. Dr. Scheffer has a non-compensated relationship as a Trial investigator with EpiMinder Inc that is relevant to AAN interests or activities. Dr. Scheffer has a non-compensated relationship as a Trial investigator with ES-Therapeutics that is relevant to AAN interests or activities. Dr. Scheffer has a non-compensated relationship as a Trial investigator with Bright Minds Biosciences that is relevant to AAN interests or activities. Dr. Scheffer has a non-compensated relationship as a Trial investigator with Marinus Pharmaceuticals that is relevant to AAN interests or activities. Dr. Scheffer has a non-compensated relationship as a Trial investigator with Neurocrine BioSciences that is relevant to AAN interests or activities. Dr. Scheffer has a non-compensated relationship as a Trial investigator with Neuren Pharmaceuticals that is relevant to AAN interests or activities. Dr. Scheffer has a non-compensated relationship as a Trial investigator with Praxis Precision Medicines that is relevant to AAN interests or activities. Dr. Scheffer has a non-compensated relationship as a Trial investigator, Scientific Advisory Board with Takeda Pharmaceuticals that is relevant to AAN interests or activities. Dr. Scheffer has a non-compensated relationship as a Trial investigator with Xenon Pharmaceuticals that is relevant to AAN interests or activities. Dr. Scheffer has a non-compensated relationship as a Trial investigator with Zogenix that is relevant to AAN interests or activities. Dr. Scheffer has a non-compensated relationship as a Journal Editorial Board with Neurology that is relevant to AAN interests or activities. Dr. Scheffer has a non-compensated relationship as a Journal Editorial Board with Epileptic Disorders that is relevant to AAN interests or activities. Dr. Scheffer has a non-compensated relationship as a Journal Editorial Board with Progress in Epileptic Disorders series that is relevant to AAN interests or activities. Dr. Scheffer has a non-compensated relationship as a Journal Editorial Board with The Lancet Neurology that is relevant to AAN interests or activities. Dr. Scheffer has a non-compensated relationship as a Director with Australian Academy of Health and Medical Sciences that is relevant to AAN interests or activities. Dr. Scheffer has a non-compensated relationship as a Director with Royal Society (Australia). that is relevant to AAN interests or activities. Dr. Scheffer has a non-compensated relationship as a Trial investigator with Shanghai Zhimeng Biopharma that is relevant to AAN interests or activities. Dr. Scheffer has a non-compensated relationship as a Trial investigator with SK Life Science that is relevant to AAN interests or activities. Dr. Scheffer has a non-compensated relationship as a Trial investigator with Supernus Pharmaceuticals that is relevant to AAN interests or activities. Dr. Scheffer has a non-compensated relationship as a Trial investigator with UCB Biopharma SRL that is relevant to AAN interests or activities. Dr. Scheffer has a non-compensated relationship as a Trial investigator with Ultragenyx that is relevant to AAN interests or activities.
Jeremy Syrjanen	Jeremy Syrjanen has nothing to disclose.
Alejandro A. Rabinstein, MD, FAAN	Dr. Rabinstein has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Boston Scientific. Dr. Rabinstein has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Shionogi . Dr. Rabinstein has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Chiesi. Dr. Rabinstein has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ceribell. Dr. Rabinstein has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurocritical care/NCS-Springer. Dr. Rabinstein has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Wolters/UptoDate. Dr. Rabinstein has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for EBSCO/DynaMed. Dr. Rabinstein has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AHA. Dr. Rabinstein has received publishing royalties from a publication relating to health care. Dr. Rabinstein has received publishing royalties from a publication relating to health care. Dr. Rabinstein has received publishing royalties from a publication relating to health care. Dr. Rabinstein has received publishing royalties from a publication relating to health care.
Mandip S. Dhamoon, MD, MPH	Dr. Dhamoon has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Faegre Baker Daniels LLP. Dr. Dhamoon has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Wellstar Health System Inc. Dr. Dhamoon has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Fabiani Cohen & Hall, LLP. Dr. Dhamoon has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Kramer, Dillof, Livingston & Moore. Dr. Dhamoon has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Robins Kaplan. Dr. Dhamoon has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Parker Waichman LLP. Dr. Dhamoon has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Heidell, Pittoni, Murphy & Bach, LLP.
Nupur Ghoshal, MD, PhD	No disclosure on file
Jeffrey M. Kornitzer, MD, FAAN	Dr. Kornitzer has nothing to disclose.
Butchi Raju Garuda, MD, FAAN	Dr. Garuda has nothing to disclose.
Fatemah Alshawaf, MD	Dr. Alshawaf has nothing to disclose.
Deanna Saylor, MD, MHS	Dr. Saylor has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for ��ɫ��. The institution of Dr. Saylor has received research support from National Institutes of Health. The institution of Dr. Saylor has received research support from ��ɫ��. Dr. Saylor has a non-compensated relationship as a Member of multiple committees and task forces focused on improving access to MS medications to people across the world with Multiple Sclerosis International Federation that is relevant to AAN interests or activities. Dr. Saylor has a non-compensated relationship as a Member of the Neurology and COVID19 committee with World Health Organization that is relevant to AAN interests or activities. Dr. Saylor has a non-compensated relationship as a Member of the International Outreach Committee, Junior and Early Career Membership Committee, and ��ɫ��al Innovation Commitees with American Neurological Association that is relevant to AAN interests or activities.
Namita Goyal, MD, FAAN	Dr. Goyal has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Goyal has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Annexon. Dr. Goyal has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abcuro. Dr. Goyal has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. Dr. Goyal has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Souffle. Dr. Goyal has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for CSL Behring. Dr. Goyal has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Argenx. Dr. Goyal has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Amgen. The institution of Dr. Goyal has received research support from Fulcrum. The institution of Dr. Goyal has received research support from Healey Platform. The institution of Dr. Goyal has received research support from Medicinova. The institution of Dr. Goyal has received research support from Transposon. The institution of Dr. Goyal has received research support from Abcuro. The institution of Dr. Goyal has received research support from Calico. The institution of Dr. Goyal has received research support from Clene. The institution of Dr. Goyal has received research support from Janssen. The institution of Dr. Goyal has received research support from PepGen. The institution of Dr. Goyal has received research support from PTC. The institution of Dr. Goyal has received research support from Roche. The institution of Dr. Goyal has received research support from Sanofi. The institution of Dr. Goyal has received research support from Prilenia. The institution of Dr. Goyal has received research support from RAPA. The institution of Dr. Goyal has received research support from Avidity. Dr. Goyal has received publishing royalties from a publication relating to health care.
Raghav Govindarajan, MD, FAAN	Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for MT pharma. Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Catalyst. Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche . Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sarepta. Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amicus. Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Govindarajan has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alexion. Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for MT pharma . Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Catalyst. Dr. Govindarajan has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Argenx. Dr. Govindarajan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biohaven. Dr. Govindarajan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for UCB. Dr. Govindarajan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Takeda. Dr. Govindarajan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Abbvie. The institution of Dr. Govindarajan has received research support from Band of Hope . The institution of Dr. Govindarajan has received research support from Alexion. Dr. Govindarajan has received publishing royalties from a publication relating to health care.
Edward Y. Zamrini, MD	Dr. Zamrini has received personal compensation for serving as an employee of George Washington University. Dr. Zamrini has received personal compensation for serving as an employee of Irvine Clinical Research. Dr. Zamrini has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NIH. Dr. Zamrini has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Eli Lilly. The institution of Dr. Zamrini has received research support from NIH. The institution of Dr. Zamrini has received research support from NIH.
Tanya Simuni, MD, FAAN	Dr. Simuni has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for cadia, AcureX, Adamas, AskBio, Amneal, Blue Rock Therapeutics, Caraway Therapeutics, Critical Path for Parkinson's Consortium (CPP), Denali, Michael J Fox Foundation, Neuroderm, Sanofi, Sinopia, Roche, Takeda and Vanqua Bio. Dr. Simuni has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for of Koneksa, Neuroderm, Sanofi, UCB, AcureX, Adamas, AskBio, Biohaven, Denali, GAIN, Neuron23 and Roche. Dr. Simuni has received research support from Amneal, Biogen, Neuroderm, Prevail, Roche, and UCB and an investigator for NINDS, MJFF, Parkinson's Foundation.
Narayan R. Kissoon, MD	Dr. Kissoon has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Vertex Pharmaceuticals. The institution of Dr. Kissoon has received research support from Nevro Corporation. The institution of Dr. Kissoon has received research support from Novo Nordisc Foundation. The institution of Dr. Kissoon has received research support from Shiratronics. Dr. Kissoon has received publishing royalties from a publication relating to health care.
Jacqueline French, MD, FAAN	Dr. French has received personal compensation in the range of $50,000-$99,999 for serving as an officer or member of the Board of Directors for Epilepsy Foundation. The institution of Dr. French has received research support from Epilepsy Study Consortium/ Epilepsy Foundation (Funded by UCB). The institution of Dr. French has received research support from GW/One8 Foundation/FACES. The institution of Dr. French has received research support from NINDS. The institution of Dr. French has received research support from Xenon. The institution of Dr. French has received research support from Cerevel. The institution of Dr. French has received research support from FACES. The institution of Dr. French has received research support from UCB. The institution of Dr. French has received research support from Epilepsy Study Consortium. The institution of Dr. French has received research support from UCB. The institution of Dr. French has received research support from Praxis. Dr. French has received personal compensation in the range of $50,000-$99,999 for serving as a Chief Medical/Innovation Officer with Epilepsy Foundation. Dr. French has a non-compensated relationship as a Consultant with Acadia Pharmaceuticals Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a consultant with Access Industries that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a consultant with Acuta Capital Partners LLC that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with AFASCI Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Agrithera, Inc. that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Alkermes that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a consultant with Alterity Therapeutics Limited that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Angelini Pharma S.p.A. that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Autifony Therapeutics Limited that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Axonis Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Bain Capital that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Beacon Biosciences that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Biogen that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Biohaven Pharma that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Bloom Science, Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Bright Minds Biosciences, Inc. that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Capsidia Biotherapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Cerebral Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Cerecin, Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, SAB with Cerevel that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consulting, SAB with Cognizance Biomarkers that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consulting with Ceribell that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Cowen that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Crossject that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Advisory Board with EcoR1 Capital that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with EG 427 that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a consultant, Advisory Board with Eisai that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Encoded Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant/Advisory Board with Engrail that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Epitel, Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with EpiMinder that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Grin Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Harmony that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Advisory Board with Ionis Pharmaceutical that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with iQure Pharma, Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with IQVIA that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Janssen Pharma that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Jazz Pharmaceutical that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Leal Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, with Livanova that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, SAB with London Research & Pharmaceuticals that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Longboard Pharmaceutical that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Maplight Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Marinus that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Medscape/Web MD that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a consultant with Modulight Bio that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Montara Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Mosaica Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a consultant with Neumarker that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Neumirna Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Neurelis that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a consulting, Advisory Board with Neurocrine that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a consultant with Neuropace that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with NeuroPro Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consulting with Neuroventis that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consulting with Neurona Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consulting, Advisory Board with Neuvarti that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Noema that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consulting with Ono Pharmaceutical that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consulting, Advisory Board with Otsuka that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a consulting, Advisory Board with Ovid Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consulting with Praxis that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with PureTech LYT Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with QurAlis Corp that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Rapport Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Receptor Holdings, Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Rivervest Venture Partners that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Sage Therapeutics, Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with SK Life Science that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Stoke that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Stream Neuroscience that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Supernus that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Takeda that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Taysha Gene Therapies that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with UCB, Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with uniQure that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Ventus Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Vida Ventures Management that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Xenon Pharmaceuticals that is relevant to AAN interests or activities.
Sean I. Savitz, MD	Dr. Savitz has nothing to disclose.
Neeta Garg, MD	Dr. Garg has nothing to disclose.
Kenneth M. Attie, MD	No disclosure on file
Maria B. Weimer, MD	Dr. Weimer has nothing to disclose.
Enrique Alvarez, MD, PhD	Dr. Alvarez has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Alvarez has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Alvarez has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Alvarez has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Alvarez has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Alvarez has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Alvarez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Alvarez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Celgene/BMS. The institution of an immediate family member of Dr. Alvarez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. The institution of Dr. Alvarez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon.
Carol M. Ulloa, MD, FAES, FAAN, FAAN	The institution of Dr. Ulloa has received research support from medtronics. An immediate family member of Dr. Ulloa has received research support from NIH.
Steven R. Messe, MD, FAHA, FAAN	Dr. Messe has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novo Nordisk. Dr. Messe has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Terumo. Dr. Messe has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for WL Gore. The institution of Dr. Messe has received research support from WL Gore. The institution of Dr. Messe has received research support from Mallinkrodt. The institution of Dr. Messe has received research support from Biogen. Dr. Messe has received intellectual property interests from a discovery or technology relating to health care. Dr. Messe has received publishing royalties from a publication relating to health care. Dr. Messe has received personal compensation in the range of $500-$4,999 for serving as a Clinical Event Committee for the CONFORMAL left atrial appendage occlusion trial with Yale Cardiovascular Research Group.
James B. Leverenz, MD, FAAN	Dr. Leverenz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Acadia. Dr. Leverenz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Leverenz has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eisai.
Stephan A. Mayer, MD	Dr. Mayer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ceribell. Dr. Mayer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Phagenesis. Dr. Mayer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ISchemaView. Dr. Mayer has stock in Neuroptics. Dr. Mayer has received publishing royalties from a publication relating to health care.
Valerie A. Block, DPTSc	Dr. Block has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. The institution of Dr. Block has received research support from National MS Society.
Andrew Woolfenden, MD	No disclosure on file
Rodica Elena Petrea, MD	Dr. Petrea has nothing to disclose.
Robert A. Brown, PhD	Dr. Brown has received stock or an ownership interest from ShadowLab Research Inc.. Dr. Brown has received intellectual property interests from a discovery or technology relating to health care. Dr. Brown has a non-compensated relationship as a consultant with the Population Council that is relevant to AAN interests or activities.
Fernando Maestu	Fernando Maestu has nothing to disclose.
William Stern	No disclosure on file
Anita Shanmugham, MS, MPH	No disclosure on file
Quynh Vo, MD	Dr. Vo has nothing to disclose.
Xiaoming Jia, MD, MEng	Dr. Jia has received personal compensation for serving as an employee of Genentech/Roche. Dr. Jia has stock in Roche.
Mario F. Mendez, MD, PhD, FAAN	Dr. Mendez has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Medical ��ɫ�� Speakers' Bureau. Dr. Mendez has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for UpToDate. The institution of Dr. Mendez has received research support from NIH. Dr. Mendez has received publishing royalties from a publication relating to health care.
Laszlo Mechtler, MD, FEAN, FASN, FAHS, FAAN	Dr. Mechtler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Impel Pharma. Dr. Mechtler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Mechtler has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbvie. Dr. Mechtler has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Genomate Health. The institution of Dr. Mechtler has received research support from The Harry Dent Family Foundation, Inc. The institution of Dr. Mechtler has received research support from Alpheus medical. The institution of Dr. Mechtler has received research support from Shiratronics. The institution of Dr. Mechtler has received research support from Abbvie Inc. The institution of Dr. Mechtler has received research support from Amgen. The institution of Dr. Mechtler has received research support from Eli Lilly Company. The institution of Dr. Mechtler has received research support from H. Lundbeck HS. The institution of Dr. Mechtler has received research support from Pfizer. Dr. Mechtler has received personal compensation in the range of $100,000-$499,999 for serving as a Ownership interest with Neurology Practce Consortium GPO. Dr. Mechtler has a non-compensated relationship as a Board member with International Headache Society that is relevant to AAN interests or activities.
Sherry Hsiang-Yi Chou, MD	Dr. Hsiang-Yi Chou has received personal compensation for serving as an employee of NIH. An immediate family member of Dr. Hsiang-Yi Chou has received personal compensation for serving as an employee of Wells Fargo. Dr. Hsiang-Yi Chou has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Grace Therapeutics. The institution of Dr. Hsiang-Yi Chou has received research support from The Neurocritical Care Society. Dr. Hsiang-Yi Chou has a non-compensated relationship as a Board of Director member with United Council of Neurologic Specialties that is relevant to AAN interests or activities. Dr. Hsiang-Yi Chou has a non-compensated relationship as a Co-chair/chair-elect, the Neurocritical Care Committee with American Heart Association, the Stroke Council that is relevant to AAN interests or activities. Dr. Hsiang-Yi Chou has a non-compensated relationship as a Co-chair/chair ellect, the Neurocritical Care Special Interest Group with American Neurologic Association that is relevant to AAN interests or activities.
Salvador Cruz-Flores, MD, FAAN	The institution of Dr. Cruz-Flores has received research support from University of Texas System.
Mark Keegan, MD, FAAN	Dr. Keegan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Keegan has received publishing royalties from a publication relating to health care. Dr. Keegan has received publishing royalties from a publication relating to health care.
Lydia Vela, MD	No disclosure on file
Aparna M. Prabhu, MD	Dr. Prabhu has nothing to disclose.
Kimford J. Meador, MD, FAAN	The institution of Dr. Meador has received research support from NIH. The institution of Dr. Meador has received research support from The Epilepsy Consortium.
Richard S. Young, MD, FAAN	Dr. Young has nothing to disclose.
Alexandra L. Czap, MD	The institution of Dr. Czap has received research support from SVIN. The institution of Dr. Czap has received research support from AAN.
Melissa Crowder, MD	No disclosure on file
Ronald C. Petersen, MD, PhD, FAAN	Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly and Co.. Dr. Petersen has received personal compensation in the range of $0-$499 for serving as a Consultant for Eisai, Inc.. Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novo Nordisk. Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Petersen has received publishing royalties from a publication relating to health care. Dr. Petersen has received publishing royalties from a publication relating to health care. Dr. Petersen has received publishing royalties from a publication relating to health care. Dr. Petersen has a non-compensated relationship as a Board of Directors with American Brain Foundation that is relevant to AAN interests or activities.
David Irwin, MD	The institution of Dr. Irwin has received research support from NIH. The institution of Dr. Irwin has received research support from Prevail. The institution of Dr. Irwin has received research support from Passage Bio. The institution of Dr. Irwin has received research support from Alector. The institution of Dr. Irwin has received research support from Transposon. The institution of Dr. Irwin has received research support from Denali. The institution of Dr. Irwin has received research support from Cervo Med.
Nicole A. Chiota-McCollum, MD, MEd	Dr. Chiota-McCollum has nothing to disclose.
Faycal Hentati, MD	No disclosure on file
Vincenzo Guidetti	No disclosure on file
Tapan R. Kavi, MD	No disclosure on file
Kate Daniello, MD, FAAN	Dr. Daniello has nothing to disclose.
Eoin P. Flanagan, MBBCh, FAAN	The institution of Dr. Flanagan has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Flanagan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Pharmacy times. The institution of Dr. Flanagan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for UCB. The institution of Dr. Flanagan has received research support from UCB. The institution of Dr. Flanagan has received research support from Roche. The institution of Dr. Flanagan has received research support from UCB. The institution of Dr. Flanagan has received research support from Merck. The institution of Dr. Flanagan has received research support from Roche. Dr. Flanagan has received publishing royalties from a publication relating to health care. Dr. Flanagan has received publishing royalties from a publication relating to health care. Dr. Flanagan has a non-compensated relationship as a Member of medical Advisory Board with The MOG Project that is relevant to AAN interests or activities. Dr. Flanagan has a non-compensated relationship as a Editorial board member with Journal of The Neurologic Sciences that is relevant to AAN interests or activities. Dr. Flanagan has a non-compensated relationship as a Editorial board member with Neuroimmunology Reports that is relevant to AAN interests or activities. Dr. Flanagan has a non-compensated relationship as a Editorial Board Member with Neurology, Neuroimmunology Neuroinflammation (N2) Journal that is relevant to AAN interests or activities. Dr. Flanagan has a non-compensated relationship as a Editorial Board Member with Neurology that is relevant to AAN interests or activities.
Annalena Venneri, PhD	No disclosure on file
David S. Knopman, MD, FAAN	Dr. Knopman has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for DIAN TU study. The institution of Dr. Knopman has received research support from NIH.
Edgar Samaniego, MD, FAAN	Dr. Samaniego has received personal compensation for serving as an employee of University of Iowa. Dr. Samaniego has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Terumo Neuro. Dr. Samaniego has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Rapid Medical. Dr. Samaniego has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for J&J Neuro. Dr. Samaniego has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Metronic. Dr. Samaniego has received personal compensation in the range of $0-$499 for serving as a Consultant for iSchemaView. Dr. Samaniego has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Society of Neurointerventional Surgery. Dr. Samaniego has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Journal of Neurointerventional Surgery.
Ralph L. Sacco, MD, MS, FAHA	Dr. Sacco has received personal compensation in the range of $100,000-$499,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Heart Association. The institution of Dr. Sacco has received research support from NIH, NINDS, NCATS, NIMHD. The institution of Dr. Sacco has received research support from FL Department of Health. Dr. Sacco has received research support from University of Washington, Seattle. Dr. Sacco has received publishing royalties from a publication relating to health care.
Natalie Diaz, MD	No disclosure on file
Mudassir Farooqui, MD	Dr. Farooqui has nothing to disclose.
Mia T. Minen, MD, FAAN	The institution of Dr. Minen has received research support from NIH. Dr. Minen has received intellectual property interests from a discovery or technology relating to health care. Dr. Minen has received personal compensation in the range of $500-$4,999 for serving as a First Contact-Primary Care Advisory Board Member with American Headache Society . Dr. Minen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PCORI grant on migraine evidence based map for stakeholders with ECRI .
Jennifer A. Tracy, MD	Dr. Tracy has nothing to disclose.
Khalid I. El-Salem, MD, FAAN	Dr. El-Salem has nothing to disclose.
Jeffrey M. Burns, MD	Dr. Burns has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Renew Research. Dr. Burns has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Burns has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amylyx. Dr. Burns has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Norris, Keplinger, Hicks and Welder. The institution of Dr. Burns has received research support from National Institutes of Health. The institution of Dr. Burns has received research support from Biogen. The institution of Dr. Burns has received research support from Eli Lilly. The institution of Dr. Burns has received research support from Amylyx. The institution of Dr. Burns has received research support from Abbvie. The institution of Dr. Burns has received research support from Astra-Zeneca.
Jessika Suescun, MD	Dr. Suescun has nothing to disclose.
Peggy Nguyen, MD	Dr. Nguyen has nothing to disclose.
Jacob C. Rube, MD	Dr. Rube has nothing to disclose.
Salim I. Dib, MD, FAAN	Dr. Dib has nothing to disclose.
Sasha Alick-Lindstrom, MD, MPH FACNS, FAES, FAAN	Dr. Alick-Lindstrom has nothing to disclose.
Atif Zafar, MD	Dr. Zafar has nothing to disclose.
Jonathan Graff-Radford, MD, FAAN	Dr. Graff-Radford has received personal compensation for serving as an employee of Mayo Clinic. Dr. Graff-Radford has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NINDS/NIH. Dr. Graff-Radford has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for JAMA Neurology. Dr. Graff-Radford has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Open evidence . The institution of Dr. Graff-Radford has received research support from NIH. The institution of Dr. Graff-Radford has received research support from Eisai. The institution of Dr. Graff-Radford has received research support from Cognition therapeutics. Dr. Graff-Radford has received personal compensation in the range of $5,000-$9,999 for serving as a Faculty Member with IMPACT AD .
Mazen M. Dimachkie, MD, FAAN	Dr. Dimachkie has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Dimachkie has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Octapharma. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ArgenX. Dr. Dimachkie has received personal compensation in the range of $0-$499 for serving as a Consultant for Catalyst. Dr. Dimachkie has received personal compensation in the range of $0-$499 for serving as a Consultant for Takeda. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medlink. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CSL Behring. Dr. Dimachkie has received personal compensation in the range of $0-$499 for serving as a Consultant for Astellas. Dr. Dimachkie has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Janssen. Dr. Dimachkie has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Dianthus. Dr. Dimachkie has received personal compensation in the range of $0-$499 for serving as a Consultant for TACT / Treat NMD. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cabaletta Bio. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Clinical Neurological Society of America, Inc . Dr. Dimachkie has received personal compensation in the range of $0-$499 for serving as a Consultant for Ig Society, Inc. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abcuro. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amicus. Dr. Dimachkie has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Horizon/Immunovant. Dr. Dimachkie has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for EMD Serono. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ipsen. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Nuvig. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ��ɫ�� (AAN). Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for American Association of Neuromuscular and Electrodiagnostic Medicine (AANEM). Dr. Dimachkie has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Annexon Biosciences. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AstraZeneca. Dr. Dimachkie has received personal compensation in the range of $0-$499 for serving as a Consultant for Candid Therapeutics. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Creyon Bio, Inc.. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Nuvig Therapeutics. Dr. Dimachkie has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB Biopharma. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Vertex Pharmaceuticals. Dr. Dimachkie has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Fortrea. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Kriya Therapeutics. The institution of Dr. Dimachkie has received research support from NIH. The institution of Dr. Dimachkie has received research support from The Myositis Association. The institution of Dr. Dimachkie has received research support from Biosensics. Dr. Dimachkie has received intellectual property interests from a discovery or technology relating to health care. Dr. Dimachkie has received intellectual property interests from a discovery or technology relating to health care. Dr. Dimachkie has received intellectual property interests from a discovery or technology relating to health care. Dr. Dimachkie has received publishing royalties from a publication relating to health care. Dr. Dimachkie has received publishing royalties from a publication relating to health care.
Deema A. Fattal, MD	An immediate family member of Dr. Fattal has received research support from American transportation center and DOD.
Mauro Zaffaroni	No disclosure on file
Nuria Carrillo, MD	No disclosure on file
Nigel S. Bamford, MD	No disclosure on file
Anand Venkatraman, MBBS	No disclosure on file
Chiara Zecca, MD	Prof. Zecca has nothing to disclose.
Virginia Meca Lallana	Virginia Meca Lallana has nothing to disclose.
Arezou Bayat, MD	No disclosure on file
Marianna Cortese, MD, PhD	Dr. Cortese has received personal compensation in the range of $500-$4,999 for serving as a speaker at educational event with Roche.
Alexandra Kvernland, MD	Dr. Kvernland has nothing to disclose.
Alexander Houck, MD	Dr. Houck has nothing to disclose.
Maxime Montembeault, PhD	Dr. Montembeault has nothing to disclose.
Christopher P. Kellner, MD	Dr. Kellner has stock in METIS Innovative. Dr. Kellner has stock in Precision Recovery. Dr. Kellner has stock in Synchron. Dr. Kellner has stock in Fluid BioMed. Dr. Kellner has stock in Proprio. Dr. Kellner has stock in Von Vascular. Dr. Kellner has stock in E8. Dr. Kellner has stock in Borvo. Dr. Kellner has stock in Phantom Neuro. Dr. Kellner has stock in Radical. Dr. Kellner has stock in Reach Neuro. Dr. Kellner has stock in Aurenar. The institution of Dr. Kellner has received research support from Integra. The institution of Dr. Kellner has received research support from Penumbra. The institution of Dr. Kellner has received research support from Viz.AI. The institution of Dr. Kellner has received research support from ICE Neurosystems. The institution of Dr. Kellner has received research support from Irras. The institution of Dr. Kellner has received research support from Microtransponder. The institution of Dr. Kellner has received research support from Medtronic. The institution of Dr. Kellner has received research support from Longeviti. The institution of Dr. Kellner has received research support from Endostream. The institution of Dr. Kellner has received research support from CVAID.
Hennan S. Teixeira, MD	Dr. Teixeira has nothing to disclose.
Alexis Alvarado Arias, MD	Dr. Alvarado Arias has nothing to disclose.
Dirk Smeets	Dirk Smeets has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for icometrix. Dirk Smeets has stock in icometrix.
Kelly D. Flemming, MD	Dr. Flemming has nothing to disclose.
Bruce H. Cohen, MD, FAAN	Dr. Cohen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abliva/NeuroVive/Pharming. Dr. Cohen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Modis/Zogenix/USB. Dr. Cohen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Precision BioSciences . Dr. Cohen has received personal compensation in the range of $0-$499 for serving as a Consultant for Pretzel. Dr. Cohen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Stealth Bio. Dr. Cohen has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Allergan. The institution of Dr. Cohen has received research support from Stealth Biotherapeutics. The institution of Dr. Cohen has received research support from BioElectron Technologies/PTC. The institution of Dr. Cohen has received research support from Astellas/MitoBridge. The institution of Dr. Cohen has received research support from Reneo Pharmaceuticals. The institution of Dr. Cohen has received research support from Abliva/Pharming. The institution of Dr. Cohen has received research support from Tisento. Dr. Cohen has received publishing royalties from a publication relating to health care. Dr. Cohen has received personal compensation in the range of $500-$4,999 for serving as a Consultant with US DOJ/HHS; DVIC. Dr. Cohen has received personal compensation in the range of $500-$4,999 for serving as a CPT Advisor with AAN. Dr. Cohen has a non-compensated relationship as a Officer with Child Neurology Society that is relevant to AAN interests or activities. Dr. Cohen has a non-compensated relationship as a Officer with Child Neurology Foundation that is relevant to AAN interests or activities.
Neha Dangayach, MD, FAAN	Dr. Dangayach has nothing to disclose.
Jason J. Sico, MD, FAAN	Dr. Sico has nothing to disclose.
John A. Detre, MD	Dr. Detre has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Hura Imaging. The institution of Dr. Detre has received research support from NIH. Dr. Detre has received personal compensation in the range of $500-$4,999 for serving as a grant proposal reviewer with NIH, VA, European Science Foundation,Deutsche Forschungsgemeinschaft.
Lauren H. Sansing, MD	Dr. Sansing has nothing to disclose.
V. Wee Yong	No disclosure on file
Kalyan Yarraguntla, MD	Dr. Yarraguntla has nothing to disclose.
Daniel Krashin, MD	Dr. Krashin has nothing to disclose.
Alexandra Boubour	Ms. Boubour has received research support from The Fulbright Program.
Nicholas E. Johnson, MD, FAAN	Dr. Johnson has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sarepta Therapuetics. Dr. Johnson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Dyne Therapeutics. Dr. Johnson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Vertex Pharma. Dr. Johnson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Avidity. Dr. Johnson has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Arthex. Dr. Johnson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Juvena. Dr. Johnson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Rgenta. Dr. Johnson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AskBio. Dr. Johnson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Johnson has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Evolyra Therapeutics . Dr. Johnson has stock in Angle Therapeutics. Dr. Johnson has stock in Juvena Therapeutics. Dr. Johnson has stock in Evolyra Therapeutics. The institution of Dr. Johnson has received research support from Novartis. The institution of Dr. Johnson has received research support from Takeda . The institution of Dr. Johnson has received research support from AMO Pharma. The institution of Dr. Johnson has received research support from Sarepta. The institution of Dr. Johnson has received research support from Dyne Therapeutics. The institution of Dr. Johnson has received research support from AskBio. The institution of Dr. Johnson has received research support from Pepgen. The institution of Dr. Johnson has received research support from ML Bio. The institution of Dr. Johnson has received research support from Vertex. The institution of Dr. Johnson has received research support from Arthex. The institution of Dr. Johnson has received research support from Avidity Biosciences. The institution of Dr. Johnson has received research support from Edgewise. Dr. Johnson has received intellectual property interests from a discovery or technology relating to health care.
Roy G. Beran, MD, FAAN	Dr. Beran has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eli Lilly. Dr. Beran has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Esai. Dr. Beran has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for somnomed. Dr. Beran has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for CMC Lawyers. Dr. Beran has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Bannisters Lawyers. Dr. Beran has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Victorian Crown prosecution. Dr. Beran has received publishing royalties from a publication relating to health care. Dr. Beran has received publishing royalties from a publication relating to health care.
Dominique L. Dive, MD	No disclosure on file
Kevan E. VanLandingham, MD, PhD, FAAN	Dr. VanLandingham has received personal compensation for serving as an employee of Greenwich Biosciences. Dr. VanLandingham has received stock or an ownership interest from Greenwich Biosciences.
Peter Turkeltaub, MD, PhD	Dr. Turkeltaub has nothing to disclose.
Mark Gudesblatt, MD	The institution of Dr. Gudesblatt has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for genentech. The institution of Dr. Gudesblatt has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen.
David Hasan	No disclosure on file
Amir Mazhari, MD	No disclosure on file
Hubert H. Fernandez, MD, FAAN	Dr. Fernandez has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Fernandez has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amneal. Dr. Fernandez has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Intrance. Dr. Fernandez has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Fernandez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie. Dr. Fernandez has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. Dr. Fernandez has received publishing royalties from a publication relating to health care. Dr. Fernandez has received personal compensation in the range of $10,000-$49,999 for serving as a Steering Committee/Advisory Committee Member with Parkinson Study Group.
Dara V. Albert, DO, FAAN	Dr. Albert has nothing to disclose.
Charles D. Smith, MD, FAAN	No disclosure on file
Carlos Cantu, MD, MSc	Dr. Cantu has nothing to disclose.
Patricia Greenstein, MD	Dr. Greenstein has nothing to disclose.
Joome Suh, MD	Dr. Suh has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Suh has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for argenx.
Tyler J. Story, PhD	No disclosure on file
John D. Medaglia, PhD	The institution of Dr. Medaglia has received research support from National Institutes of Health.
Matthew Schindler, MD, PhD	Dr. Schindler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapuetics. Dr. Schindler has received personal compensation in the range of $5,000-$9,999 for serving as a ��ɫ��al Presenter with Annenberg Center.
Judith D. Steinberg, MD	No disclosure on file
Lucia Giannini	No disclosure on file
Jr-Wei Wu, MD	Dr. Wu has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Pfizer . Dr. Wu has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Abbvie . Dr. Wu has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for International Headache Society (IHS). The institution of Dr. Wu has received research support from National Science and Technology Council . The institution of an immediate family member of Dr. Wu has received research support from National Science and Technology Council .
Tracy J. Koehler	Tracy J. Koehler has nothing to disclose.
Brian Gold	No disclosure on file
Chaim Lebovits	No disclosure on file
Sarah Marmol, MD	Dr. Marmol has nothing to disclose.
Joseph Biederman, MD	No disclosure on file
Ana Morales	No disclosure on file
Nasir Fakhri, MD	No disclosure on file
Johana Bauer	No disclosure on file
Benjamin P. Trewin, MBBS, PhD, FRACP	Dr. Trewin has received research support from University of Sydney.
Sarah N. Silverstein	No disclosure on file
Jon W. Collins, PharmD	No disclosure on file
Kristina an Haack	No disclosure on file
J S. Andrews	J Scott Andrews has received personal compensation for serving as an employee of Eli Lilly & Company. J Scott Andrews has received stock or an ownership interest from Eli Lilly & Company.
Gregory A. Jicha, MD, PhD	Dr. Jicha has nothing to disclose.
Cho Soo-Jin	Cho Soo-Jin has nothing to disclose.
Trung P. Nguyen, MD	The institution of Dr. Nguyen has received research support from National Institute on Aging. The institution of Dr. Nguyen has received research support from Texas Alzheimer's Research and Care Consortium. The institution of Dr. Nguyen has received research support from Biogen.
Daniel Gratch	No disclosure on file
Hsiangkuo Yuan, MD, PhD	An immediate family member of Dr. Yuan has received personal compensation for serving as an employee of Merck. Dr. Yuan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Pfizer. Dr. Yuan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Yuan has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pfizer. Dr. Yuan has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Salvia. Dr. Yuan has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cerenovous. Dr. Yuan has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Regional Anesthesia and Pain Medicine. Dr. Yuan has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Current Headache and Pain Reports. Dr. Yuan has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for MedLink Neurology. Dr. Yuan has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Cephalalgia. The institution of Dr. Yuan has received research support from NIH. The institution of Dr. Yuan has received research support from American Headache Society. The institution of Dr. Yuan has received research support from Pfizer. Dr. Yuan has received publishing royalties from a publication relating to health care. Dr. Yuan has received publishing royalties from a publication relating to health care. Dr. Yuan has received personal compensation in the range of $500-$4,999 for serving as a Grant reviewer with NIH. Dr. Yuan has received personal compensation in the range of $10,000-$49,999 for serving as a Invited speaker with Chinese Stroke Association.
Kunal Bhatia, MD	Dr. Bhatia has nothing to disclose.
Saskia Bresch, MD	Dr. Bresch has nothing to disclose.
Miriam L. Freimer, MD, FAAN	Dr. Freimer has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for argenx. Dr. Freimer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for alexion. Dr. Freimer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for J and J. Dr. Freimer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. The institution of Dr. Freimer has received research support from Alnylum. The institution of Dr. Freimer has received research support from UCB. The institution of Dr. Freimer has received research support from NIH. The institution of Dr. Freimer has received research support from Janssen. Dr. Freimer has received research support from Avidity. Dr. Freimer has received research support from Fulcrum. The institution of Dr. Freimer has received research support from Dept of defense. The institution of an immediate family member of Dr. Freimer has received research support from Abcurro. Dr. Freimer has received personal compensation in the range of $10,000-$49,999 for serving as a presentations/teaching with UCB.
Lawrence W. Brown, MD	Dr. Brown has received personal compensation in the range of $5,000-$9,999 for serving as a member. Data Safety Monitoring Board with Best Pharmaceuticals for Children Act (NIH). Dr. Brown has a non-compensated relationship as a member, Transition Practices Advisory Committee with Child Neurology Foundation that is relevant to AAN interests or activities.
Michael Shaw	Mr. Shaw has nothing to disclose.
Larissa Felt	No disclosure on file
Nicole Gonzales, MD	The institution of Dr. Gonzales has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology.
Myla D. Goldman, MD, MSc, FAAN	Dr. Goldman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentec. Dr. Goldman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Immunic. Dr. Goldman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis Pharmceuticals. Dr. Goldman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Kiniska. Dr. Goldman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics. Dr. Goldman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Brainstorm Cell Therapeutics Ltd., . Dr. Goldman has received personal compensation in the range of $500-$4,999 for serving as a Study Section Member with NIH. Dr. Goldman has received personal compensation in the range of $0-$499 for serving as a Grant Review Committee Member with Department of Defense.
Jaya Trivedi, MD, FAAN	The institution of Dr. Trivedi has received research support from Avidity.
Daniel Ontaneda, MD, PhD, FAAN	Dr. Ontaneda has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Ontaneda has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech/Roche. Dr. Ontaneda has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen Idec. Dr. Ontaneda has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS. Dr. Ontaneda has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. The institution of Dr. Ontaneda has received research support from NIH. The institution of Dr. Ontaneda has received research support from PCORI. The institution of Dr. Ontaneda has received research support from NMSS. The institution of Dr. Ontaneda has received research support from Genetech.
Alex Baeta	Alex Baeta has nothing to disclose.
Sankar P. Gorthi, MD, FAAN	Dr. Gorthi has nothing to disclose.
Raffaella Cerqua	No disclosure on file
Fatma Yesim Parman, MD	Dr. Parman has nothing to disclose.
Dinesh V. Jillella, MD	Dr. Jillella has nothing to disclose.
Dejan Jakimovski, MD, PhD	Dr. Jakimovski has nothing to disclose.
Laurie Gutmann, MD, FAAN	The institution of Dr. Gutmann has received research support from NIH. The institution of Dr. Gutmann has received research support from Harmony . Dr. Gutmann has received publishing royalties from a publication relating to health care.
Paola Zaratin, PhD	Dr. Zaratin has received personal compensation for serving as an employee of FONDAZIONE ITALIANA SCLEROSI MULTIPLA.
Eric Vidoni, PhD, PT	No disclosure on file
Nils Petersen, MD	The institution of Dr. Petersen has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Silkroad Medical. Dr. Petersen has received research support from NIH.
Michelle M. Mielke, PhD	Dr. Mielke has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Mielke has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai. Dr. Mielke has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly. Dr. Mielke has received personal compensation in the range of $500-$4,999 for serving as a Consultant for LabCorp. Dr. Mielke has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche. Dr. Mielke has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Siemens Healthineers. Dr. Mielke has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sunbird Bio. Dr. Mielke has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eisai. Dr. Mielke has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Roche. Dr. Mielke has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novo Nordisk.
Sylvia Klineova, MD	Dr. Klineova has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. Dr. Klineova has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Klineova has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen. Dr. Klineova has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion.
Bibiana Bielekova, MD, FAAN	Dr. Bielekova has received research support from National Institutes of Allergy and Infectious Diseases. Dr. Bielekova has received intellectual property interests from a discovery or technology relating to health care. Dr. Bielekova has received publishing royalties from a publication relating to health care.
Manuel Murie	No disclosure on file
Amy Z. Crepeau, MD	Dr. Crepeau has nothing to disclose.
Jeffrey M. Gelfand, MD, MS, FAAN	Dr. Gelfand has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Arialys. Dr. Gelfand has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ventyx Bio. An immediate family member of Dr. Gelfand has received personal compensation in the range of $50,000-$99,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Headache: The Journal of Head and Face Pain. The institution of Dr. Gelfand has received research support from Genentech/Roche. The institution of Dr. Gelfand has received research support from Vigil Neurosciences. An immediate family member of Dr. Gelfand has received publishing royalties from a publication relating to health care. Dr. Gelfand has received publishing royalties from a publication relating to health care. Dr. Gelfand has received publishing royalties from a publication relating to health care. Dr. Gelfand has a non-compensated relationship as a Trial Steering Committee Chairperson and member with Roche / Genentech that is relevant to AAN interests or activities.
Adam De Havenon, MD, FAAN	Dr. De Havenon has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novo Nordisk. Dr. De Havenon has or had stock in Certus.Dr. De Havenon has or had stock in TitinKM. The institution of Dr. De Havenon has received research support from NIH/NINDS. Dr. De Havenon has received publishing royalties from a publication relating to health care.
Robert C. Griggs, MD, FAAN	Dr. Griggs has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Strongbridge Pharmaceuticals. Dr. Griggs has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Idera Pharmaceuticals. Dr. Griggs has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Solid Biopharma. Dr. Griggs has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Santhera Pharmaceuticals. Dr. Griggs has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. Dr. Griggs has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Lippincott. The institution of Dr. Griggs has received research support from PTC Pharmaceuticals. The institution of Dr. Griggs has received research support from Sarepta Pharmaceuticals. The institution of Dr. Griggs has received research support from National Institutes of Health. The institution of Dr. Griggs has received research support from Santhere Pharmaceuticals. Dr. Griggs has received personal compensation in the range of $500-$4,999 for serving as a Study section member with National Institutes of Health. Dr. Griggs has a non-compensated relationship as a Board of Directors;Chair Research Advisory Committee with American Brain Foundation that is relevant to AAN interests or activities.
Joseph R. Berger, MD, FAAN	Dr. Berger has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Myers Squibb/Celgene. Dr. Berger has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cycle Pharma. Dr. Berger has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Dice Therapeutics. Dr. Berger has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech/Roche. Dr. Berger has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Gilead. Dr. Berger has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merck/. Dr. Berger has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Morphic. Dr. Berger has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Berger has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sandoz. Dr. Berger has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Takeda. Dr. Berger has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics. Dr. Berger has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for MAPI. Dr. Berger has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ExcisionBio. Dr. Berger has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Population Bio. Dr. Berger has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for TG Therapeutics. Dr. Berger has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Assorted .
Mark B. Skeen, MD, FAAN	Dr. Skeen has received personal compensation for serving as an employee of VeraSci. Dr. Skeen has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. Dr. Skeen has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Alexion. Dr. Skeen has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Bristol Myers Squibb. Dr. Skeen has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for EMD/Serono. Dr. Skeen has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Skeen has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. Dr. Skeen has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alexion. Dr. Skeen has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Bristol Myers Squib. Dr. Skeen has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for EMD/ Serono. The institution of Dr. Skeen has received research support from National MS Society. Dr. Skeen has received personal compensation in the range of $50,000-$99,999 for serving as a Retiree with US Navy.
Lenora M. Lehwald, MD	No disclosure on file
Jennifer McGuire, MD	Dr. McGuire has received research support from NIH.
Nabila Dahodwala, MD, FAAN	Dr. Dahodwala has received personal compensation in the range of $0-$499 for serving as a Consultant for Genetech. Dr. Dahodwala has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mediflix. Dr. Dahodwala has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Acadia. Dr. Dahodwala has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Post and Schell. Dr. Dahodwala has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for O'Brien & Ryan, LLP. Dr. Dahodwala has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for MotleyRice. The institution of Dr. Dahodwala has received research support from AbbVie. The institution of Dr. Dahodwala has received research support from Medtronic.
Santiago Ortega Gutierrez, MD	Dr. Ortega Gutierrez has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for stryker. Dr. Ortega Gutierrez has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for medtronic. Dr. Ortega Gutierrez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medtronic. The institution of Dr. Ortega Gutierrez has received research support from stryker. The institution of Dr. Ortega Gutierrez has received research support from Medtronic. The institution of Dr. Ortega Gutierrez has received research support from Methinks. The institution of Dr. Ortega Gutierrez has received research support from NIH. The institution of Dr. Ortega Gutierrez has received research support from PCORI.
Bruce A. Cree, MD, PhD, MAS, FAAN	The institution of Dr. Cree has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. The institution of Dr. Cree has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. The institution of Dr. Cree has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi. The institution of Dr. Cree has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for TG Therapeutics. The institution of Dr. Cree has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Cree has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neuron23. Dr. Cree has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Boston Pharma. Dr. Cree has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Hexal/Sandoz. Dr. Cree has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Immunic AG. The institution of Dr. Cree has received research support from Genentech. The institution of Dr. Cree has received research support from Kyverna. Dr. Cree has received publishing royalties from a publication relating to health care.
John A. Lincoln, MD, PhD	The institution of Dr. Lincoln has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi-Genzyme. Dr. Lincoln has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen. The institution of Dr. Lincoln has received research support from Deaprtment of Defense. The institution of Dr. Lincoln has received research support from National Institutes of Health. The institution of Dr. Lincoln has received research support from EMD-Serono. Dr. Lincoln has received intellectual property interests from a discovery or technology relating to health care.
Alzira A. Carvalho, MD	No disclosure on file
Edgard Pereira, MD	No disclosure on file
Regina Krel, MD	No disclosure on file
Nadeem I. Khan, MD	Dr. Khan has nothing to disclose.
Mariano Marrodan, MD	Dr. Marrodan has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Marrodan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck, Astra Zeneca, Gador, Biogen, Roche and Novartis.
Sarah Horn, MD	Dr. Horn has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AbbVie. The institution of Dr. Horn has received research support from Alzheimer's Association.
Claire Roberts	No disclosure on file
Ruturaj Masvekar, PhD	Dr. Masvekar has nothing to disclose.
James K. Sheffield, MD	Dr. Sheffield has received personal compensation for serving as an employee of BMS.
Abby L. Olsen, MD	An immediate family member of Dr. Olsen has received personal compensation for serving as an employee of Rheos Medicines. An immediate family member of Dr. Olsen has received personal compensation for serving as an employee of Novasenta. An immediate family member of Dr. Olsen has received personal compensation for serving as an employee of Biohaven. The institution of Dr. Olsen has received research support from NINDS. The institution of Dr. Olsen has received research support from DoD. The institution of Dr. Olsen has received research support from American Parkinson's Disease Association. The institution of Dr. Olsen has received research support from Alzheimer's Association.
Pavnit Kukreja, PharmD	Dr. Kukreja has received personal compensation for serving as an employee of AbbVie. Dr. Kukreja has stock in AbbVie.
Surabhi Kaul, MD	No disclosure on file
Sarah Berth, MD	No disclosure on file
Fabiane Lima, MD	No disclosure on file
Stephanie Jarvis	Stephanie Jarvis has nothing to disclose.
Andrea Pilotto	Andrea Pilotto has nothing to disclose.
Sachin Kapur, MD	No disclosure on file
Christopher Hemond, MD	The institution of Dr. Hemond has received research support from Consorium of Multiple Sclerosis Centers. The institution of Dr. Hemond has received research support from National Institute Of Neurological Disorders And Stroke of the National Institutes of Health. Dr. Hemond has received personal compensation in the range of $0-$499 for serving as a Member of Data Safety and Monitoring Board with National Institute Of Neurological Disorders And Stroke of the National Institutes of Health.
Eric J. Seachrist, MD	Dr. Seachrist has or had stock in Medtronic.Dr. Seachrist has or had stock in Pfizer. The institution of Dr. Seachrist has received research support from Bristol Myers Squibb. Dr. Seachrist has a non-compensated relationship as a Topic Group, QOD Committee, and Wellness Program Committee with ��ɫ�� that is relevant to AAN interests or activities.
Megan Iammarino, PT	Dr. Iammarino has nothing to disclose.
Lydiane Mondot	Lydiane Mondot has nothing to disclose.
Cyrus A. Raji, MD, PhD	Prof. Raji has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Brainreader ApS. Prof. Raji has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Apollo Health . Prof. Raji has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Neurevolution Medicine.
Ritvij Bowry, MD	Dr. Bowry has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Astrazeneca.
Irati Zubizarreta	No disclosure on file
Patrick B. Moloney, MBBS	No disclosure on file
Brooke Hartenstein	Ms. Hartenstein has nothing to disclose.
Isobel A. Hawes	Ms. Hawes has nothing to disclose.
Jihene B. Sassi	Ms. Sassi has nothing to disclose.
Cedric Laloyaux, PhD	Dr. Laloyaux has received personal compensation for serving as an employee of UCB.
Sahar H. Osman, MD	Dr. Osman has nothing to disclose.
Gabriela Tuttrup, MD	Dr. Tuttrup has nothing to disclose.
Khaled Abdalla, MD	Dr. Abdalla has nothing to disclose.
Paula K. Lee, MD	No disclosure on file
Kalyan Reddy Malgireddy, MD	No disclosure on file
Irene Pulido Valdeolivas	No disclosure on file
Omar Siddiqi, MD	The institution of Dr. Siddiqi has received research support from NIH.
Ritu Bagla, MD	Dr. Bagla has nothing to disclose.
Ching Tsao, MD	Dr. Tsao has nothing to disclose.
Martin Valis, MD	Dr. Valis has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Valis has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck. Dr. Valis has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Teva.
Xiyan Yi, MD	Dr. Yi has nothing to disclose.
Syeda Maria Muzammil, MD	Dr. Muzammil has nothing to disclose.
Paul B. Hart	Mr. Hart has nothing to disclose.
Miroslav Brozman, MD	No disclosure on file
Wei Zheng, MD	No disclosure on file
Alberto D. Rivero, MD	No disclosure on file
Deepak K. Gupta, MBBS	The institution of Dr. Gupta has received research support from Department of Defense.
Ka-Ho Wong	The institution of Mr. Wong has received research support from The Sumaira Foundation . The institution of Mr. Wong has received research support from The Siegel Rare Neuroimmune Association.
Hussam Shaker, MD	Dr. Shaker has nothing to disclose.
Yash Jalundhwala, PhD	Dr. Jalundhwala has received personal compensation for serving as an employee of AbbVie . An immediate family member of Dr. Jalundhwala has received personal compensation for serving as an employee of AbbVie . Dr. Jalundhwala has received stock or an ownership interest from AbbVie.
Donna M. Wilcock, PhD	Dr. Wilcock has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for AC Immune. Dr. Wilcock has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alector. Dr. Wilcock has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AvroBio. Dr. Wilcock has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Journal of Neuroscience.
Janet F. Waters, MD, FAAN	An immediate family member of Dr. Waters has received personal compensation for serving as an employee of Haemonetics. An immediate family member of Dr. Waters has received personal compensation for serving as an employee of Vitalant. An immediate family member of Dr. Waters has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Haemonetics. An immediate family member of Dr. Waters has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Vitalant. An immediate family member of Dr. Waters has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Vitalant. An immediate family member of Dr. Waters has received publishing royalties from a publication relating to health care.
Pablo Martinez Martin	No disclosure on file
Nadine Akbar	No disclosure on file
J. H. Harvey, DO	Dr. Harvey has received personal compensation for serving as an employee of Neuralogix. Dr. Harvey has received personal compensation for serving as an employee of Integris . Dr. Harvey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Jazz Pharmaceuticals. Dr. Harvey has stock in Epiminder.
Michelle C. Johansen, MD	Dr. Johansen has received research support from NINDS/NIA. Dr. Johansen has received research support from American Heart Association.
Philippe J. Macedo, MD	No disclosure on file
Kathie Lin, MD	Dr. Lin has nothing to disclose.
Mohamed Ridha, MD	Dr. Ridha has nothing to disclose.
Ahmed Saied	Mr. Saied has nothing to disclose.
Melinda S. Martin, PhD	Dr. Martin has received personal compensation for serving as an employee of UCB. Dr. Martin has received stock or an ownership interest from UCB.
Fallon Schloemer, DO	Dr. Schloemer has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Lilly . Dr. Schloemer has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbvie .
Ornella M. Dubaz, MD	No disclosure on file
Sam Hooshmand, DO	Dr. Hooshmand has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genetech USA. Dr. Hooshmand has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for TG Therapeutics . Dr. Hooshmand has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. Dr. Hooshmand has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genetech USA. Dr. Hooshmand has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for EMD Serono. Dr. Hooshmand has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for TG Therapeutics . Dr. Hooshmand has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amgen . The institution of Dr. Hooshmand has received research support from Novartis .
Ambica Nakhasi, MD	No disclosure on file
Tahseen Mozaffar, MD, FAAN	Dr. Mozaffar has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion Pharmaceuticals. Dr. Mozaffar has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Argenx. Dr. Mozaffar has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi-Genzyme. Dr. Mozaffar has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Amicus. Dr. Mozaffar has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Grifols. Dr. Mozaffar has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Astellas Gene Therapy. Dr. Mozaffar has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Bayer. Dr. Mozaffar has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sarepta. Dr. Mozaffar has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Applied Therapeutics. The institution of Dr. Mozaffar has received research support from NIH. The institution of Dr. Mozaffar has received research support from Muscular Dystrophy Association. The institution of Dr. Mozaffar has received research support from Sanofi. The institution of Dr. Mozaffar has received research support from Argenx. The institution of Dr. Mozaffar has received research support from Amicus Therapeutics. The institution of Dr. Mozaffar has received research support from Astellas Gene Therpay. The institution of Dr. Mozaffar has received research support from Cartesian. The institution of Dr. Mozaffar has received research support from Cabaletta. Dr. Mozaffar has received personal compensation in the range of $500-$4,999 for serving as a Study Section Member with NIH.
Brenda L. Banwell, MD, FAAN	Dr. Banwell has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Banwell has received personal compensation in the range of $0-$499 for serving as a Consultant for UCB. Dr. Banwell has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Dr. Banwell has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Banwell has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech. Dr. Banwell has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. The institution of Dr. Banwell has received research support from National MS Society. The institution of Dr. Banwell has received research support from NIH.
William S. Burgin, MD	Dr. Burgin has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for VuEssence. Dr. Burgin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Burgin has stock in VuEssence. The institution of Dr. Burgin has received research support from VuEssence. The institution of Dr. Burgin has received research support from Bristol-Myers Squibb. The institution of Dr. Burgin has received research support from ReNeuron.
Krzysztof Bujarski, MD	Dr. Bujarski has nothing to disclose.
Dongya Huang, MD	No disclosure on file
Kimberly A. Hart, MA	No disclosure on file
Sheffali Gulati, MD, FAMS, FIAP, FNASc, FIANs	Prof. Gulati has nothing to disclose.
Scott Grossman, MD	Dr. Grossman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Acuta Pharmaceuticals.
Noushin Jazebi, MD	Dr. Jazebi has nothing to disclose.
Elia Sechi, MD	Dr. Sechi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Dr. Sechi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Argenx.
Mohamed Taha, MD	Dr. Taha has nothing to disclose.
Jamila Ahdidan	No disclosure on file
Danmeng Wei, MBBS	No disclosure on file
Syeda Dania Shujaat, MD, MBBS	No disclosure on file
Yu D. Cheng, MD, PhD	No disclosure on file
Christopher Perrone, MD	Dr. Perrone has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono.
Christina Catherine, MD	Dr. Catherine has nothing to disclose.
Shyam S. Moudgil, MD, FAAN	Dr. Moudgil has nothing to disclose.
Jesse Fishman, PharmD	No disclosure on file
Chirag N. Savani, MD	No disclosure on file
Samuel Lichtman-Mikol, BA	Mr. Lichtman-Mikol has nothing to disclose.
Maria Kristina C. Dorotan, MD	Dr. Dorotan has nothing to disclose.
John Chen	John Chen has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB. John Chen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. John Chen has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB.
Ilya Nasrallah, MD, PhD	Dr. Nasrallah has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eisai. Dr. Nasrallah has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen. Dr. Nasrallah has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer. Dr. Nasrallah has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Cassiday Schade LLP. The institution of Dr. Nasrallah has received research support from NIH. The institution of Dr. Nasrallah has received research support from ASNR.
Denise Y. Harvey	The institution of Denise Y. Harvey has received research support from NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS.
Praveen Hariharan, MD	Dr. Hariharan has nothing to disclose.
John P. Holton-Burke, MD	No disclosure on file
Connie G. Tang, MD	Dr. Tang has nothing to disclose.
Christina Law, NP	No disclosure on file
Barry Miller	No disclosure on file
Shani Peter, MD	No disclosure on file
Moein Amin, MD	Dr. Amin has nothing to disclose.
Sudipto Dolui, PhD	Dr. Dolui has nothing to disclose.
Blair Apple	No disclosure on file
Cindy Cecilia	No disclosure on file
Jonas Graf	No disclosure on file
Sonia Koul	No disclosure on file
Susan T. Iannaccone, MD, FAAN	Dr. Iannaccone has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AveXis. Dr. Iannaccone has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Iannaccone has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sarepta. Dr. Iannaccone has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AveXis. Dr. Iannaccone has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sarepta. Dr. Iannaccone has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Catabasis. The institution of Dr. Iannaccone has received research support from AveXis. The institution of Dr. Iannaccone has received research support from Biogen. The institution of Dr. Iannaccone has received research support from Sarepta. The institution of Dr. Iannaccone has received research support from PTC Therapeutics. The institution of Dr. Iannaccone has received research support from FibroGen. The institution of Dr. Iannaccone has received research support from ReveraGen. The institution of Dr. Iannaccone has received research support from MDA. The institution of Dr. Iannaccone has received research support from PPMD. The institution of Dr. Iannaccone has received research support from NIH. Dr. Iannaccone has received personal compensation in the range of $0-$499 for serving as a grant reviewer with NIH.
Douglas L. Arnold, MD, FAAN	Dr. Arnold has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Arnold has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for BMS. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Frequency Therapeutics. Dr. Arnold has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merck. Dr. Arnold has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Arnold has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Dr. Arnold has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Shionogi. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Xfacto communications. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biohaven. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Find therapeutics. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GSK. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Idorsia. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Kiniksa. Dr. Arnold has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Clario.
Katerina Mensikova	Katerina Mensikova has nothing to disclose.
Diana Sima	Diana Sima has received personal compensation for serving as an employee of icometrix.
Aaron E. Miller, MD, FAAN	Dr. Miller has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Accordant Health Services (Caremark). Dr. Miller has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Corevitas (formerly known as Corrona). Dr. Miller has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for MAPI=Pharma. Dr. Miller has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Viatris (Mylan). Dr. Miller has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Guidepoint Global. Dr. Miller has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Gerson Lehrman Group. Dr. Miller has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen Idec. Dr. Miller has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Alexion. Dr. Miller has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Amgen (Horizon Therapeutics). Dr. Miller has received personal compensation in the range of $50,000-$99,999 for serving as an Expert Witness for Sterne Kessler. Dr. Miller has received publishing royalties from a publication relating to health care.
Daniel Woo, MD, FAAN	The institution of Dr. Woo has received research support from NIH.
Michael A. Williams, MD, FAAN	Dr. Williams has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for the Hydrocephalus Association, a not-for-profit patient advocacay organization. The institution of Dr. Williams has received research support from NASA. The institution of Dr. Williams has received research support from Translational Research Insitute for Space Health (TRISH). The institution of Dr. Williams has received research support from NINDS.
Michel T. Torbey, MD, MPH, FAAN	Dr. Torbey has nothing to disclose.
Linda S. Williams, MD, FAAN	The institution of Dr. Williams has received research support from VA HSR&D.
Jose Ramon Ara, MD	No disclosure on file
Babar Khokhar, MD, FAAN	Dr. Khokhar has nothing to disclose.
Maria Petracca, PhD	Dr. Petracca has nothing to disclose.
Deepa Sirsi, MD	No disclosure on file
Stephen A. Johnson, MD	The institution of Dr. Johnson has received research support from ALS Association.
Fnu Abhi Pandhi, MD	No disclosure on file
Sajid Suriya, MD	Dr. Suriya has nothing to disclose.
Rujuta B. Wilson, MD	Dr. Wilson has nothing to disclose.
Kevin N. Sheth, MD, FAAN	Dr. Sheth has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ceribell. Dr. Sheth has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Zoll. Dr. Sheth has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NControl. Dr. Sheth has received stock or an ownership interest from Astrocyte. Dr. Sheth has received stock or an ownership interest from Alva. The institution of Dr. Sheth has received research support from Biogen. The institution of Dr. Sheth has received research support from Novartis. The institution of Dr. Sheth has received research support from Bard. The institution of Dr. Sheth has received research support from Hyperfine. Dr. Sheth has received intellectual property interests from a discovery or technology relating to health care.
Neil A. Busis, MD, FAAN	Dr. Busis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ��ɫ��. Dr. Busis has received personal compensation in the range of $0-$499 for serving as a Consultant for American Medical Association. Dr. Busis has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology Today. Dr. Busis has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology Clinical Practice.
Darin T. Okuda, MD, FAAN	Dr. Okuda has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Okuda has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cortechs AI. Dr. Okuda has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Okuda has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech. Dr. Okuda has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi. Dr. Okuda has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Octave Bioscience. Dr. Okuda has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Pfizer. Dr. Okuda has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Zenas BioPharma. The institution of Dr. Okuda has received research support from Novartis. The institution of Dr. Okuda has received research support from Alexion. Dr. Okuda has received intellectual property interests from a discovery or technology relating to health care.
Bianca C. Madeira, MD	No disclosure on file
Brian Callaghan, MD, MS, FAAN	Dr. Callaghan has received personal compensation for serving as an employee of University of Michigan. Dr. Callaghan has received personal compensation for serving as an employee of Ann Arbor Veterans Affairs. Dr. Callaghan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Dynamed. Dr. Callaghan has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for ��ɫ��. Dr. Callaghan has received personal compensation in the range of $50,000-$99,999 for serving as an Expert Witness for Medico-legal work. Dr. Callaghan has received personal compensation in the range of $50,000-$99,999 for serving as an Expert Witness for Vaccine Injury Compensation Program. The institution of Dr. Callaghan has received research support from ��ɫ��. The institution of Dr. Callaghan has received research support from JDRF. The institution of Dr. Callaghan has received research support from NIA. Dr. Callaghan has received personal compensation in the range of $500-$4,999 for serving as a Grant Reviewer with NIH.
A. M. Barrett, MD, FAAN	The institution of Dr. Barrett has received research support from Veterans Health Association. The institution of Dr. Barrett has received research support from National Institutes of Health. The institution of Dr. Barrett has received research support from Mabel H Flory Trust. Dr. Barrett has received personal compensation in the range of $0-$499 for serving as a author, chapter with WebMD. Dr. Barrett has received personal compensation in the range of $10,000-$49,999 for serving as a scientific advisor with Winifred Masterson Burke Foundation.
Raymond P. Roos, MD, FAAN	Dr. Roos has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for MedLink. Dr. Roos has stock in Amazon. Dr. Roos has stock in Amgen. Dr. Roos has stock in Apple. Dr. Roos has stock in Cigna. Dr. Roos has stock in IBM. Dr. Roos has stock in Ionis. Dr. Roos has stock in Pfizer. Dr. Roos has received research support from Lohengrin Foundation.
James M. Gilchrist, MD, FAAN	Dr. Gilchrist has received publishing royalties from a publication relating to health care.
Boulenouar Mesraoua, MD, FAAN	Dr. Mesraoua has nothing to disclose.
Judith M. Spies, MBBS, PhD	Dr. Spies has nothing to disclose.
Linda C. Wendell, MD, FAAN	Dr. Wendell has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Various. An immediate family member of Dr. Wendell has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Various. Dr. Wendell has stock in Apple. An immediate family member of Dr. Wendell has stock in Apple.
Temitope A. Lawal, MD	Dr. Lawal has nothing to disclose.
Eleonora Tavazzi, MD	No disclosure on file
Andrea Tettamanti	No disclosure on file
Manjari Tripathi, MD	Dr. Tripathi has nothing to disclose.
Jayashree Sundararajan, MD	Dr. Sundararajan has nothing to disclose.
Daniel Schwartz	No disclosure on file
Nadege Gilles	Ms. Gilles has nothing to disclose.
Tina M. Burton, MD	Dr. Burton has nothing to disclose.
Asfi Rafiuddin, MD	No disclosure on file
Fredric J. Cohen, MD	No disclosure on file
Gema E. Giler, MD	No disclosure on file
Casey F. Jeffreys, MD	The institution of Dr. Jeffreys has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for EMD Serono. The institution of Dr. Jeffreys has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. The institution of Dr. Jeffreys has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics. The institution of Dr. Jeffreys has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Clinical Neurological Society of America Inc.. Dr. Jeffreys has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Hall Booth Smith PC. The institution of Dr. Jeffreys has received research support from Novartis.
Ann Clark, PharmD	No disclosure on file
Ernest Wang	No disclosure on file
Christine M. Coquery, PhD	No disclosure on file
Yanjun Bao, PhD	Ms. Bao has received personal compensation for serving as an employee of AbbVie.
Enrique Gomez Figueroa, MD, MSc	Dr. Gomez Figueroa has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen Mexico. Dr. Gomez Figueroa has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Astra Zeneca Mexico. Dr. Gomez Figueroa has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Johnson & Johnson LATAM.
Muhammad Waleed Zeb, MD, MBBS	No disclosure on file
Steven E. Lo, MD	Dr. Lo has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Neurocrine.
Hassan Jassim Al Hail, MD, FAAN	Dr. Al Hail has nothing to disclose.
Vamshi Rao, MD	No disclosure on file
Vince Tran	No disclosure on file
Eric Segal, MD	Dr. Segal has received personal compensation for serving as an employee of Lundbeck. Dr. Segal has received personal compensation for serving as an employee of Eisai. Dr. Segal has received personal compensation for serving as an employee of Neurelis. Dr. Segal has received personal compensation for serving as an employee of Zogenix. Dr. Segal has received personal compensation for serving as an employee of Aquestive. Dr. Segal has received personal compensation for serving as an employee of Greenwich Biosciences. Dr. Segal has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Aquestive. Dr. Segal has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurelis. Dr. Segal has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Greenwhich Bioscience. Dr. Segal has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Greenwhich Bioscience. Dr. Segal has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Neurelis.
Neda Sattarnezhad Oskouei, MD	Dr. Sattarnezhad Oskouei has received research support from National Institutes of Health (NIH). Dr. Sattarnezhad Oskouei has received research support from National Institute of Allergy and Infectious Diseases (NIAID).
Pouya Khankhanian, MD	No disclosure on file
Alfonso Fasano, MD, PhD, FAAN	Dr. Fasano has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Abbott. Dr. Fasano has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbvie. Dr. Fasano has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ipsen. Dr. Fasano has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Medtronic. Dr. Fasano has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Boston Scientific. Dr. Fasano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbott. Dr. Fasano has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medtronic. Dr. Fasano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ceregate. Dr. Fasano has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Inbrain Neuroelectronics. Dr. Fasano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Syneos Health. Dr. Fasano has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Annovis. Dr. Fasano has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for CADTH. Dr. Fasano has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for International Parkinson and Movement Disorders Society. The institution of Dr. Fasano has received research support from Boston Scientific. The institution of Dr. Fasano has received research support from Medtronic. The institution of Dr. Fasano has received research support from Abbvie. The institution of Dr. Fasano has received research support from Canadian Institutes of Health Research (CIHR). The institution of Dr. Fasano has received research support from Michael J Fox Foundation. The institution of Dr. Fasano has received research support from Bluerock Therapeutics. Dr. Fasano has received publishing royalties from a publication relating to health care. Dr. Fasano has a non-compensated relationship as a Medical Advisory Committee with CenteR for Advancing Neurological Innovation to Application (CRANIA) that is relevant to AAN interests or activities. Dr. Fasano has a non-compensated relationship as a Medical Advisory Committee with HopeNET that is relevant to AAN interests or activities. Dr. Fasano has a non-compensated relationship as a Medical Advisory Committee with International Essential Tremor Foundation that is relevant to AAN interests or activities. Dr. Fasano has a non-compensated relationship as a Member with Tremor Research Group that is relevant to AAN interests or activities. Dr. Fasano has a non-compensated relationship as a Co-Chair with Tremor Study Group of the IPMDS that is relevant to AAN interests or activities. Dr. Fasano has a non-compensated relationship as a Vice-Chair with NPH Study Group of the IPMDS that is relevant to AAN interests or activities. Dr. Fasano has a non-compensated relationship as a Vice-Chair with Industry Committee of the IPMDS that is relevant to AAN interests or activities.
Andrew M. Southerland, MD, FAAN	Dr. Southerland has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Plaintiffs and Defense Cases related to Stroke and Vascular Neurology.. The institution of Dr. Southerland has received research support from American Heart Association. The institution of Dr. Southerland has received research support from NIH. The institution of Dr. Southerland has received research support from Abbvie Pharmaceuticals, Inc.. Dr. Southerland has received intellectual property interests from a discovery or technology relating to health care. Dr. Southerland has received intellectual property interests from a discovery or technology relating to health care.
Irene Litvan, MD, FAAN	Dr. Litvan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Aprinoia. Dr. Litvan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck. Dr. Litvan has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Frontiers in Neurology. Dr. Litvan has received personal compensation in the range of $50,000-$99,999 for serving as a Chief Editor with Frontiers in Neurology.
Sara E. Hocker, MD, FAAN	The institution of Dr. Hocker has received research support from Yale University. Dr. Hocker has received publishing royalties from a publication relating to health care.
Barbara Voetsch, MD, PhD	The institution of Dr. Voetsch has received research support from NIH StrokeNet . Dr. Voetsch has received publishing royalties from a publication relating to health care. Dr. Voetsch has received personal compensation in the range of $500-$4,999 for serving as a International Stroke Conference attendee (travel-related expenses) with AHA/ASA. Dr. Voetsch has a non-compensated relationship as a member of the Massachusetts Systems of Care Workgroup with AHA/ASA that is relevant to AAN interests or activities.
Young-Min Lim, MD	Dr. Lim has nothing to disclose.
Srikanth Muppidi, MD, FAAN	Dr. Muppidi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion. Dr. Muppidi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for argenx. Dr. Muppidi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB/Ra Pharma. Dr. Muppidi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Horizont Pharma. Dr. Muppidi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for J & J pharma. Dr. Muppidi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Dianthus Pharma. Dr. Muppidi has received publishing royalties from a publication relating to health care.
Marcelo E. Lancman, MD	No disclosure on file
Aarti Sarwal, MD, FAAN	Dr. Sarwal has received personal compensation in the range of $0-$499 for serving as a Consultant for Stimdia, Inc. Dr. Sarwal has received personal compensation in the range of $0-$499 for serving as a Consultant for Sheinkei. Dr. Sarwal has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Society of Critical Care Medicine . Dr. Sarwal has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Society of Neuroimaging . The institution of Dr. Sarwal has received research support from Butterfly, Inc. The institution of Dr. Sarwal has received research support from Bard. The institution of Dr. Sarwal has received research support from Biogen. The institution of Dr. Sarwal has received research support from Novartis. The institution of Dr. Sarwal has received research support from CVR Global. The institution of Dr. Sarwal has received research support from NIH/NIA R01 AG066910-01 . The institution of Dr. Sarwal has received research support from Image Monitoring. Dr. Sarwal has received personal compensation in the range of $500-$4,999 for serving as a Speaker/Faculty, CME courses with Society of Critical Care Medicine . Dr. Sarwal has received personal compensation in the range of $500-$4,999 for serving as a Speaker at annual congress with Intensive Care Society. Dr. Sarwal has received personal compensation in the range of $500-$4,999 for serving as a Speaker at annual congress with Indian Society of Critical Care. Dr. Sarwal has received personal compensation in the range of $500-$4,999 for serving as a speaker/Faculty for Annual meeting, travel compensation with European Society of Intensive Care Medicine. Dr. Sarwal has received personal compensation in the range of $500-$4,999 for serving as a Speaker with ISICEM. Dr. Sarwal has a non-compensated relationship as a Social Media Editor with Neurocritical Care that is relevant to AAN interests or activities. Dr. Sarwal has a non-compensated relationship as a Secretary with American Society of Neuroimaging that is relevant to AAN interests or activities. Dr. Sarwal has a non-compensated relationship as a President with Association of Indian Neurologists in America that is relevant to AAN interests or activities. Dr. Sarwal has a non-compensated relationship as a Member, Board of Directors with Neurocritical Care Society that is relevant to AAN interests or activities. Dr. Sarwal has a non-compensated relationship as a Section Chair, Neurosciences Section with Society of Critical Care Medicine that is relevant to AAN interests or activities.
Claudio Gobbi, MD	Dr. Gobbi has nothing to disclose.
Xuan Li	No disclosure on file
Jacob L. McCauley	No disclosure on file
Swarna Rajagopalan, MD	Dr. Rajagopalan has nothing to disclose.
Virginia Sturm, PhD	Dr. Sturm has nothing to disclose.
Erik Roberson, MD, PhD	Dr. Roberson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lilly. Dr. Roberson has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Society for Neuroscience. The institution of Dr. Roberson has received research support from NIH. The institution of Dr. Roberson has received research support from Alzheimer's Drug Discovery Foundation. The institution of Dr. Roberson has received research support from Bluefield Project. Dr. Roberson has received intellectual property interests from a discovery or technology relating to health care. Dr. Roberson has received publishing royalties from a publication relating to health care. Dr. Roberson has received personal compensation in the range of $10,000-$49,999 for serving as a Scientific Advisory Board with Kissick Family Foundation.
Joel C. Morgenlander, MD, FAAN	Dr. Morgenlander has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Duke University.
Julio C. Rojas-Martinez, MD, PhD	Dr. Rojas-Martinez has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ferrer International, S.A.. The institution of Dr. Rojas-Martinez has received research support from NIH/NIA. The institution of Dr. Rojas-Martinez has received research support from Eli Lilly. The institution of Dr. Rojas-Martinez has received research support from Eisai. The institution of Dr. Rojas-Martinez has received research support from Amylyx.
Christopher P. Robinson, DO	Dr. Robinson has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for law firms.
Stewart A. Factor, DO, FAAN	Dr. Factor has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Neurocrine. Dr. Factor has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Factor has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Takeda. The institution of Dr. Factor has received research support from Biohaven. The institution of Dr. Factor has received research support from Neurocrine. The institution of Dr. Factor has received research support from Supernus. The institution of Dr. Factor has received research support from Sun Pharmaceuticals Advanced Research Company. The institution of Dr. Factor has received research support from Aspen. The institution of Dr. Factor has received research support from RHO. Dr. Factor has received publishing royalties from a publication relating to health care. Dr. Factor has received publishing royalties from a publication relating to health care. Dr. Factor has received publishing royalties from a publication relating to health care. Dr. Factor has received publishing royalties from a publication relating to health care.
Tobias Walbert, MD, PhD, FAAN	Dr. Walbert has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Walbert has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Orbus Therapeutics. Dr. Walbert has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Springworks Therapeutics . Dr. Walbert has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Springworks Therapeutics . Dr. Walbert has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Alexion .
Dean M. Wingerchuk, MD, FAAN	Dr. Wingerchuk has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon Therapeutics. Dr. Wingerchuk has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Wingerchuk has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Wingerchuk has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Wingerchuk has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol Meyer Squibb. Dr. Wingerchuk has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB Pharma. Dr. Wingerchuk has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AstraZeneca. Dr. Wingerchuk has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Wingerchuk has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abcuro. Dr. Wingerchuk has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Wolters Kluwers.
Chafic Y. Karam, MD	Dr. Karam has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Alnylam. Dr. Karam has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi. Dr. Karam has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Argenx. Dr. Karam has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Annexon. Dr. Karam has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Nuvig. Dr. Karam has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Applied therapeutics. Dr. Karam has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. Dr. Karam has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Astra Zeneca. Dr. Karam has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Intellia. Dr. Karam has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Takeda. Dr. Karam has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Vertex.
Sherri A. Braksick, MD, FAAN	Dr. Braksick has nothing to disclose.
Jennifer Graves, MD, PhD	Dr. Graves has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Graves has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. Dr. Graves has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for MSJ. The institution of Dr. Graves has received research support from Octave. The institution of Dr. Graves has received research support from Sanofi. The institution of Dr. Graves has received research support from EMD Serono.
Kavit Shah, MD	Dr. Shah has nothing to disclose.
Ivo N. Van Schaik, MD	No disclosure on file
Meeryo Choe, MD, FAAN	Dr. Choe has received personal compensation for serving as an employee of Harvard-Westlake School. Dr. Choe has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Legal Cases. The institution of Dr. Choe has received research support from NIH. Dr. Choe has a non-compensated relationship as a Board of Directors with NABIS that is relevant to AAN interests or activities. Dr. Choe has a non-compensated relationship as a Consultant with USA Swimming Concussion Task Force that is relevant to AAN interests or activities.
Jean Mathieu, MD	Dr. Mathieu has nothing to disclose.
Ali A. Habib, MD	Dr. Habib has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Alexion. Dr. Habib has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for argenx. Dr. Habib has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Immunovant. Dr. Habib has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for UCB. Dr. Habib has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer. Dr. Habib has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech/Roche. Dr. Habib has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for NMD Pharma. Dr. Habib has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Horizon/ Amgen. Dr. Habib has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Grifols. Dr. Habib has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Kyverna. Dr. Habib has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Jansen/Johnson & Johnson. Dr. Habib has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMDSerono/Merck. Dr. Habib has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NIH/NINDS. Dr. Habib has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Immunis Biomedical. Dr. Habib has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Hoffman-La Roche. Dr. Habib has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Habib has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alexion. Dr. Habib has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for argenx. Dr. Habib has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for UCB. Dr. Habib has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Jansen/Joohnson & Johnson. The institution of Dr. Habib has received research support from Alexion. The institution of Dr. Habib has received research support from Horizon/Amgen. The institution of Dr. Habib has received research support from Immunovant. The institution of Dr. Habib has received research support from UCB. The institution of Dr. Habib has received research support from argenx. The institution of Dr. Habib has received research support from CabalettaBio. The institution of Dr. Habib has received research support from Regeneron. The institution of Dr. Habib has received research support from Arcellx. The institution of Dr. Habib has received research support from Novartis. The institution of Dr. Habib has received research support from EMDSerono/Merck. The institution of Dr. Habib has received research support from Cour Pharmaceuticals.
Luis Idrovo Freire, MD	No disclosure on file
Tobias Loddenkemper, MD, FAAN	No disclosure on file
Christopher Giza, MD, FAAN	Dr. Giza has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Medical Network Speakers Bureau. Dr. Giza has stock in Highmark Interactive. The institution of Dr. Giza has received research support from UCLA: Brain Injury Research Center, Steve Tisch BrainSPORT Program, Easton Clinic for Brain Health. Dr. Giza has received publishing royalties from a publication relating to health care. Dr. Giza has a non-compensated relationship as a Advisory Board with Major League Soccer that is relevant to AAN interests or activities. Dr. Giza has a non-compensated relationship as a Advisory Board with National Basketball Association that is relevant to AAN interests or activities. Dr. Giza has a non-compensated relationship as a Consultant with United States Soccer Federation that is relevant to AAN interests or activities. Dr. Giza has a non-compensated relationship as a Co-founder & Advisor with Symptomwise that is relevant to AAN interests or activities.
Arielle M. Kurzweil, MD, FAAN	Dr. Kurzweil has nothing to disclose.
Lee Birnbaum, MD	Dr. Birnbaum has nothing to disclose.
Mark Hamilton, MD	Dr. Hamilton has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Integra International. Dr. Hamilton has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer Nature. The institution of Dr. Hamilton has received research support from Hydrocephalus Association. The institution of Dr. Hamilton has received research support from NIH. The institution of Dr. Hamilton has received research support from Alberta Innovates.
Ravan J. Carter	No disclosure on file
Mohamad Orabi, MD	No disclosure on file
Jung Bin Kim, MD	No disclosure on file
Nour Baki, MD	No disclosure on file
Salman Zahoor, MBBS	Dr. Zahoor has nothing to disclose.
Hatem Shehata, MD	Dr. Shehata has nothing to disclose.
Paul W. Hurd, MD	No disclosure on file
David P. Bissig, MD	Dr. Bissig has received personal compensation in the range of $100,000-$499,999 for serving as a Physician with University of California - Davis.
Jennifer Arjona	No disclosure on file
Carmela Tartaglia, MD	Dr. Tartaglia has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. The institution of Dr. Tartaglia has received research support from NIH. The institution of Dr. Tartaglia has received research support from University of Toronto.
Alicja Kalinowska-Lyszczarz, MD	No disclosure on file
Gary S. Gronseth, MD, FAAN	Dr. Gronseth has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Brain & Life. Dr. Gronseth has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology. Dr. Gronseth has received personal compensation in the range of $0-$499 for serving as a Member/EBM consultant Guideline Development Subcommittee with AAN.
Stephen Krieger, MD, FAAN	Dr. Krieger has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. Dr. Krieger has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for EMD Serono. Dr. Krieger has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech. Dr. Krieger has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Krieger has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for TG Therapeutics. Dr. Krieger has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Krieger has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cycle. The institution of Dr. Krieger has received research support from Novartis. The institution of Dr. Krieger has received research support from Bristol Myers Squibb. The institution of Dr. Krieger has received research support from Biogen. The institution of Dr. Krieger has received research support from Sanofi.
Sandra Weintraub, PhD, FAAN	Dr. Weintraub has nothing to disclose.
Christiana Evers	No disclosure on file
Churl-Su Kwon, MBBS	Dr. Kwon has nothing to disclose.
Peter A. Ljubenkov, MD	Dr. Ljubenkov has nothing to disclose.
Alessandro Biffi, MD	Dr. Biffi has received personal compensation for serving as an employee of Eli Lilly And Company. Dr. Biffi has stock in Eli Lilly And Company.
Shyam S. Rao, MD	No disclosure on file
Irene Vavasour, PhD	Dr. Vavasour has nothing to disclose.
Avinash R. Sagi, MBBS	No disclosure on file
Mahesh Jayaraman	No disclosure on file
Yu-Ting Chen, MD	Dr. Chen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alnylam.
Lucinda L. Hugos, PT	Ms. Hugos has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GW Pharmaceuticals. Ms. Hugos has received personal compensation in the range of $0-$499 for serving as a Consultant for Evidera, Inc.. Ms. Hugos has received personal compensation in the range of $0-$499 for serving as a Consultant for Techspert.io Ltd.. Ms. Hugos has received research support from Portland VA. Ms. Hugos has received research support from Oregon Health & Science University. Ms. Hugos has received research support from Oregon Health & Science University. Ms. Hugos has received publishing royalties from a publication relating to health care.
Tijil Agarwal, MD	Dr. Agarwal has nothing to disclose.
Stefan Nicolau, MD	The institution of Dr. Nicolau has received research support from Muscular Dystrophy association. The institution of Dr. Nicolau has received research support from American Brain Foundation. The institution of Dr. Nicolau has received research support from American Neuromuscular Foundation.
Payam Moein, MD	No disclosure on file
Yasser Kabbani, MD	No disclosure on file
Benjamin M. Greenberg, MD, FAAN	Dr. Greenberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Greenberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Greenberg has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for EMD Serono. Dr. Greenberg has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amgen. Dr. Greenberg has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Sanofi/Genzyme. Dr. Greenberg has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech/Roche. Dr. Greenberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Signant. Dr. Greenberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for IQVIA. Dr. Greenberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sandoz. Dr. Greenberg has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Clene. Dr. Greenberg has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for TG Therapeutics. Dr. Greenberg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for IQVIA. Dr. Greenberg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abcuro. Dr. Greenberg has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Siegel Rare Neuroimmune Association. Dr. Greenberg has or had stock in GenrAb.Dr. Greenberg has or had stock in Clene.Dr. Greenberg has received intellectual property interests from a discovery or technology relating to health care. Dr. Greenberg has received publishing royalties from a publication relating to health care.
Teerin Liewluck, MD, FAAN	Dr. Liewluck has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sarepta Therapeutics. Dr. Liewluck has received publishing royalties from a publication relating to health care.
David A. Wolk, MD, FAAN	Dr. Wolk has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly. Dr. Wolk has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Functional Neuromodulation. Dr. Wolk has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for GSK. The institution of Dr. Wolk has received research support from Biogen. Dr. Wolk has received publishing royalties from a publication relating to health care. Dr. Wolk has received personal compensation in the range of $5,000-$9,999 for serving as a CME speaker with Eli Lilly.
Jeffrey Ralph, MD	No disclosure on file
Yazan M. Suradi, MD	No disclosure on file
Stefano Magon	Stefano Magon has received personal compensation for serving as an employee of F. Hoffmann-La Roche Ltd.. Stefano Magon has stock in F. Hoffmann-La Roche Ltd..
Adeolu O. Morawo, MD	Dr. Morawo has nothing to disclose.
Lixin Zhou	Lixin Zhou has nothing to disclose.
Elizabeth Fisher	Elizabeth Fisher has received personal compensation for serving as an employee of Biogen. Elizabeth Fisher has stock in Biogen. Elizabeth Fisher has received intellectual property interests from a discovery or technology relating to health care.
Fei-Fei Zhai	Fei-Fei Zhai has nothing to disclose.
Gene Y. Sung, MD, MPH	The institution of Dr. Sung has received research support from NIH.
Richard F. Lewis, MD	No disclosure on file
Amro Stino, MD	Dr. Stino has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for CSL Behring. Dr. Stino has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Argenx. Dr. Stino has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Takeda. Dr. Stino has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Dr. Stino has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Annexon. The institution of Dr. Stino has received research support from GBS-CIDP Foundation. The institution of Dr. Stino has received research support from Bristol Myers Squibb.
Sevasti Bostantjopoulou-Kambouroglou, MD	No disclosure on file
Michael Reznik, MD	Dr. Reznik has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Morrison Mahoney. The institution of Dr. Reznik has received research support from NIDUS.
Brian Mac Grory, MB BCh BAO	An immediate family member of Dr. Mac Grory has received personal compensation for serving as an employee of Sanofi. Dr. Mac Grory has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Stroke. The institution of Dr. Mac Grory has received research support from National Institutes of Health. The institution of Dr. Mac Grory has received research support from American Heart Association.
Andreas Jeromin, PhD	Dr. Jeromin has received personal compensation for serving as an employee of AlzPath, Inc. Dr. Jeromin has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Quanterx.
Lauren C. Frey, MD	No disclosure on file
Julie A. Fields, PhD	The institution of Dr. Fields has received research support from National Institutes of Health. The institution of Dr. Fields has received research support from Patient-Centered Outcomes Research Institute.
Antje Bischof, MD	Dr. Bischof has nothing to disclose.
Russell Sawyer, MD	No disclosure on file
Deepti Putcha, PhD	No disclosure on file
Elizabeth Spurgeon, MD	Dr. Spurgeon has nothing to disclose.
Tatiana Foroud, PhD	The institution of Dr. Foroud has received research support from NIH. The institution of Dr. Foroud has received research support from Michael J. Fox Foundation. The institution of Dr. Foroud has received research support from Parkinson Foundation. Dr. Foroud has received personal compensation in the range of $500-$4,999 for serving as a Member of an Advisory Committee with Mayo Clinic, University of Pennsylvania, Allen Institute, Mt. Sinai, Van Andel Institute.
Jiangyong Min, MD	Dr. Min has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medtronic . Dr. Min has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for CredentialMed, LLC. The institution of Dr. Min has received research support from Corerwell Health Foundation .
Gaetano Perrotta, MD	No disclosure on file
Yael Shiloh-Malawsky, MD	Dr. Shiloh-Malawsky has nothing to disclose.
Gabriel Pardo, MD, FAAN	Dr. Pardo has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche Genentech. Dr. Pardo has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi Genzyme. Dr. Pardo has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for EMD Serono. Dr. Pardo has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Pardo has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for TG Therapeutics. Dr. Pardo has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen . Dr. Pardo has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Bristol Myers Squibb. Dr. Pardo has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for EMD Serono. Dr. Pardo has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Pardo has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Roche Genentech. Dr. Pardo has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Sanofi Genzyme. Dr. Pardo has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for TG Therapeutics. Dr. Pardo has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Amgen. Dr. Pardo has or had stock in Progentec Diagnostics.Dr. Pardo has or had stock in Cadenza Bio.
Tamer Abdelhak, MD	Dr. Abdelhak has nothing to disclose.
Cristina Valencia Sanchez, MD	Dr. Valencia Sanchez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG therapeutics. Dr. Valencia Sanchez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Valencia Sanchez has a non-compensated relationship as a member of the medical advisory board with The MOG Project that is relevant to AAN interests or activities.
Bassel Raad, MD	No disclosure on file
Zahinoor Ismail, MD	No disclosure on file
Eric D. Marsh, MD, PhD	Dr. Marsh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Acadia Pharmacuticals. Dr. Marsh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Stoke Therapeutics. Dr. Marsh has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Acadia Pharmaceuticals. The institution of Dr. Marsh has received research support from NIH. The institution of Dr. Marsh has received research support from Rett Syndrome Research Trust. The institution of Dr. Marsh has received research support from International Rett Syndrome Foundation. The institution of Dr. Marsh has received research support from Eagles Autism Challenge. The institution of Dr. Marsh has received research support from LouLou Foundation. The institution of Dr. Marsh has received research support from International CDKL5 Resarch Foundation. The institution of Dr. Marsh has received research support from Acadia Pharmaceuticals. The institution of Dr. Marsh has received research support from Marinus. The institution of Dr. Marsh has received research support from Stoke Therapeutics. The institution of Dr. Marsh has received research support from Takeda Pharmaceuticals. Dr. Marsh has received personal compensation in the range of $500-$4,999 for serving as a Grant Review with NIH. Dr. Marsh has received personal compensation in the range of $5,000-$9,999 for serving as a Expert Witness with Department of Human Services. Dr. Marsh has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Medscape.
Aparna Vaddiparti, MD	Dr. Vaddiparti has nothing to disclose.
Jennifer Wax, MD	No disclosure on file
Hamidreza Saber, MD	No disclosure on file
Renato Arruda, MD	No disclosure on file
Ming Yao	Ming Yao has nothing to disclose.
Lakshmi Arbatti, NLP	Mrs. Arbatti has received personal compensation for serving as an employee of Grey Matter Technologies, LLC.
Steven Fussner, MD	No disclosure on file
Ibrahim Migdady, MD	Dr. Migdady has nothing to disclose.
Katarina B. Dakay, DO	No disclosure on file
Gloria Ortiz-Guerrero	No disclosure on file
Ana G. Cristancho, MD, PhD	Dr. Cristancho has nothing to disclose.
Utku Uysal, MD	Dr. Uysal has nothing to disclose.
James Jackson	James Jackson has nothing to disclose.
David Chaar, MD	Dr. Chaar has nothing to disclose.
Jessica Collins, PhD	No disclosure on file
Casey J. Judge, DO	Dr. Judge has nothing to disclose.
Mohammad Rauf A. Chaudhry, MD	Dr. Chaudhry has nothing to disclose.
Elizabeth Dvorak	No disclosure on file
Poljanka Johnson	Ms. Johnson has nothing to disclose.
Adam Staffaroni	Adam Staffaroni has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alector. Adam Staffaroni has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Aviado Bio. Adam Staffaroni has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CervoMed. Adam Staffaroni has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Prevail Therepeutics/Eli Lilly. Adam Staffaroni has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Takeda. The institution of Adam Staffaroni has received research support from NIH. The institution of Adam Staffaroni has received research support from Bluefield Project To Cure FTD. The institution of Adam Staffaroni has received research support from AFTD/ALSA. Adam Staffaroni has received personal compensation in the range of $500-$4,999 for serving as a Scientific Advisory Board member with AADF.
James R. Ghattas, DO	No disclosure on file
Tarek E. Ali, MBBS	Dr. Ali has nothing to disclose.
Aidan Azher, MD	Dr. Azher has nothing to disclose.
Thangjam S. Singh, MD, MBBS	No disclosure on file
Amr Mohammed	No disclosure on file
Ricardo Bruña	No disclosure on file
Sean P. Reilly	No disclosure on file
Michelle Rainka, PharmD	Dr. Rainka has stock in Abbvie. Dr. Rainka has stock in acadia. Dr. Rainka has stock in alon. Dr. Rainka has stock in biogen. Dr. Rainka has stock in bristol myers squib. Dr. Rainka has stock in eisai. Dr. Rainka has stock in Lilly. Dr. Rainka has stock in novartis. Dr. Rainka has stock in pfizer. Dr. Rainka has stock in roche. Dr. Rainka has stock in Sage. Dr. Rainka has stock in alkermes.
Alexandra B. Kornbluh, MD	Dr. Kornbluh has nothing to disclose.
Tamra I. Ranasinghe, MD	Dr. Ranasinghe has nothing to disclose.
Muhammad Rizwan Husain, MD	Dr. Husain has nothing to disclose.
Sergio A. Castillo-Torres, MD	No disclosure on file
Katherine Moretz, MD	No disclosure on file
Nathan P. Fenstermacher	Mr. Fenstermacher has nothing to disclose.
Juan Pablo Pauta Martinez, MD	Dr. Pauta Martinez has nothing to disclose.
Donna Tippett	No disclosure on file
Jason Weller, MD	Dr. Weller has nothing to disclose.
Jenny J. Feng, MD	Dr. Feng has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Feng has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol Myers Squibb. Dr. Feng has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Feng has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon.
Elisabetta Signoriello	Elisabetta Signoriello has nothing to disclose.
Ghazala Perven, MD	Dr. Perven has nothing to disclose.
Eoin Finegan, MBBS	Dr. Finegan has nothing to disclose.
Reza Bavarsad Shahripour, MD	Dr. Bavarsad Shahripour has nothing to disclose.
GyeongMo Sohn, MD	Dr. Sohn has nothing to disclose.
Sushant Puri, MBBS	Dr. Puri has nothing to disclose.
Neel N. Patel	No disclosure on file
Syed A. Quadri, MD	Dr. Quadri has nothing to disclose.
Martin A. Myers, MD	No disclosure on file
Yuehui Hong	Ms. Hong has nothing to disclose.
Flavia Nelson, MD	Dr. Nelson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Brystol Meyer Squib. Dr. Nelson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Nelson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Nelson has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Genetech. The institution of Dr. Nelson has received research support from NIH. Dr. Nelson has received research support from Novartis.
Hai Chen, MD, PhD	Dr. Chen has nothing to disclose.
Michael R. Sperling, MD, FAAN	Dr. Sperling has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurelis. The institution of Dr. Sperling has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medtronic. Dr. Sperling has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB Pharma. Dr. Sperling has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Medscape. Dr. Sperling has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for International Medical Press. Dr. Sperling has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Projects for Knowledge. The institution of Dr. Sperling has received research support from SK Life Science. The institution of Dr. Sperling has received research support from UCB Pharma . The institution of Dr. Sperling has received research support from Takeda. The institution of Dr. Sperling has received research support from Neurelis. The institution of Dr. Sperling has received research support from Engage Therapeutics . The institution of Dr. Sperling has received research support from Medtronic. The institution of Dr. Sperling has received research support from Cavion. The institution of Dr. Sperling has received research support from Xenon Pharma. The institution of Dr. Sperling has received research support from Cerevel. The institution of Dr. Sperling has received research support from National Institutes of Health . The institution of Dr. Sperling has received research support from DARPA. Dr. Sperling has received publishing royalties from a publication relating to health care. Dr. Sperling has received publishing royalties from a publication relating to health care. Dr. Sperling has received personal compensation in the range of $500-$4,999 for serving as a Vice President with Epilepsy Consortium .
Larry B. Goldstein, MD, FAHA, FAAN	The institution of Dr. Goldstein has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen. The institution of Dr. Goldstein has received research support from NIH. The institution of Dr. Goldstein has received research support from NIH. Dr. Goldstein has received intellectual property interests from a discovery or technology relating to health care. Dr. Goldstein has received publishing royalties from a publication relating to health care.
Divya Singhal, MD, FAAN	Dr. Singhal has nothing to disclose.
Gregory J. Esper, MD, MBA, FAAN	Dr. Esper has or had stock in NeuroOne Medical Technologies, Inc.Dr. Esper has or had stock in Focused Cryo, Inc. The institution of an immediate family member of Dr. Esper has received research support from Centers for Disease Control. The institution of Dr. Esper has received research support from Health and Human Services Assistant Secretary for Preparedness and Response. An immediate family member of Dr. Esper has received publishing royalties from a publication relating to health care.
Tanuja Chitnis, MD, FAAN	Dr. Chitnis has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Chitnis has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche-Genentech. Dr. Chitnis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Octave Biosciences. Dr. Chitnis has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi. The institution of Dr. Chitnis has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. The institution of Dr. Chitnis has received research support from Novartis. The institution of Dr. Chitnis has received research support from Sanofi. The institution of Dr. Chitnis has received research support from Octave. The institution of Dr. Chitnis has received research support from Genentech-Roche. The institution of Dr. Chitnis has received research support from Tiziana Life Sciences. The institution of Dr. Chitnis has received research support from Bristol-Myers Squibb. The institution of Dr. Chitnis has received research support from Wesley Clover.
Ali Mahta, MD	Dr. Mahta has received research support from Brown University Health.
Deepmala Nandanwar, MD	Dr. Nandanwar has nothing to disclose.
Jason H. Margolesky, MD, FAAN	Dr. Margolesky has nothing to disclose.
Joshua Barton, MD	No disclosure on file
Mayur Chalia, MD	Dr. Chalia has nothing to disclose.
Ihtesham A. Qureshi, MD	No disclosure on file
Zara Fatima, MD	No disclosure on file
Umer Najib, MD, FAAN	Dr. Najib has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer. Dr. Najib has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lundbeck . Dr. Najib has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Abbvie . The institution of Dr. Najib has received research support from Eli Lilly. The institution of Dr. Najib has received research support from Abbvie.
Eldbjorg Hustad, MD, PhD	No disclosure on file
Joyce A. Jimenez Zambrano, MD	Dr. Jimenez Zambrano has nothing to disclose.
Riadh Gouider, MD, FAAN	Dr. Gouider has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Gouider has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Gouider has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Gouider has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Gouider has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Hikma. The institution of Dr. Gouider has received research support from Clinical Investigation Center. The institution of Dr. Gouider has received research support from Menactrims.
Shailee S. Shah, MD	Dr. Shah has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon Therapeutics. Dr. Shah has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Shah has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Shah has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Shah has received publishing royalties from a publication relating to health care.
Hisham G. Elkhider, MD	Dr. Elkhider has nothing to disclose.
ShuTing Chen	The institution of ShuTing Chen has received research support from Ministry of Science and Technology (Taiwan). The institution of ShuTing Chen has received research support from Taipei Veterans General Hospital .
Traci Aladeen, PharmD	Dr. Aladeen has nothing to disclose.
Leila Saadatpour, MD	Dr. Saadatpour has nothing to disclose.
Revital Aricha	Revital Aricha has nothing to disclose.
Phong T. Vu, MD	Dr. Vu has nothing to disclose.
Nabil Wees, MD	Dr. Wees has nothing to disclose.
Ann Van De Walle Jones, MD	Dr. Van De Walle Jones has nothing to disclose.
Peter Sguigna, MD	Dr. Sguigna has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Sguigna has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Sguigna has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Horizon Therapeutics. The institution of Dr. Sguigna has received research support from Genentech. The institution of Dr. Sguigna has received research support from Clene Nanomedicine. The institution of Dr. Sguigna has received research support from The International Progressive Multiple Sclerosis Alliance through the National Multiple Sclerosis Society. The institution of Dr. Sguigna has received research support from PCORI. The institution of Dr. Sguigna has received research support from DOD/CDMRP. The institution of Dr. Sguigna has received research support from Alexion. Dr. Sguigna has received intellectual property interests from a discovery or technology relating to health care.
Melissa Schorn, ARNP, DNP	No disclosure on file
Shu-Yang Zhang	No disclosure on file
Panagiotis Zis, MBBS, PhD	No disclosure on file
Sarah Ganji, MD	No disclosure on file
Mark A. Pippenger, MD	No disclosure on file
Christine Tomkinson, MD	No disclosure on file
Emmanuelle Waubant, MD, PhD, FAAN	The institution of Dr. Waubant has received research support from NIH. The institution of Dr. Waubant has received research support from NMSS. The institution of Dr. Waubant has received research support from PCORI. The institution of Dr. Waubant has received research support from Race to Erase MS. The institution of Dr. Waubant has received research support from Roche. The institution of Dr. Waubant has received research support from Department of Defense. Dr. Waubant has received publishing royalties from a publication relating to health care.
Marco A. Arruda, MD, PhD	No disclosure on file
David W. Brandes, MD, FAAN	No disclosure on file
Ruple S. Laughlin, MD, FAAN	Dr. Laughlin has nothing to disclose.
Ann H. Tilton, MD, FAAN	Dr. Tilton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ipsen. Dr. Tilton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Tilton has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ipsen. Dr. Tilton has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie. Dr. Tilton has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Ipsen. Dr. Tilton has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbvie. Dr. Tilton has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Up to Date.
Ami Cuneo, MD	Dr. Cuneo has nothing to disclose.
Francisco Gascon	Francisco Gascon has received personal compensation in the range of $500-$4,999 for serving as a Consultant for SANOFI. Francisco Gascon has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ROCHE. Francisco Gascon has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for SANOFI. Francisco Gascon has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ROCHE. Francisco Gascon has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BIOGEN. Francisco Gascon has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for MERCK. Francisco Gascon has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for ROCHE. Francisco Gascon has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for SANOFI. The institution of Francisco Gascon has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for NOVARTIS. Francisco Gascon has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for TEVA. Francisco Gascon has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for ALMIRALL.
Jennifer Bain, MD, PhD	Dr. Bain has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Guidepoint Consulting. Dr. Bain has received personal compensation in the range of $0-$499 for serving as a Consultant for M3 Consulting. Dr. Bain has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Legal Company . Dr. Bain has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Grin Therapeutics. The institution of Dr. Bain has received research support from Yellow Brick Road Project.
Catherine Kopil	No disclosure on file
Deena Nasr, DO	Dr. Nasr has nothing to disclose.
Ovais Inamullah, MD	Dr. Inamullah has nothing to disclose.
Julie McDaniel, MD	Dr. McDaniel has nothing to disclose.
Carlos R. Camara-Lemarroy, MD	Dr. Camara-Lemarroy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for emd serono. Dr. Camara-Lemarroy has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for novartis. Dr. Camara-Lemarroy has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for amgen. Dr. Camara-Lemarroy has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for novartis.
Sara Moreno Garcia, MD	No disclosure on file
Bonnie Wong, MD, MPH	Dr. Wong has nothing to disclose.
Shannon Y. Chiu, MD, MSc	Dr. Chiu has received research support from NIH.
Ferdinand Schweser, PhD	Dr. Schweser has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier.
Serdar Ceylaner	Serdar Ceylaner has nothing to disclose.
Fei Han	Fei Han has nothing to disclose.
Ming-Li Li	No disclosure on file
Jun Ni	Jun Ni has nothing to disclose.
Muhammad Affan, MD	Dr. Affan has nothing to disclose.
Sebastiano Galantucci	Mr. Galantucci has nothing to disclose.
Brian Appleby, MD	Dr. Appleby has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Acadia. Dr. Appleby has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Ionis. Dr. Appleby has received personal compensation in the range of $0-$499 for serving as a Consultant for Sangamo. The institution of Dr. Appleby has received research support from CJD Foundation. The institution of Dr. Appleby has received research support from Ionis. The institution of Dr. Appleby has received research support from Alector. The institution of Dr. Appleby has received research support from CDC. The institution of Dr. Appleby has received research support from NIH. Dr. Appleby has received publishing royalties from a publication relating to health care. Dr. Appleby has received publishing royalties from a publication relating to health care.
Sarah Madani, MD	No disclosure on file
Jeffrey S. Phillips, PhD	No disclosure on file
Chantal Bhan, DO	Dr. Bhan has nothing to disclose.
Orell Mielke, MD	No disclosure on file
Zoe Katsarou, MD	No disclosure on file
Matthew Carraro	Dr. Carraro has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Carraro has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. Dr. Carraro has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Carraro has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG therapeutics. Dr. Carraro has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Carraro has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for EMD Serono. Dr. Carraro has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for TG therapeutics. Dr. Carraro has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. Dr. Carraro has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Sanofi.
Christina Kourkoulis	No disclosure on file
Sunil Sheth, MD	Dr. Sheth has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Penumbra. Dr. Sheth has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cerenovus. Dr. Sheth has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Imperative Care.
Muhammad M. Alvi, MD, FAAN	Dr. Alvi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Brainomix.
Andrew T. DeMarco, PhD, CCC-SLP	Dr. DeMarco has nothing to disclose.
Anthony E. Lang, MD, FAAN	Dr. Lang has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for AbbVie, Amylyx, Aprinoia, Biogen, BioAdvance, Biohaven, BioVie, BlueRock, BMS, Denali, Janssen, Lilly, Pharma 2B, Sun Pharma, and UCB. Dr. Lang has received personal compensation in the range of $50,000-$99,999 for serving as an Expert Witness for medicolegal cases related to paraquat. The institution of Dr. Lang has received research support from AbbVie. Dr. Lang has received intellectual property interests from a discovery or technology relating to health care. Dr. Lang has received publishing royalties from a publication relating to health care.
Richard B. Lipton, MD, FAAN	Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Allergan/Abbvie. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Amgen. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biohaven. Dr. Lipton has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Eli Lilly. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lundbeck. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for GlaxoSmithKline. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Teva. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Vedanta. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Grifols. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Pfizer. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Axon. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Satsuma. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cool Tech. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BDSI. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Linpharma. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Axsome. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Clexio. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Shiratronics. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Allergan/Abbvie. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biohaven. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eli Lilly. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck. Dr. Lipton has or had stock in Biohaven.Dr. Lipton has or had stock in Manistee.Dr. Lipton has or had stock in Axon.Dr. Lipton has or had stock in CoolTech. The institution of Dr. Lipton has received research support from Teva. The institution of Dr. Lipton has received research support from Amgen. The institution of Dr. Lipton has received research support from Allergan/Abbvie. The institution of Dr. Lipton has received research support from Gammacore. The institution of Dr. Lipton has received research support from Axsome. The institution of Dr. Lipton has received research support from Charleston Labs. The institution of Dr. Lipton has received research support from Eli Lilly. The institution of Dr. Lipton has received research support from Satsuma. The institution of Dr. Lipton has received research support from NIH . The institution of Dr. Lipton has received research support from Veterans Administration. Dr. Lipton has received publishing royalties from a publication relating to health care.
Bradley F. Boeve, MD, FAAN	Dr. Boeve has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Rainwater Charitable Foundation. The institution of Dr. Boeve has received research support from Alector. The institution of Dr. Boeve has received research support from EIP Pharma. The institution of Dr. Boeve has received research support from Transposon. The institution of Dr. Boeve has received research support from Cognition Therapeutics. Dr. Boeve has received publishing royalties from a publication relating to health care.
Milena Stosic, MD	No disclosure on file
Leonardo F. Bonilha, MD	Dr. Bonilha has nothing to disclose.
Lydia Sharp, MD	The institution of Dr. Sharp has received research support from McNair Foundation. The institution of Dr. Sharp has received research support from ALS Association.
Joseph Zachariah, DO	Dr. Zachariah has nothing to disclose.
Alicia E. Bennett, DO	Dr. Bennett has nothing to disclose.
Verena C. Samara, MD	An immediate family member of Dr. Samara has received personal compensation for serving as an employee of Supernus. The institution of Dr. Samara has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. The institution of Dr. Samara has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Argenx. The institution of Dr. Samara has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for UCB. The institution of Dr. Samara has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Johnson and Johnson. An immediate family member of Dr. Samara has stock in Supernus.
Michael Bazelot, PhD	No disclosure on file
Lisa Eunyoung Lee	Lisa Eunyoung Lee has nothing to disclose.
Asad M. Yousuf, MD	No disclosure on file
Stephen W. English, MD	Dr. English has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Brainomix.
Yasmeen Rauf, MBBS	Dr. Rauf has nothing to disclose.
Stewart A. Weber, MD	No disclosure on file
Anusha Boyanpally, MBBS	No disclosure on file
Billie Durn	No disclosure on file
Tom Fuchs	Mr. Fuchs has nothing to disclose.
Kathleen C. Somera-Molina, PhD	Dr. Somera-Molina has received personal compensation for serving as an employee of Biogen. Dr. Somera-Molina has received stock or an ownership interest from Biogen.
Ashutosh Kaushal, MD	No disclosure on file
Catherine McDermott	No disclosure on file
Mihir Kakara, MD	Dr. Kakara has nothing to disclose.
Elizabeth Poole	No disclosure on file
Arthur Alcantara Lima, MD	Dr. Alcantara Lima has nothing to disclose.
Amjad Tarboosh, MD	No disclosure on file
Sara Dawit, MD	Dr. Dawit has nothing to disclose.
Eric Kimmel, MD	No disclosure on file
Akta Patel, DO	No disclosure on file
Adriana Carra	No disclosure on file
Nikesh Bajaj, DO	Dr. Bajaj has received personal compensation for serving as an employee of Barrow Neurologal Institute Fellowship .
Shaoleen Khaled	No disclosure on file
Shilpa Chaku, MD	No disclosure on file
Alexis A. Lizarraga, MD	Dr. Lizarraga has nothing to disclose.
Shareena A. Rahman, MD	Dr. Rahman has nothing to disclose.
Siva P. Pesala, MD	No disclosure on file
Sirin Gandhi, MBBS	Dr. Gandhi has nothing to disclose.
Torrey B. Birch, MD, FAAN	Dr. Birch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Annexon Biosciences.
Abdullah Ishaque	Abdullah Ishaque has nothing to disclose.
Francisco Perez Miralles, MD	Dr. Perez Miralles has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Mylan. Dr. Perez Miralles has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Roche. Dr. Perez Miralles has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Sanofi-Aventis. Dr. Perez Miralles has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen.
Matthew Varon, MD	Dr. Varon has nothing to disclose.
Owen T. Owens, DO	Dr. Owens has nothing to disclose.
Christa B. Swisher, MD	Dr. Swisher has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB.
Rajiv Patni, MD	No disclosure on file
Abul K. Shoab, MD, FAAN	Dr. Shoab has nothing to disclose.
David T. Poliner, DO	No disclosure on file
Diana Mnatsakanova, MD	Dr. Mnatsakanova has received personal compensation in the range of $500-$4,999 for serving as a Consultant for OptumRx. Dr. Mnatsakanova has received research support from Mitsubishi .
Matthew Chung, MD	No disclosure on file
Laura Gaetano	Laura Gaetano has received personal compensation for serving as an employee of Roche. Laura Gaetano has received stock or an ownership interest from Roche.
Mary Comeau	No disclosure on file
Andrew Lin, MD	No disclosure on file
Annie S. Daniel, MBBS	Dr. Daniel has nothing to disclose.
Annemie Ribbens	Annemie Ribbens has received personal compensation for serving as an employee of icometrix. Annemie Ribbens has stock in icometrix. Annemie Ribbens has received intellectual property interests from a discovery or technology relating to health care.
Tracy Brandt, PhD	No disclosure on file
Tapan Mehta, MD	Dr. Mehta has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Balt, Medtronic, J&J, Terumo.
Jeffrey Ruta, MD	Dr. Ruta has nothing to disclose.
Neill R. Graff-Radford, MD, FAAN	The institution of Dr. Graff-Radford has received research support from Biogen. The institution of Dr. Graff-Radford has received research support from Lilly. The institution of Dr. Graff-Radford has received research support from Eisai. The institution of Dr. Graff-Radford has received research support from Biogen. Dr. Graff-Radford has received publishing royalties from a publication relating to health care.
Eelco F. Wijdicks, MD, FAAN	Dr. Wijdicks has received publishing royalties from a publication relating to health care.
Milvia Y. Pleitez, MD	An immediate family member of Dr. Pleitez has received stock or an ownership interest from Medtronic. Dr. Pleitez has received stock or an ownership interest from Abbvie. An immediate family member of Dr. Pleitez has received stock or an ownership interest from Merck. Dr. Pleitez has received stock or an ownership interest from QualCom.
Chun Chu, MD, PhD	Dr. Chu has nothing to disclose.
Stephen Hantus, MD	Dr. Hantus has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai. Dr. Hantus has received personal compensation in the range of $0-$499 for serving as a Consultant for UCB.
Ivo Bach, MD	Dr. Bach has nothing to disclose.
Bradford Dickerson, MD, FAAN	Dr. Dickerson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Dickerson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Acadia. Dr. Dickerson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Arkuda. Dr. Dickerson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai. Dr. Dickerson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lantheus. Dr. Dickerson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lilly. Dr. Dickerson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Dickerson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novo Nordisk. Dr. Dickerson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Dickerson has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Arkuda. Dr. Dickerson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Acadia. Dr. Dickerson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lilly. Dr. Dickerson has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. Dr. Dickerson has received publishing royalties from a publication relating to health care. Dr. Dickerson has received publishing royalties from a publication relating to health care.
Nawaz Hack, MD	Dr. Hack has nothing to disclose.
Yvette Bordelon, MD, PhD, FAAN	Dr. Bordelon has nothing to disclose.
Douglas C. Wallace	No disclosure on file
Nicholas S. Potter, MD, PhD	Dr. Potter has nothing to disclose.
James Martinez	No disclosure on file
Stevon H. Boyett, DO	No disclosure on file
Nicholas A. Jones, PharmD	No disclosure on file
Fred Odago, MD	No disclosure on file
Andrew R. Romeo, MD	No disclosure on file
Cassandra P. Cross, MD	No disclosure on file
David E. Hale, Jr., MD	Dr. Hale has nothing to disclose.
Nikhil Choudhary, PT	No disclosure on file
Pamela Best	Ms. Best has nothing to disclose.
Ahmer Asif, MD	Dr. Asif has nothing to disclose.
Amina Nasri, MD	Dr. Nasri has nothing to disclose.
Fatima Al-Maadid, MD	No disclosure on file
Prashant Natteru, MBBS	Dr. Natteru has nothing to disclose.
Amy Brin	No disclosure on file
Arjun Seth, MD	Dr. Seth has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Argenx. Dr. Seth has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB Pharma. Dr. Seth has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Johnson and Johnson. Dr. Seth has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. Dr. Seth has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi.
Jessica Frey, MD	The institution of Dr. Frey has received research support from Tourette Association of America.
Smathorn Thakolwiboon, MD	Dr. Thakolwiboon has nothing to disclose.
Sylvie Goldman, PhD	Dr. Goldman has nothing to disclose.
Ji Y. Chong, MD	Dr. Chong has nothing to disclose.
Alok Dabi, MD, MBBS, FAAN	Dr. Dabi has nothing to disclose.
Harmanpreet Tiwana, MD	No disclosure on file
Ryan Castoro, DO	No disclosure on file
Jeffrey B. Schachter, MD	Dr. Schachter has nothing to disclose.
Riley Bove, MD, FAAN	Dr. Bove has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion. Dr. Bove has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amgen. Dr. Bove has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genzyme-Sanofi. Dr. Bove has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for TG Therapeutics. Dr. Bove has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for EMD-Serono. Dr. Bove has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cadenza. The institution of Dr. Bove has received research support from Biogen. The institution of Dr. Bove has received research support from Eli Lilly. The institution of Dr. Bove has received research support from Novartis. The institution of Dr. Bove has received research support from Roche Genentech.
Kiran Thakur, MD, FAAN	Dr. Thakur has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Delve Bio.
Christina Azevedo, MD, FAAN	Dr. Azevedo has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi Genzyme. Dr. Azevedo has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Zenas Biopharma. Dr. Azevedo has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Azevedo has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon Therapeutics. Dr. Azevedo has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Azevedo has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Wood, Smith, Henning & Berman LLP. The institution of Dr. Azevedo has received research support from National Multiple Sclerosis Society. The institution of Dr. Azevedo has received research support from National Institutes of Health/National Institutes of Neurological Disorders and Stroke. The institution of Dr. Azevedo has received research support from National Multiple Sclerosis Society.
Laura J. Balcer, MD, MSCE, FAAN	An immediate family member of Dr. Balcer has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Children's Hospital of Philadelphia.
Daniel Vela-Duarte, MD	Dr. Vela-Duarte has nothing to disclose.
Muhammad Al-Lozi, MD	Dr. Al-Lozi has nothing to disclose.
Rachel W. Pan, MD	No disclosure on file
Thomas Finnegan, Jr., PhD	Dr. Finnegan has nothing to disclose.
Alana Kornspun, MD	No disclosure on file
Daniel Prefasi	No disclosure on file
Ding-Ding Zhang	Ding-Ding Zhang has nothing to disclose.
Elisheva R. Coleman, MD	Dr. Coleman has nothing to disclose.
Alexander Bartnik	No disclosure on file
Daniele Litterio A. Spitaleri	Daniele Litterio A. Spitaleri has received research support from Novartis.
Charlotte Zhong, DO	No disclosure on file
Michael Isfort, MD	Dr. Isfort has nothing to disclose.
Anusha Mannava, MD	No disclosure on file
Daniel D. Barnett, MD	Dr. Barnett has nothing to disclose.
Neha Godbole	Ms. Godbole has nothing to disclose.
Mitchell S. Elkind, MD, MS, FAAN	Dr. Elkind has received personal compensation for serving as an employee of American Heart Association. Dr. Elkind has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Atria Academy.
Richard A. Rudick, MD, FAAN	Dr. Rudick has received personal compensation for serving as an employee of Biogen. Dr. Rudick has received stock or an ownership interest from Biogen. Dr. Rudick has received publishing royalties from a publication relating to health care.
Aksel Siva, MD	Dr. Siva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Siva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Siva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi-Genzyme. Dr. Siva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen - TR. Dr. Siva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Siva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ali Raif Pharmaceuticals, Turkiye. Dr. Siva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanovel Pharmaceuticals, Turkiye. Dr. Siva has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Siva has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abdi Ibrahim Ilac - TR. Dr. Siva has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck Serono . The institution of Dr. Siva has received research support from Turkish MS Society. The institution of Dr. Siva has received research support from The Scientific and Technological Research Council Of Turkey - Health Sciences Research Grants.
Matthew Senjem	Matthew Senjem has received stock or an ownership interest from Align Technology, Inc.. Matthew Senjem has received stock or an ownership interest from Inovio Biomedical Corp.. Matthew Senjem has received stock or an ownership interest from Johnson & Johnson. Matthew Senjem has received stock or an ownership interest from Mesa Laboratories, Inc.. Matthew Senjem has received stock or an ownership interest from Nvidia Inc.. Matthew Senjem has received stock or an ownership interest from LHC Group, Inc.. Matthew Senjem has received stock or an ownership interest from Natus Medical Incorporated. Matthew Senjem has received stock or an ownership interest from Varex Imaging Corporation. Matthew Senjem has received personal compensation in the range of $100,000-$499,999 for serving as a IT Technical Specialist II with Mayo Clinic.
Bakri Elsheikh, MD, FAAN	Dr. Elsheikh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen . Dr. Elsheikh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Argnex . The institution of Dr. Elsheikh has received research support from Biogen. The institution of Dr. Elsheikh has received research support from Cure SMA.
Matthew L. Flaherty, MD	Dr. Flaherty has received personal compensation for serving as an employee of Sense Diagnostics, Inc. Dr. Flaherty has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Boeringher Engelheim. Dr. Flaherty has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for CSL Behring. Dr. Flaherty has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Alexion. Dr. Flaherty has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for various law firms. Dr. Flaherty has stock in Sense Diagnostics, Inc. The institution of Dr. Flaherty has received research support from NINDS. Dr. Flaherty has received intellectual property interests from a discovery or technology relating to health care.
David Hojnacki, MD, FAAN	Dr. Hojnacki has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Hojnacki has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Hojnacki has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen.
Ryan Hays, MD, MBA, FAES, FAAN	Dr. Hays has nothing to disclose.
Claudio Solaro, MD	No disclosure on file
Lana Chahine, MD, FAAN	Dr. Chahine has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Gray Matters Technology. The institution of Dr. Chahine has received research support from UPMC. The institution of Dr. Chahine has received research support from MJFF. The institution of Dr. Chahine has received research support from Denali/Biogen. Dr. Chahine has received publishing royalties from a publication relating to health care.
Eugen Trinka	Eugen Trinka has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Eugen Trinka has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai. Eugen Trinka has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bial. Eugen Trinka has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GW Pharmaceuticals. The institution of Eugen Trinka has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Rapport. The institution of Eugen Trinka has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbott. The institution of Eugen Trinka has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Eugen Trinka has received research support from European Union. Eugen Trinka has received publishing royalties from a publication relating to health care.
Fabio Nascimento, MD	Dr. Nascimento has received publishing royalties from a publication relating to health care.
Emily J. Gilmore, MD	Dr. Gilmore has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for carpl.ai. Dr. Gilmore has received personal compensation in the range of $0-$499 for serving as a Consultant for AAN. Dr. Gilmore has received research support from NIH.
Lluis Ramio Torrenta	Lluis Ramio Torrenta has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for SANOFI. Lluis Ramio Torrenta has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ROCHE. Lluis Ramio Torrenta has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for SANOFI. Lluis Ramio Torrenta has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for ROCHE. Lluis Ramio Torrenta has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for BIOGEN. Lluis Ramio Torrenta has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for MERCK. Lluis Ramio Torrenta has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for TEVA. Lluis Ramio Torrenta has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for ALMIRALL.
Sara Beenders	No disclosure on file
Aditi Sharma, MBBS	Dr. Sharma has nothing to disclose.
Jeffrey Lambe, MD	Dr. Lambe has nothing to disclose.
Victor Mantelatto Bonsi	Victor Mantelatto Bonsi has nothing to disclose.
Luanne Metz, MD	The institution of Dr. Metz has received research support from Multiple Sclerosis Society of Canada. The institution of Dr. Metz has received research support from Calgary Health Trust. The institution of Dr. Metz has received research support from Government of Alberta.
Robert Zivadinov, MD, PhD, FAAN	The institution of Dr. Zivadinov has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS. The institution of Dr. Zivadinov has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Omnicuris. The institution of Dr. Zivadinov has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Myrobalan. Dr. Zivadinov has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. Dr. Zivadinov has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for EMD Serono. Dr. Zivadinov has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Bristol Myers Squibb. The institution of Dr. Zivadinov has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen.
Argye E. Hillis, MD, MA	Dr. Hillis has received personal compensation for serving as an employee of Johns Hopkins University. Dr. Hillis has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Heart Association. The institution of Dr. Hillis has received research support from NIH. Dr. Hillis has received publishing royalties from a publication relating to health care. Dr. Hillis has received personal compensation in the range of $500-$4,999 for serving as a NIDCD Council Member with NIH.
Orhun H. Kantarci, MD	Dr. Kantarci has nothing to disclose.
Christine Lebrun Frenay, MD, FAAN	Dr. Lebrun Frenay has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Revue Neurologique. The institution of Dr. Lebrun Frenay has received research support from FRANCE SEP.
Niels Bergsland	Prof. Bergsland has nothing to disclose.
Marcelo C. Kremenchutzky, MD, FAAN	No disclosure on file
Evanthia Bernitsas, MD, FAAN	Dr. Bernitsas has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. Dr. Bernitsas has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Vanda. The institution of Dr. Bernitsas has received research support from Roche/Genentech.
Gioacchino Tedeschi, MD	Dr. Tedeschi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Tedeschi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lilly. Dr. Tedeschi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis.
Jens Kuhle, MD	Dr. Kuhle has nothing to disclose.
Karen Marr, BA	No disclosure on file
Yi-Cheng Zhu, MD, PhD	Dr. Zhu has nothing to disclose.
Jonathan Howard, MD	Dr. Howard has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for MCE Conferences. Dr. Howard has received publishing royalties from a publication relating to health care. Dr. Howard has received publishing royalties from a publication relating to health care. Dr. Howard has received publishing royalties from a publication relating to health care. Dr. Howard has a non-compensated relationship as a Test writer with ABPN that is relevant to AAN interests or activities.
Oscar Fernandez, MD	No disclosure on file
Nitin Goyal, MD	No disclosure on file
Stephanie Grover, MSc, CCRP	No disclosure on file
David Pellerin, MD	Dr. Pellerin has nothing to disclose.
Klaudia Kukulka	No disclosure on file
Hunter L. Mitchell, MD	Dr. Mitchell has nothing to disclose.
Sarah Cotton	Sarah Cotton has nothing to disclose.
David Lacomis, MD, FAAN	Dr. Lacomis has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cytokinetics. The institution of Dr. Lacomis has received research support from Mitsubishi Tanabe. The institution of Dr. Lacomis has received research support from NIH. Dr. Lacomis has received publishing royalties from a publication relating to health care.
Murali Ramanathan, PhD	The institution of Dr. Ramanathan has received research support from DoD. Dr. Ramanathan has received publishing royalties from a publication relating to health care.
Jason S. Mackey, MD	Dr. Mackey has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for legal firms. The institution of Dr. Mackey has received research support from PCORI.
Francesco Sacca, MD, FAAN	Dr. Sacca has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Alexion. Dr. Sacca has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Argenx. Dr. Sacca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lexeo. Dr. Sacca has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. Dr. Sacca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genpharm. Dr. Sacca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Sacca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medpharma. Dr. Sacca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Madison Pharma. Dr. Sacca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Zai Lab. Dr. Sacca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Dianthus. Dr. Sacca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Reata. Dr. Sacca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sandoz. Dr. Sacca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neopharm Israel. Dr. Sacca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Johnson&Johnson. Dr. Sacca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Sacca has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Astrazeneca. The institution of Dr. Sacca has received research support from AIFA. The institution of Dr. Sacca has received research support from FARA.
Umer Akbar, MD	Dr. Akbar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for LANGaware.
Rodrigo Zepeda, MD	The institution of Dr. Zepeda has received research support from NIH.
Clara Chisari, MD	Clara Chisari, MD has nothing to disclose.
Brian G. Weinshenker, MD, FAAN	Dr. Weinshenker has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CANbridge Pharmaceuticals. Dr. Weinshenker has received personal compensation in the range of $0-$499 for serving as a Consultant for CALIBR. Dr. Weinshenker has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Horizon. Dr. Weinshenker has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Weinshenker has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche Group (Chugai, Genentech, Roche). Dr. Weinshenker has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB Pharmaceuticals. Dr. Weinshenker has received research support from Guthy Jackson Charitable Foundation. Dr. Weinshenker has received intellectual property interests from a discovery or technology relating to health care.
Geoffrey Manley, MD, PhD	The institution of Dr. Manley has received research support from NIH-NINDS. The institution of Dr. Manley has received research support from US Department of Defense. The institution of Dr. Manley has received research support from US Department of Defense/MTEC. The institution of Dr. Manley has received research support from One Mind. The institution of Dr. Manley has received research support from Neurotrauma Sciences, LLC. The institution of Dr. Manley has received research support from NFL Scientific Advisory Board.
Nils Henninger, MD, PhD, FANA, FWSO	Dr. Henninger has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Henninger has stock in United Health. Dr. Henninger has stock in Novo Nordisk. Dr. Henninger has stock in Elli Lilly. Dr. Henninger has stock in Kenvue. Dr. Henninger has stock in Voyager. Dr. Henninger has stock in Alnylam. Dr. Henninger has stock in Entrada. The institution of Dr. Henninger has received research support from NIH. Dr. Henninger has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Verge Genomics.
Dawit K. Worku, MD	No disclosure on file
Danielle Sandsmark, MD	The institution of Dr. Sandsmark has received research support from NINDS. The institution of Dr. Sandsmark has received research support from BrainBox Solutions Inc. The institution of Dr. Sandsmark has received research support from Department of Defense.
Ken Cheung	Ken Cheung has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Tsumura.
Shabnam Pakneshan, MD	No disclosure on file
Rafia Shafqat, MD	No disclosure on file
Mohammad Ghatali, MD	Dr. Ghatali has nothing to disclose.
Vincent H. Bargnes III	Mr. Bargnes has received research support from Harry Dent Family Foundation.
Marcus Yountz, MD, FAAN	Dr. Yountz has received personal compensation for serving as an employee of Alexion, AstraZeneca Rare Disease. Dr. Yountz has stock in AstraZeneca.
Benjamin Turner, MD, MBBS	No disclosure on file
Cheran Elangovan, MD	Dr. Elangovan has nothing to disclose.
Paulus Sugianto, MD, FAAN	No disclosure on file
Kamal Shouman, MD	Dr. Shouman has nothing to disclose.
Hae Young Baang, MD	Dr. Baang has nothing to disclose.
Ivan Cuesta Isabel, MD	No disclosure on file
Maryamnaz Zaribaf, MD	No disclosure on file
Cina Sasannejad, MD	No disclosure on file
Asuncion Avila-Rivera, MD	No disclosure on file
Mohammed Al-Dulaimi, MD	Dr. Al-Dulaimi has nothing to disclose.
Anna Maria Rita Repice	No disclosure on file
Faizan Yasin	No disclosure on file
Cecilia Cappelen-Smith, MBBS, PhD, FRACP	Dr. Cappelen-Smith has nothing to disclose.
Gabriella Spinicci, MD	No disclosure on file
Scott I. Otallah, MD	Dr. Otallah has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Merck.
Jiang-Tao Zhang	No disclosure on file
David Wood, PhD	No disclosure on file
Neil Manering, MD	Dr. Manering has nothing to disclose.
Yasser Khorchid, MD	No disclosure on file
Benjamin Chapin, MD	Dr. Chapin has nothing to disclose.
Kimia Ghavami, MD	No disclosure on file
Wilmot Bonnet, MD	Dr. Bonnet has nothing to disclose.
Lalitha Kurada, PhD	No disclosure on file
Natalie F. Miller, PT	Dr. Miller has received personal compensation for serving as an employee of ATOM International. Dr. Miller has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Casimir.
Russell Nichols	Russell Nichols has received personal compensation for serving as an employee of Eli Lilly and Company. Russell Nichols has received stock or an ownership interest from Eli Lilly and Company.
Meaghan Berns, MD	Dr. Berns has nothing to disclose.
Dora Dujmic	No disclosure on file
Wonshik Kim, MD	No disclosure on file
Marjo Nylund	Ms. Nylund has received research support from The Finnish MS Foundation. Ms. Nylund has received research support from Maire Taponen Foundation. Ms. Nylund has received research support from The Finnish Cultural Foundation.
Laura Myers	The institution of Laura Myers has received research support from VA.
Irina Podkorytova	Irina Podkorytova has nothing to disclose.
Andrew D. Goodman, MD, FAAN	Dr. Goodman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Swan Bio. Dr. Goodman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Goodman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Goodman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lilly. Dr. Goodman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Goodman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics. Dr. Goodman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for IMCYSE. Dr. Goodman has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Pfizer. The institution of Dr. Goodman has received research support from Atara. The institution of Dr. Goodman has received research support from Genzyme. The institution of Dr. Goodman has received research support from EMD-Serono.
Mya C. Schiess, MD, FAAN	Dr. Schiess has nothing to disclose.
Angela L. Genge, MD	Dr. Genge has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for AL-S Pharma. Dr. Genge has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amylyx. Dr. Genge has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Quralis. Dr. Genge has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MTPA. Dr. Genge has received personal compensation in the range of $0-$499 for serving as a Consultant for WAVE. Dr. Genge has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for eikonizo. Dr. Genge has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for rapa.
Edward Fox, MD, PhD, FAAN	Dr. Fox has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion Pharmaceuticals. Dr. Fox has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Fox has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. Dr. Fox has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for EMD Serono. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for GW Pharmaceuticals. Dr. Fox has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Fox has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol Myers Squibb. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Fox has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Alexion. Dr. Fox has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. Dr. Fox has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Genentech. Dr. Fox has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Bristol Myers Squibb. The institution of Dr. Fox has received research support from Biogen. The institution of Dr. Fox has received research support from Genentech. The institution of Dr. Fox has received research support from Celgene - BMS. The institution of Dr. Fox has received research support from Chugai. The institution of Dr. Fox has received research support from Novartis. The institution of Dr. Fox has received research support from EMD-Serono. The institution of Dr. Fox has received research support from TG Therapeutics. The institution of Dr. Fox has received research support from AbbVie. The institution of Dr. Fox has received research support from Sanofi Genzyme. The institution of Dr. Fox has received research support from AbbVie.
Roberta Lanzillo	Roberta Lanzillo has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck, Biogen. Roberta Lanzillo has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen, Roche, Novartis.
Carl Langefeld	No disclosure on file
Manoj Malhotra, MD	Dr. Malhotra has received personal compensation for serving as an employee of Eisai.
Sarah A. Morrow, MD, MSC, FRCPC, FAAN	Dr. Morrow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono/Merck. Dr. Morrow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Celgene. Dr. Morrow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Morrow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Morrow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for SanofiGenzyme. Dr. Morrow has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen Idec. Dr. Morrow has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Novartis. Dr. Morrow has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Roche. The institution of Dr. Morrow has received research support from Celgene. The institution of Dr. Morrow has received research support from SanofiGenzyme. The institution of Dr. Morrow has received research support from Novartis.
Timothy M. Ellmore, PhD	Prof. Ellmore has nothing to disclose.
Paolo Preziosa	Mr. Preziosa has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bristol Myers Squibb . Mr. Preziosa has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi Genzyme. Mr. Preziosa has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Mr. Preziosa has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Mr. Preziosa has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck.
Eero Rissanen, MD	Dr. Rissanen has received research support from Sigrid Juselius Foundation.
Jesper Hagemeier	No disclosure on file
Sankar Bandyopadhyay, MD, FAAN	Dr. Bandyopadhyay has nothing to disclose.
Eugene L. Scharf, MD	The institution of Dr. Scharf has received research support from American Brain Foundation. The institution of Dr. Scharf has received research support from NIH. Dr. Scharf has received personal compensation in the range of $500-$4,999 for serving as a Presenter with Grand Rounds. Dr. Scharf has a non-compensated relationship as a Steering committee with Johnson and Johnson that is relevant to AAN interests or activities.
Oleksandra Dryn, MD	No disclosure on file
David Ritter, MD, PhD	No disclosure on file
Adithya Varma, MSc	No disclosure on file
Gretchen L. Birbeck, MD, MPH, DTMH, FAAN	An immediate family member of Dr. Birbeck has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Various. Dr. Birbeck has a non-compensated relationship as a Ambassador for Zambia with RSTMH that is relevant to AAN interests or activities.
Daniel Pelletier, MD	Dr. Pelletier has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Pelletier has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi Genzyme. Dr. Pelletier has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche. Dr. Pelletier has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Polpharma Biologics.
Matthew P. Wicklund, MD, FAAN	Dr. Wicklund has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amicus Therapeutics. Dr. Wicklund has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi-Genzyme. Dr. Wicklund has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sarepta Therapeutics. Dr. Wicklund has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Spark Therapeutics. Dr. Wicklund has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ultragenyx. Dr. Wicklund has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Vertex Pharmaceuticals. The institution of Dr. Wicklund has received research support from Orphazyme. The institution of Dr. Wicklund has received research support from Muscular Dystrophy Association. The institution of Dr. Wicklund has received research support from Coalition to Cure Calpain 3. The institution of Dr. Wicklund has received research support from Sarepta Therapeutics. The institution of Dr. Wicklund has received research support from ML Bio. The institution of Dr. Wicklund has received research support from Alexion. The institution of Dr. Wicklund has received research support from Acceleron. The institution of Dr. Wicklund has received research support from Edgewise. The institution of Dr. Wicklund has received research support from Fulcrum. The institution of Dr. Wicklund has received research support from Roche-Genentech. The institution of Dr. Wicklund has received research support from Avidity. Dr. Wicklund has received research support from Harmony Bioscience.
Petr Hlustik, MD, PhD	The institution of Prof. Hlustik has received research support from Czech Health Research Council (AZV CR).
Julaine M. Florence	Ms. Florence has nothing to disclose.
Bernard Brais, MD	Dr. Brais has nothing to disclose.
Reza Seyedsadjadi, MD	Dr. Seyedsadjadi has received personal compensation for serving as an employee of American Neurological Association. Dr. Seyedsadjadi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for SwanBio Therapeutics. Dr. Seyedsadjadi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pfizer. Dr. Seyedsadjadi has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. The institution of Dr. Seyedsadjadi has received research support from Cystinosis Research Foundation.
Kunio Nakamura, PhD	Dr. Nakamura has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for INmune Bio. The institution of Dr. Nakamura has received research support from Biogen. The institution of Dr. Nakamura has received research support from PCORI. The institution of Dr. Nakamura has received research support from NIH. The institution of Dr. Nakamura has received research support from Genzyme. The institution of Dr. Nakamura has received research support from NIH. The institution of Dr. Nakamura has received research support from Genzyme. The institution of Dr. Nakamura has received research support from Novartis. The institution of Dr. Nakamura has received research support from DOD. Dr. Nakamura has received intellectual property interests from a discovery or technology relating to health care.
Federica Esposito	Federica Esposito has received personal compensation in the range of $0-$499 for serving as a Consultant for Merck. Federica Esposito has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Federica Esposito has received personal compensation in the range of $0-$499 for serving as a Consultant for Novartis. Federica Esposito has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Federica Esposito has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. The institution of Federica Esposito has received research support from Italian MS Society. The institution of Federica Esposito has received research support from Italian Ministry of Health. The institution of Federica Esposito has received research support from ERA Net. The institution of Federica Esposito has received research support from European Commission. Federica Esposito has received intellectual property interests from a discovery or technology relating to health care.
Gunjan Parikh, MD	The institution of Dr. Parikh has received research support from Department of Defense. The institution of Dr. Parikh has received research support from NINDS. The institution of Dr. Parikh has received research support from NIH.
Ramin Zand, MD	Dr. Zand has received personal compensation in the range of $100,000-$499,999 for serving as an Expert Witness for StrokeExperts. The institution of Dr. Zand has received research support from NIH. The institution of Dr. Zand has received research support from PCORI.
Sumit Verma, MD	Dr. Verma has nothing to disclose.
Christoph Stretz, MD, FAAN	The institution of Dr. Stretz has received research support from American Heart Association. The institution of Dr. Stretz has received research support from Duke University Medical Center/NIH. The institution of Dr. Stretz has received research support from University of Cincinnati/NINDS.
Apoorva Kelkar, MS	Ms. Kelkar has nothing to disclose.
James F. Howard, Jr., MD, FAAN	Dr. Howard has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for argenx . Dr. Howard has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Regeneron Pharmaceuticals. Dr. Howard has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion Pharmaceuticals. Dr. Howard has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AMGEN (Horizon Therapeutics). Dr. Howard has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Howard has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biohaven Ltd. Dr. Howard has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for CorEvitas. Dr. Howard has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck EMD Serono. Dr. Howard has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cartesian Therapeutics. Dr. Howard has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NMD Pharma. Dr. Howard has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for H. Lundbeck A/S. Dr. Howard has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Seismic Therapeutics. Dr. Howard has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB Pharma. Dr. Howard has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Vor Biopharma. Dr. Howard has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Academic CME. Dr. Howard has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for PeerView CME. Dr. Howard has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Platform Q CME. Dr. Howard has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for MJH LifeSci. Dr. Howard has or had stock in Johnson & Johnson dividends.Dr. Howard has or had stock in Pfizer dividends. An immediate family member of Dr. Howard has or had stock in GlaxoSmithKline dividends.Dr. Howard has or had stock in Bristol Myer Squbb dividends.Dr. Howard has or had stock in AbbieVie Inc. The institution of Dr. Howard has received research support from Alexion Pharmaceuticals. The institution of Dr. Howard has received research support from argenx . The institution of Dr. Howard has received research support from UCB Biosciences. The institution of Dr. Howard has received research support from NIH. The institution of Dr. Howard has received research support from Centers for Disease Control/Research Triangle Institute. The institution of Dr. Howard has received research support from Cartestian Therapeutics. The institution of Dr. Howard has received research support from NMD Pharma. The institution of Dr. Howard has received research support from Ad Scientiam. The institution of Dr. Howard has received research support from Merck EMD Serono. Dr. Howard has a non-compensated relationship as a Scientific Advisiory Board member, Committee member with Myasthenia Gravis Foundation of America that is relevant to AAN interests or activities. Dr. Howard has a non-compensated relationship as a Committee member with American Assoc Neuromuscular and Electrodiagnostic Medicine that is relevant to AAN interests or activities.
Yonas E. Geda, MD	The institution of Dr. Geda has received research support from NIH.
Jose G. Romano, MD, FAAN	Dr. Romano has stock in Vycor Medical/NovaVision. The institution of Dr. Romano has received research support from NIH/NINDS. The institution of Dr. Romano has received research support from NIH/NHLBI.
Leslie A. Morrison, MD, FAAN	No disclosure on file
David Z. Rose, MD	Dr. Rose has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Boston Scientific. Dr. Rose has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Chiesi USA. Dr. Rose has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Medtronic. Dr. Rose has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Boehringer Ingelheim . Dr. Rose has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for CSL-Behring .
Alberto Maud, MD	Dr. Maud has nothing to disclose.
Navya Joseph, MD	Dr. Joseph has nothing to disclose.
Besher Tolaymat	No disclosure on file
Ali Ebrahim, MD	Dr. Ebrahim has nothing to disclose.
Manuela Altieri	No disclosure on file
Giuseppe Lanzino, MD	Dr. Lanzino has nothing to disclose.
Matilde Inglese, MD, PhD	Dr. Inglese has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for SANOFI GENZYME. Dr. Inglese has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BIOGEN. Dr. Inglese has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NOVARTIS. Dr. Inglese has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for MERCK-SERONO. Dr. Inglese has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ROCHE. Dr. Inglese has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for MS Journal.
Michelle Cameron, MD	Dr. Cameron has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Greenwich Biosciences/Jazz . Dr. Cameron has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Adamas Pharmaceuticals. Dr. Cameron has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer. The institution of Dr. Cameron has received research support from National MS Society. The institution of Dr. Cameron has received research support from Department of Veterans Affairs. Dr. Cameron has received publishing royalties from a publication relating to health care.
Francesco Patti, MD	Dr. Patti has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. The institution of Dr. Patti has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Almirall. Dr. Patti has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Meyers. Dr. Patti has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Johnson and Johnson. The institution of Dr. Patti has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Merck. The institution of Dr. Patti has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. The institution of Dr. Patti has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. The institution of Dr. Patti has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi. Dr. Patti has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion, Almirall, Bayer, Biogen, Bristol Meyers and Squibb Merck, Roche, Sanofi, TEVA. Dr. Patti has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for University of Catania and AISM/FISM, Fondazione Italiana Sclerosi Multipla. Dr. Patti has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Frontiers in Neurology.
Chad Hoyle, MD	Dr. Hoyle has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for National Football League. Dr. Hoyle has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Avexis. Dr. Hoyle has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Reata. The institution of Dr. Hoyle has received research support from REATA. The institution of Dr. Hoyle has received research support from TAKEDA.
Frederick W. Foley, PhD	No disclosure on file
Benjamin Ellezam, MD	No disclosure on file
Jennifer Osborne, NP	No disclosure on file
Ayaz M. Khawaja, MD	Dr. Khawaja has nothing to disclose.
Gilles Edan	Gilles Edan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Celgene. Gilles Edan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Gilles Edan has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Biogen. Gilles Edan has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Merck.
Roy H. Hamilton, MD, MS, FANA, FAAN	Dr. Hamilton has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Highland Instruments. Dr. Hamilton has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Cognito Therapeutics. Dr. Hamilton has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for McKnight Brain Research Foundation. The institution of Dr. Hamilton has received research support from NIH. The institution of Dr. Hamilton has received research support from Department of Defense. The institution of Dr. Hamilton has received research support from Chan Zuckerberg Initiative.
Marisara Dieppa, MD	Dr. Dieppa has nothing to disclose.
Clinton B. Wright, MD, FAAN	An immediate family member of Dr. Wright has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. Dr. Wright has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Abali Milne Kalil. Dr. Wright has received publishing royalties from a publication relating to health care. An immediate family member of Dr. Wright has received personal compensation in the range of $500-$4,999 for serving as a surveyor with ASTRO.
Courtney S. Casserly, MD, FAAN	Dr. Casserly has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Casserly has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Soliris. Dr. Casserly has received personal compensation in the range of $500-$4,999 for serving as a Consultant for biogen idec. Dr. Casserly has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for sanofi genzyme. Dr. Casserly has received personal compensation in the range of $500-$4,999 for serving as a Consultant for roche. Dr. Casserly has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Casserly has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Horizon Theraputics. Dr. Casserly has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for roche. Dr. Casserly has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Soliris. Dr. Casserly has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for novartis. Dr. Casserly has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen Idec. Dr. Casserly has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMG Serono. The institution of Dr. Casserly has received research support from Biogen Idec. The institution of Dr. Casserly has received research support from Western Libraries. The institution of Dr. Casserly has received research support from Western University.
Conor Fearon, MD	Dr. Fearon has nothing to disclose.
Franck G. Amyot, PhD	Dr. Amyot has nothing to disclose.
Krishna Mourya Galla, MD	No disclosure on file
Kavneet Kaur, MD	Dr. Kaur has nothing to disclose.
Sara Shapouran, MD	Dr. Shapouran has nothing to disclose.
Somayeh Meysami, MD	Dr. Meysami has nothing to disclose.
Priyanka Madaan	Priyanka Madaan has nothing to disclose.
Keith Foster	No disclosure on file
Megan Margiotta, MD	No disclosure on file
Kathryn Fitzgerald, PhD	Dr. Fitzgerald has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Setpoint Medical. The institution of Dr. Fitzgerald has received research support from NIH. The institution of Dr. Fitzgerald has received research support from National MS Society.
Ying Sun, MD	No disclosure on file
Ahmad Yusuf Solaiman, MD	Dr. Yusuf Solaiman has nothing to disclose.
Keith Carolus	No disclosure on file
Rajesh Pahwa, MD, FAAN	Dr. Pahwa has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Abbott. Dr. Pahwa has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for AbbVie. Dr. Pahwa has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for ACADIA. Dr. Pahwa has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Amneal. Dr. Pahwa has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Lundbeck. Dr. Pahwa has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Supernus. Dr. Pahwa has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Insightec. Dr. Pahwa has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Jaaz. Dr. Pahwa has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Fasikl. Dr. Pahwa has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genetech. Dr. Pahwa has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merz. Dr. Pahwa has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Mitsubishi Tanabe. Dr. Pahwa has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Photopharmics. The institution of Dr. Pahwa has received research support from Abbott. The institution of Dr. Pahwa has received research support from Abbvie. The institution of Dr. Pahwa has received research support from Biogen. The institution of Dr. Pahwa has received research support from Parkinson Foundation. The institution of Dr. Pahwa has received research support from Roche. The institution of Dr. Pahwa has received research support from Sage. The institution of Dr. Pahwa has received research support from Sun Pharma. The institution of Dr. Pahwa has received research support from Theravance. The institution of Dr. Pahwa has received research support from Neuroderm. The institution of Dr. Pahwa has received research support from Ask Bio. The institution of Dr. Pahwa has received research support from Blue Rock. The institution of Dr. Pahwa has received research support from Cerevance. The institution of Dr. Pahwa has received research support from Fasikl. The institution of Dr. Pahwa has received research support from Scion. The institution of Dr. Pahwa has received research support from UCB. The institution of Dr. Pahwa has received research support from Ono. The institution of Dr. Pahwa has received research support from Intra-cellular Therapies. The institution of Dr. Pahwa has received research support from Ask Bio. The institution of Dr. Pahwa has received research support from Michael J Fox Foundation . The institution of Dr. Pahwa has received research support from Neuron 23. The institution of Dr. Pahwa has received research support from Roche.
Frederik Barkhof, MD, PhD	Frederik Barkhof has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Frederik Barkhof has received personal compensation in the range of $0-$499 for serving as a Consultant for Biogen. Frederik Barkhof has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Combinostics. Frederik Barkhof has received personal compensation in the range of $500-$4,999 for serving as a Consultant for IXICO. Frederik Barkhof has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Frederik Barkhof has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EISAI.
Xavier Montalban, MD, PhD, FAAN	The institution of Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. The institution of Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Merck/ EMD Serono. The institution of Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. The institution of Dr. Montalban has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Teva. The institution of Dr. Montalban has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Hoffmann-La Roche. The institution of Dr. Montalban has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Actelion/ Janssen Pharmaceuticals. The institution of Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for BMS/ Celgene. The institution of Dr. Montalban has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi/ Genzyme. The institution of Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BIAL PD. The institution of Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PeerVoice. The institution of Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Samsung Biosys. The institution of Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Zenas BioPharma. Dr. Montalban has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Actelion/ Janssen Pharmaceuticals. Dr. Montalban has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BMS/ Celgene. Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck/ EMD Serono. Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Hoffmann-La Roche. Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi-Genzyme. The institution of Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Immunic Therapeutics. The institution of Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Viatris/ Mylan. The institution of Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sandoz. The institution of Dr. Montalban has received research support from Biogen. The institution of Dr. Montalban has received research support from Hoffmann-La Roche. The institution of Dr. Montalban has received research support from Sanofi/ Genzyme. The institution of Dr. Montalban has received research support from Merck/ EMD Serono. The institution of Dr. Montalban has received research support from Novartis. The institution of Dr. Montalban has received research support from Teva Pharmaceuticals. The institution of Dr. Montalban has received research support from Actelion/ Janssen Pharmaceuticals. The institution of Dr. Montalban has received research support from BMS/ Celgene.
Scott Przybelski	Scott Przybelski has nothing to disclose.
Fabrizio Giuliani, MD	Dr. Giuliani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Giuliani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Hoffman-LaRoche. The institution of Dr. Giuliani has received research support from Canadian Institute of Health Research. The institution of Dr. Giuliani has received research support from University of Alberta Hospital Foundation. The institution of Dr. Giuliani has received research support from Hoffman-LaRoche. The institution of Dr. Giuliani has received research support from Novartis.
Prashanthi Vemuri, PhD	The institution of Dr. Vemuri has received research support from NIH.
Natalia Murinova, MD, FAAN	Dr. Murinova has nothing to disclose.
Christopher Schwarz	The institution of Christopher Schwarz has received research support from NIH.
Duk Soo Kim, DO	No disclosure on file
Elie Sader, MD	No disclosure on file
Olivia Thornburg	Olivia Thornburg has nothing to disclose.
Chelsea S. Kidwell, MD	No disclosure on file
Charles H. Tegeler, MD	Dr. Tegeler has nothing to disclose.
Patrizia Pantano	Patrizia Pantano has nothing to disclose.
Mohamad Koubeissi, MD, FAAN	Dr. Koubeissi has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for SK Life Sciences.
Fen Bao	Fen Bao has nothing to disclose.
Sanjay Kalra, MD	The institution of Dr. Kalra has received research support from Brain Canada Foundation. The institution of Dr. Kalra has received research support from Biogen.
Aziz I. Shaibani, MD, FAAN	Dr. Shaibani has nothing to disclose.
Christiana E. Hall, MD	No disclosure on file
Gilles Allali, MD, PhD	Dr. Allali has nothing to disclose.
E. Ann Yeh, MD, MA, FRCPC	Dr. Yeh has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pipeline therapeutics. Dr. Yeh has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Yeh has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for SCN. Dr. Yeh has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. The institution of Dr. Yeh has received research support from CIHR. The institution of Dr. Yeh has received research support from National MS Society. The institution of Dr. Yeh has received research support from SickKids Foundation. The institution of Dr. Yeh has received research support from MSSC. The institution of Dr. Yeh has received research support from Garry Hurvitz Foundation. The institution of Dr. Yeh has received research support from Leong Centre. The institution of Dr. Yeh has received research support from OMSLife. The institution of Dr. Yeh has received research support from Canada's Drug Agency. Dr. Yeh has received personal compensation in the range of $0-$499 for serving as a Author with Medscape. Dr. Yeh has a non-compensated relationship as a Editorial Board with Neurology that is relevant to AAN interests or activities. Dr. Yeh has a non-compensated relationship as a Editorial Board with MSJ that is relevant to AAN interests or activities.
Feza Deymeer, MD	No disclosure on file
Appaji Rayi, MD, FAAN	Dr. Rayi has nothing to disclose.
Gianfranco Costantino, MD	No disclosure on file
Melanie Glenn, MD	No disclosure on file
Linda P. Lowes, PT PhD	The institution of Ms. Lowes has received research support from Sarepta Therapeutics.
Carla E. Santiago-Martinez	Ms. Santiago-Martinez has nothing to disclose.
Michael L. James, MD	Dr. James has nothing to disclose.
Teresa D. Gasalla, MD	Dr. Gasalla has received personal compensation for serving as an employee of UCB Biosciences Inc. Dr. Gasalla has stock in UCB Pharma.
S. Ahmad Sajjadi, MD, PhD, MRCP, FAAN	Dr. Sajjadi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GUIDEPOINT. Dr. Sajjadi has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Alzheimer Research and Therapy. The institution of Dr. Sajjadi has received research support from NIH.
Debra Guntrum, MS, FNP	Ms. Guntrum has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Avexis. Ms. Guntrum has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sarepta. Ms. Guntrum has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PTC.
Chad E Glasser, PharmD	Mr. Glasser has received personal compensation for serving as an employee of Cyclerion Therapeutics. Inc. Mr. Glasser has stock in Cyclerion Therapeutics Inc.. Mr. Glasser has received intellectual property interests from a discovery or technology relating to health care.
Ying Cui	No disclosure on file
Sukriye Damla Kara, MD	Dr. Kara has nothing to disclose.
Courtney Curran, MD	Dr. Curran has nothing to disclose.
Sridar Narayanan	Sridar Narayanan has received personal compensation for serving as an employee of NeuroRx Research. Sridar Narayanan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech Inc.. The institution of Sridar Narayanan has received research support from Immunotec Inc.
Xiang Fang, MD, PhD, FAAN	Dr. Fang has nothing to disclose.
Nathan DeTurk, MD, MBA	No disclosure on file
Beau Billings	No disclosure on file
Alphonse Hubsch	Alphonse Hubsch has received personal compensation for serving as an employee of CSL Behring. Alphonse Hubsch has stock in CSL Behring .
Tingting Hua	No disclosure on file
Nicholas Swingle, MD	No disclosure on file
Aisha R. Saand, MD	No disclosure on file
Molly B. Ungrady	No disclosure on file
Chao Xu	Chao Xu has nothing to disclose.
Ramon R. Diaz-Arrastia, MD, PhD, FAAN	Dr. Diaz-Arrastia has stock in BrainBox, LLC. Dr. Diaz-Arrastia has stock in Nia Therpeutics. The institution of Dr. Diaz-Arrastia has received research support from National Institutes of Health. The institution of Dr. Diaz-Arrastia has received research support from Department of Defense.
David E. Blum, MD	Dr. Blum has received personal compensation for serving as an employee of Neurona Therapeutics. Dr. Blum has stock in Neurona Therapeutics.
Francesca Ammoscato	No disclosure on file
Aldo Mendez Ruiz, MD	No disclosure on file
Damien Ferguson, MBBS	No disclosure on file
David T. Finkelstein, MD	No disclosure on file
David Gritsch, MD, PhD	Dr. Gritsch has nothing to disclose.
Kristine C. Arandela, MD	Dr. Arandela has nothing to disclose.
Jacob Manske, MD	No disclosure on file
Justin A. Morrison	Mr. Morrison has nothing to disclose.
Megan T. Moyer, NP	No disclosure on file
Claudia Kawas, MD	The institution of Dr. Kawas has received research support from NIH.
Jayashri Srinivasan, MD, PhD, MRCP, FAAN	Dr. Srinivasan has nothing to disclose.
Orhan Aktas, MD	Dr. Aktas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Aktas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen/Horizon. Dr. Aktas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Aktas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mitsubish Tanake. Dr. Aktas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Aktas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AstraZeneca. Dr. Aktas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Dr. Aktas has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Dr. Aktas has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Aktas has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amgen/Horizon. The institution of Dr. Aktas has received research support from German Research Foundation. The institution of Dr. Aktas has received research support from German Ministry of Science. The institution of Dr. Aktas has received research support from Neuromyelitis optica Study Group (NEMOS).
Ken Uchino, MD	Dr. Uchino has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Aboott Laboratories, Inc.. Dr. Uchino has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for ACP JOURNAL CLUB. The institution of Dr. Uchino has received research support from NIH.
David Leppert, MD	Dr. Leppert has received personal compensation for serving as an employee of GeNeuro. Dr. Leppert has received personal compensation for serving as an employee of GeNeuro. Dr. Leppert has received personal compensation for serving as an employee of Geneuro. Dr. Leppert has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Leppert has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Dr. Leppert has received personal compensation in the range of $0-$499 for serving as a Consultant for Orion. Dr. Leppert has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Dr. Leppert has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Quanterix. Dr. Leppert has stock in Novartis.
Elisabetta Sarasso	Elisabetta Sarasso has nothing to disclose.
Brian Westerhuis, MD	Dr. Westerhuis has nothing to disclose.
Carol Moore	No disclosure on file
Luca Massacesi	The institution of Luca Massacesi has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. Luca Massacesi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Luca Massacesi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Luca Massacesi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Luca Massacesi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck-Serono. Luca Massacesi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Johnson and Johnson. Luca Massacesi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Luca Massacesi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Horizon. The institution of Luca Massacesi has received research support from Tuscan Region Government. The institution of Luca Massacesi has received research support from Sanofi. The institution of Luca Massacesi has received research support from Roche. Luca Massacesi has received research support from Merck-Serono.
Roberto Prado, MD, PhD	No disclosure on file
Sherita Chapman, MD	Dr. Chapman has received personal compensation in the range of $100,000-$499,999 for serving as a Stroke Section Chief with VA Medical Center.
Betsy N. Williams, PhD	Dr. Williams has received personal compensation for serving as an employee of IQVIA.
Todd Grinnell, PhD	Todd Grinnell, PhD has received personal compensation for serving as an employee of Sunovion Pharmaceuticals Inc..
Matthew E. Ehrlich, MD	No disclosure on file
Kiel Woodward, MD	Dr. Woodward has nothing to disclose.
Nilufer Yalcin, MD	Dr. Yalcin has nothing to disclose.
Alejandro Kohler	No disclosure on file
Muhammad Niazi, MD	No disclosure on file
Subhendu Rath, MBBS	Dr. Rath has nothing to disclose.
Fuad-al Ali, MD	No disclosure on file
Esther Cubo Delgado, MD, PhD, FAAN	Dr. Cubo Delgado has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie. Dr. Cubo Delgado has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Zambon. Dr. Cubo Delgado has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbvie. The institution of Dr. Cubo Delgado has received research support from Spanish health ministry. The institution of Dr. Cubo Delgado has received research support from European union grant.
Wengui Yu, MD, PhD	Dr. Yu has nothing to disclose.
James T. Becker, PhD	No disclosure on file
Gavin Giovannoni, MD	Dr. Giovannoni has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Giovannoni has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi. Dr. Giovannoni has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Merck KGaA. Dr. Giovannoni has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche-Genentech. Dr. Giovannoni has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Moderna. Dr. Giovannoni has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sandoz. Dr. Giovannoni has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Astoria Biologica. Dr. Giovannoni has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Zenas. Dr. Giovannoni has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Giovannoni has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Giovannoni has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Giovannoni has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Medscape.
Daniel M. Harrison, MD, FAAN	Dr. Harrison has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Horizon Therapeutics. Dr. Harrison has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American College of Physicians. The institution of Dr. Harrison has received research support from Roche-Genentech. Dr. Harrison has received publishing royalties from a publication relating to health care.
Stephen J. Marks, MD	No disclosure on file
Khaled Asi, MD	No disclosure on file
James F. Sumowski	Mr. Sumowski has nothing to disclose.
Kathleen Sherman	An immediate family member of Ms. Sherman has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Total Solutions. An immediate family member of Ms. Sherman has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for APA.
Claire E. Delpirou Nouh, MD	The institution of Dr. Delpirou Nouh has received research support from Oklahomas Nathan Shock Center. Dr. Delpirou Nouh has a non-compensated relationship as a Volunteer/Board member with Oklahoma Alzheimer Association that is relevant to AAN interests or activities.
Rebecca Roush	No disclosure on file
Maria Sepúlveda	No disclosure on file
Marcelo E. Bigal, MD, PhD	No disclosure on file
Matthew Rizzo, MD, FAAN	The institution of Dr. Rizzo has received research support from NIH.
Michael McDermott	No disclosure on file
William Martens	William Martens has nothing to disclose.
Gustavo J. Rodriguez, MD	Dr. Rodriguez has nothing to disclose.
Rakesh Khatri, MD, FAAN	Dr. Khatri has received personal compensation in the range of $0-$499 for serving as a Survey consultant with Alpha insight . Dr. Khatri has received personal compensation in the range of $0-$499 for serving as a Survey consultant with Survey company .
Machteld E. Hillen, MD, FAAN	The institution of Dr. Hillen has received research support from Genentech.
Eva Martinez-Caceres	No disclosure on file
Alessandro D'Ambrosio	No disclosure on file
Michelle R. Caunca, MD, PhD	Ms. Caunca has nothing to disclose.
Lokesh A. Rukmangadachar, MD	Dr. Rukmangadachar has nothing to disclose.
Muhammad Azeem, MD	No disclosure on file
Nada A. Elsaid	Mrs. Elsaid has nothing to disclose.
Dustin J. Paul, DO	Dr. Paul has nothing to disclose.
Maria Palmeri	Ms. Palmeri has nothing to disclose.
Amber M. Alexander	Amber M. Alexander has nothing to disclose.
Leah K. Forsberg, PhD	Ms. Forsberg has nothing to disclose.
Danish Kherani, MD	Dr. Kherani has nothing to disclose.
Ana-Luiza Sayao, MD	Dr. Sayao has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Sayao has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Serono. Dr. Sayao has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Sayao has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Sayao has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Serono. Dr. Sayao has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen.
Elanagan Nagarajan, MD	Dr. Nagarajan has nothing to disclose.
David Holden	No disclosure on file
Emily Roll	No disclosure on file
Robert P. Lisak, MD, FAAN	Dr. Lisak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Argnex. Dr. Lisak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GLG Consulting. Dr. Lisak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Third Bridge Consulting. Dr. Lisak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Clearview Consulting. Dr. Lisak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Takeda. Dr. Lisak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alivar Therapeutics. Dr. Lisak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ANI Pharmaceuticals. Dr. Lisak has received personal compensation in the range of $0-$499 for serving as a Consultant for Coleman Research. Dr. Lisak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Horizon. Dr. Lisak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Immunic. Dr. Lisak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Guidepoint Consulting. Dr. Lisak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Tedus Consulting. Dr. Lisak has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for COUR Pharma. The institution of Dr. Lisak has received research support from NINDS. The institution of Dr. Lisak has received research support from Argenx. The institution of Dr. Lisak has received research support from Ra Pharmaceuticals. Dr. Lisak has received publishing royalties from a publication relating to health care. Dr. Lisak has received publishing royalties from a publication relating to health care.
Pablo Villoslada, MD, PhD, FAAN	Dr. Villoslada has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Oculis. Dr. Villoslada has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Bionure. Dr. Villoslada has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Telara Therapeutics. Dr. Villoslada has or had stock in Attune Neurosciences.Dr. Villoslada has or had stock in Bionure Therapeutics.Dr. Villoslada has or had stock in Spiral Therapeutics.Dr. Villoslada has or had stock in Adhera Health.Dr. Villoslada has or had stock in Clarity technologies.Dr. Villoslada has or had stock in QMENTA Inc. The institution of Dr. Villoslada has received research support from Start2Cure Foundation. The institution of Dr. Villoslada has received research support from European Commission. The institution of Dr. Villoslada has received research support from Instituto Salud Carlos III. The institution of Dr. Villoslada has received research support from Focused Ultrasound Foundation and ALS Foundation. The institution of Dr. Villoslada has received research support from Caixa Foundation. Dr. Villoslada has received intellectual property interests from a discovery or technology relating to health care.
Kimbra L. Kenney, MD, FAAN	Dr. Kenney has nothing to disclose.
Gorazd B. Stokin, MD, PhD, FAAN	Dr. Stokin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Terumo. Dr. Stokin has received research support from CNS.
Darine Kassar, MD	Dr. Kassar has nothing to disclose.
Marius Ringelstein	Marius Ringelstein has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Marius Ringelstein has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion.
Patricia C. Dugan, MD	No disclosure on file
Roman Herzig, MD, PhD	Roman Herzig, MD, PhD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AstraZeneca. Roman Herzig, MD, PhD has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Boehringer Ingelheim . Roman Herzig, MD, PhD has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Care Comm.
Daniel P. Perl, MD	No disclosure on file
Dana E. Greenia, RN, MS	No disclosure on file
Christian Barro, MD, PhD	Dr. Barro has nothing to disclose.
Ilaria Cani, MD	No disclosure on file
Asad Ikram, MD, MBBS	Dr. Ikram has nothing to disclose.
Jason S. Gill, MD, PhD	Dr. Gill has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Elite Medical Experts. The institution of Dr. Gill has received research support from NIH-NINDS.
Ira Shoulson, MD	Dr. Shoulson has received research support from Vaccinex.
Prompan Mingbunjerdsuk, MD	No disclosure on file
Alexandria E. Matic, MD	No disclosure on file
Canan duman ilki	No disclosure on file
Carolyn L. Taylor, MD	No disclosure on file
Virginia Baker, MD	Dr. Baker has nothing to disclose.
Sharon Bottomley, NP	No disclosure on file
Kathy A. Deanda, RN, MSN	No disclosure on file
Megan Feeney, MPH	Ms. Feeney has nothing to disclose.
Scott Moody	No disclosure on file
Yang Mao-Draayer, MD	Dr. Mao-Draayer has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen Idec. Dr. Mao-Draayer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genzyme-Sanofi. Dr. Mao-Draayer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Mao-Draayer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genzyme-Sanofi. Dr. Mao-Draayer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Mao-Draayer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizone. Dr. Mao-Draayer has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen Idec. The institution of Dr. Mao-Draayer has received research support from NIH .
Arthur Toga	No disclosure on file
Fiona E. Costello, MD	Dr. Costello has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Costello has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Costello has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Costello has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Dr. Costello has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Accure Therapeutics. Dr. Costello has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for the Sumaira Foundation.
Eric E. Smith, MD	Dr. Smith has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Heart Association. Dr. Smith has received publishing royalties from a publication relating to health care. Dr. Smith has received publishing royalties from a publication relating to health care.
Jill S. Goldman, MS MPhil CGC	No disclosure on file
Mikolaj Pawlak, MD PhD	Dr. Pawlak has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Surgalign . Dr. Pawlak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Pawlak has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Inteneural Networks Inc. Dr. Pawlak has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for RSQ. Dr. Pawlak has received publishing royalties from a publication relating to health care.
Barbara Changizi, MD	Dr. Changizi has nothing to disclose.
Mushtaq H. Qureshi, MD	No disclosure on file
Felipe De Los Rios La Rosa, MD	Dr. De Los Rios La Rosa has nothing to disclose.
Jasem Y. Al-Hashel, MD	Dr. Al-Hashel has nothing to disclose.
Bardia Nourbakhsh, MD	Dr. Nourbakhsh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics . Dr. Nourbakhsh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alkermes. The institution of Dr. Nourbakhsh has received research support from Genentech. The institution of Dr. Nourbakhsh has received research support from National MS Society . The institution of Dr. Nourbakhsh has received research support from Department of Defense. The institution of Dr. Nourbakhsh has received research support from NIH. The institution of Dr. Nourbakhsh has received research support from Axsome Therapeutics. The institution of Dr. Nourbakhsh has received research support from TG Therapeutics .
Omar Saeed, MD	Dr. Saeed has nothing to disclose.
Bryan D. Walker, PA	Mr. Walker has received personal compensation for serving as an employee of EMD Serono.
Joseph F. Carrera, MD	Dr. Carrera has nothing to disclose.
Laura Danielson, MD	Dr. Danielson has nothing to disclose.
Hui Yang, PhD	No disclosure on file
Sami M. Aboumatar, MD	Dr. Aboumatar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai. Dr. Aboumatar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for SK Life Science, Inc.. Dr. Aboumatar has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eisai. Dr. Aboumatar has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sunovion.
Kelsey Satkowiak, MD	No disclosure on file
Ian Bakk	Mr. Bakk has nothing to disclose.
Kevin Nolasco	Kevin Nolasco has nothing to disclose.
Melissa Cook, MD	Dr. Cook has nothing to disclose.
Sherif M. Hamdy, MD	No disclosure on file
Gregory Fenton, MD	No disclosure on file
Shanglin Li, MD	No disclosure on file
Mohamed Hegazy, MD	No disclosure on file
Jamasb Sayadi	No disclosure on file
Tracey Yee	No disclosure on file
Lisa Keefner	No disclosure on file
Lee Elisevich	No disclosure on file
Hamza I. Maqsood, MD	Dr. Qureshi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for AstraZeneca.
Amit Bar-Or, MD, FRCPC	Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche Genentech. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merk/EMD Serono. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi-Genzyme. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for cabaletta. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche/Genentech. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck/EMD Serono. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi/Genzyme. The institution of Dr. Bar-Or has received research support from Novartis. The institution of Dr. Bar-Or has received research support from Biogen. The institution of Dr. Bar-Or has received research support from Roche/Genentech.
Felicia Goldstein	No disclosure on file
Ruth-Ann Marrie, MD, PhD	The institution of Dr. Marrie has received research support from CIHR. The institution of Dr. Marrie has received research support from MS Canada. The institution of Dr. Marrie has received research support from National MS Society. The institution of Dr. Marrie has received research support from Crohn's and Colitis Canada. The institution of Dr. Marrie has received research support from US Department of Defense. The institution of Dr. Marrie has received research support from The Arthritis Society. The institution of Dr. Marrie has received research support from CMSC.
Ging-Yuek R. Hsiung, MD, FAAN	Dr. Hsiung has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eisai. Dr. Hsiung has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eli Lilly. The institution of Dr. Hsiung has received research support from CIHR. The institution of Dr. Hsiung has received research support from NIH. The institution of Dr. Hsiung has received research support from Eli Lilly. The institution of Dr. Hsiung has received research support from Biogen.
Richard A. Macdonell, MD, FAAN	Dr. Macdonell has nothing to disclose.
Mefkure Eraksoy, MD	Dr. Eraksoy has nothing to disclose.
Lonni Schultz, PhD	Dr. Schultz has nothing to disclose.
Kushak Suchdev, MD	Dr. Suchdev has nothing to disclose.
Ruta N. Yardi, MD	Dr. Yardi has nothing to disclose.
Yael Barnett, MD	No disclosure on file
Abdullah Alshammaa, MD	Dr. Alshammaa has nothing to disclose.
Ping Wang	No disclosure on file
Andrea R. Zammit, PhD	Dr. Zammit has nothing to disclose.
Diana R. Kerwin, MD	Diana Kerwin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche/Genentech. Diana Kerwin has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Eli Lilly. Diana Kerwin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eisai. Diana Kerwin has received research support from NIH. The institution of Diana Kerwin has received research support from Lilly. The institution of Diana Kerwin has received research support from Global Alzheimer's Platform. The institution of Diana Kerwin has received research support from AbbVie.
Rahul H. Rahangdale, MD	Dr. Rahangdale has nothing to disclose.
Ellen M. Mowry, MD, FAAN	Dr. Mowry has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Octave. Dr. Mowry has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for SetPoint. The institution of Dr. Mowry has received research support from Genentech/Roche. The institution of Dr. Mowry has received research support from Biogen. Dr. Mowry has received publishing royalties from a publication relating to health care.
Mercedes P. Jacobson, MD	The institution of Dr. Jacobson has received research support from Engage. The institution of Dr. Jacobson has received research support from XENON. The institution of Dr. Jacobson has received research support from SK Life Sciences.
Sara Llufriu	Sara Llufriu has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Sara Llufriu has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Sara Llufriu has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merci. Sara Llufriu has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbot. Sara Llufriu has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi.
Farhaan S. Vahidy, MBBS, PhD	Dr. Vahidy has nothing to disclose.
Mohamed Gomaa, PhD	No disclosure on file
Aina Teniente-Serra	No disclosure on file
Zainab Alalawi, MD	No disclosure on file
Stefan Baral	No disclosure on file
Zoya Zaeem, MD	Dr. Zaeem has nothing to disclose.
Richard A. Lewis, MD, FAAN	Dr. Lewis has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Argenx. Dr. Lewis has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for CSL Behring. Dr. Lewis has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Lewis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Grifols. Dr. Lewis has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Takeda. Dr. Lewis has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Nuvig. Dr. Lewis has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Dianthus. Dr. Lewis has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Janssen. Dr. Lewis has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Medscape. Dr. Lewis has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Annexon. Dr. Lewis has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Immunovant. Dr. Lewis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BioCryst. Dr. Lewis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NervoSave. Dr. Lewis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Annexon. Dr. Lewis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Lewis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. Dr. Lewis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Immunovant. Dr. Lewis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TGTX. Dr. Lewis has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Boehringer-Ingleheim. Dr. Lewis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Intellia. Dr. Lewis has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Cartesian. Dr. Lewis has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for CME Outfitters. Dr. Lewis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PeerVision. Dr. Lewis has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Up to Date. Dr. Lewis has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Lewis has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Boehringer Ingelheim. Dr. Lewis has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alnylam. Dr. Lewis has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Lewis has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Intellia. Dr. Lewis has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Shernoff et al. Dr. Lewis has received publishing royalties from a publication relating to health care.
Douglas S. Goodin, MD	No disclosure on file
Amy Wolf, MSM	No disclosure on file
Eva A. Mistry, MD	Dr. Mistry has received personal compensation in the range of $500-$4,999 for serving as a Consultant for RAPID AI. Dr. Mistry has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AbbVIe. The institution of Dr. Mistry has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Silvercreek Pharma. Dr. Mistry has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Takeda Pharmaceuticals. Dr. Mistry has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for InspireMD. Dr. Mistry has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Shionogi. Dr. Mistry has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Heart Association. The institution of Dr. Mistry has received research support from National Institutes of Health. The institution of Dr. Mistry has received research support from Patient Centered Outcomes Research Institure.
Laura Palmer	No disclosure on file
Peter Brown, DO	Dr. Brown has nothing to disclose.
Julian Acosta, MD	Dr. Acosta has nothing to disclose.
James M. Gee	No disclosure on file
Ian R.A. Mackenzie, MD, FRCP	No disclosure on file
Osman Mir, MD	No disclosure on file
Maged M. Abdel-Naseer, MD, FAAN	No disclosure on file
Mark C. Eldaief, MD	No disclosure on file
Morgan Figurelle, MD	Dr. Figurelle has nothing to disclose.
Anudeep Yelam, MD	Dr. yelam has nothing to disclose.
Steven Levine, MD, FAHA	Dr. Levine has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for MEDLINK. Dr. Levine has received personal compensation in the range of $50,000-$99,999 for serving as an Expert Witness for Law Firms. The institution of Dr. Levine has received research support from NIH.
Karen L. Furie, MD	The institution of Dr. Furie has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen/BMS. Dr. Furie has received personal compensation in the range of $50,000-$99,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for BMJ/JNNP. The institution of Dr. Furie has received research support from NINDS.
Robert T. Wechsler, MD, PhD, FAAN	The institution of Dr. Wechsler has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Otsuka. The institution of Dr. Wechsler has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for UCB. The institution of Dr. Wechsler has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for SK Life Science. The institution of Dr. Wechsler has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Aquestive. The institution of Dr. Wechsler has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Engage. The institution of Dr. Wechsler has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Jazz. The institution of Dr. Wechsler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cerevel. The institution of Dr. Wechsler has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Eisai. The institution of Dr. Wechsler has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sunovion. The institution of Dr. Wechsler has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Eliem. The institution of Dr. Wechsler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. The institution of Dr. Wechsler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Epalex. The institution of Dr. Wechsler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Engrail. The institution of Dr. Wechsler has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Equilibre. The institution of Dr. Wechsler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Rapport. The institution of Dr. Wechsler has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neurona. Dr. Wechsler has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Neurelis. Dr. Wechsler has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Sunovion. Dr. Wechsler has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for UCB. Dr. Wechsler has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Greenwich/Jazz. Dr. Wechsler has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Eisai. Dr. Wechsler has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Aquestive. Dr. Wechsler has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for SK Life Science. Dr. Wechsler has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Epilepsy Studies Consortium. Dr. Wechsler has a non-compensated relationship as a Board President with Epilepsy Foundation of Idaho that is relevant to AAN interests or activities.
Timothy L. Vollmer, MD, FAAN	The institution of Dr. Vollmer has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen IDEC. The institution of Dr. Vollmer has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech/Roche. The institution of Dr. Vollmer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Siranax. The institution of Dr. Vollmer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Celgene. The institution of Dr. Vollmer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. The institution of Dr. Vollmer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Meyers Squib. The institution of Dr. Vollmer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Viela Bios. The institution of Dr. Vollmer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. The institution of Dr. Vollmer has received research support from Rocky Mountain MS Center. The institution of Dr. Vollmer has received research support from Biogen. The institution of Dr. Vollmer has received research support from Actelion. The institution of Dr. Vollmer has received research support from Genentech/Roche. The institution of Dr. Vollmer has received research support from Anokion. The institution of Dr. Vollmer has received research support from TG Therapeutics.
Abu Nasar	No disclosure on file
Florian P. Thomas, MD, PhD, MA, FAAN	Dr. Thomas has received personal compensation for serving as an employee of Hackensack Meridian Health. Dr. Thomas has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for MND. Dr. Thomas has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Journal of Spinal Cord Medicine. Dr. Thomas has a non-compensated relationship as a Board Member, Metro New Jersey with National MS Society that is relevant to AAN interests or activities. Dr. Thomas has a non-compensated relationship as a Board Member with American Paraplegia Society that is relevant to AAN interests or activities.
Cornelia Laule, PhD	The institution of Dr. Laule has received research support from Multiple Sclerosis Society of Canada. The institution of Dr. Laule has received research support from Natural Sciences and Engineering Research Council of Canada (NSERC). The institution of Dr. Laule has received research support from International Collaboration on Repair Discoveries (ICORD).
Roland G. Henry, PhD	Dr. Henry has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MEDDAY. Dr. Henry has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Henry has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Henry has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi/Genzyme.
Iram Zaman, DO, FAAN	Dr. Zaman has nothing to disclose.
Liying Cui, PhD	No disclosure on file
Oscar S. Gershanik, MD	No disclosure on file
Bappaditya Ray, MD	Dr. Ray has nothing to disclose.
Wim Van Hecke, PhD	Dr. Van Hecke has received personal compensation for serving as an employee of icometrix.
Niraj A. Arora, MD	Dr. Arora has nothing to disclose.
Robert L. Carruthers, MD	Dr. Carruthers has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Carruthers has received personal compensation in the range of $0-$499 for serving as a Consultant for Roche and Genentech. The institution of Dr. Carruthers has received research support from Roche and Genentech .
Taha Nisar, MD	Dr. Nisar has nothing to disclose.
Nico Papinutto	No disclosure on file
Noemi Piramide, MSc	Noemi Piramide has nothing to disclose.
Alan K. Jacobs, MD, FAAN	Dr. Jacobs has received personal compensation for serving as an employee of Immunovant, Inc. Dr. Jacobs has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Galler Consulting.
Peter Smith, PhD	No disclosure on file
Vijay Ramaswamy, MD	No disclosure on file
Jose R. Rodriguez, MD	No disclosure on file
Satheesh Kumar Bokka, MD	No disclosure on file
Meghana S. Kinariwala, MD	Dr. Srinivas has nothing to disclose.
Matthew William Rondeau, PA	Matthew William Rondeau has a non-compensated relationship as a Senior contributor to Neurology Podcast with AAN that is relevant to AAN interests or activities.
Caroline Atlas	No disclosure on file
Jan O. Aasly, MD, PhD	No disclosure on file
John Q. Trojanowski, MD, PhD	Dr. Trojanowski has nothing to disclose.
Domingo O. Garcea, MD	No disclosure on file
Fernando Cubillos	Mr. Cubillos has nothing to disclose.
Yael Gothelf	Yael Gothelf, 18041 has received personal compensation for serving as an employee of Brainstorm Cell Therapeutics.
Daniel Freedman, DO	Dr. Freedman has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for MedStudy. Dr. Freedman has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Stoll Keenon Ogden.
Anibal Chertcoff	Anibal Chertcoff has nothing to disclose.
Ann Weideman	No disclosure on file
Claudio Cordani	Claudio Cordani has nothing to disclose.
Regan Fong, PhD	No disclosure on file
Carmela San Luis, MD	No disclosure on file
Nadia N. Bowling, MD	No disclosure on file
Miguela Marie A. Senga, MD	Dr. Senga has nothing to disclose.
Jennifer Chima, MD	Dr. Chima has nothing to disclose.
Yanal R. Shaheen, MD	Dr. Shaheen has nothing to disclose.
David W. Loring, PhD, FAAN	Dr. Loring has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer Nature. Dr. Loring has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for ILAE. The institution of Dr. Loring has received research support from NIH. Dr. Loring has received publishing royalties from a publication relating to health care.
Pierre Labauge, MD	Dr. Labauge has nothing to disclose.
Christopher P. Eckstein, MD	The institution of Dr. Eckstein has received research support from Biogen. The institution of Dr. Eckstein has received research support from Genzyme.
Preet M. Varade, MD	Dr. Varade has nothing to disclose.
Ian J. Butler, MD	No disclosure on file
Guido J. Falcone, MD	The institution of Dr. Falcone has received research support from NIH. The institution of Dr. Falcone has received research support from AHA.
Anup D. Patel, MD, FAAN	Dr. Patel has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB Pharma. Dr. Patel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck. The institution of Dr. Patel has received research support from PCORI. Dr. Patel has received personal compensation in the range of $10,000-$49,999 for serving as a Webinar Development with Medscape. Dr. Patel has received personal compensation in the range of $500-$4,999 for serving as a Other capacity with Guidepoint. Dr. Patel has a non-compensated relationship as a Chair Quality Committee with AAN that is relevant to AAN interests or activities. Dr. Patel has a non-compensated relationship as a Committee Member with Child Neurology Society that is relevant to AAN interests or activities. Dr. Patel has a non-compensated relationship as a Board of Directors - member with AAN Institute that is relevant to AAN interests or activities.
Jeffrey R. Buchhalter, MD, FAAN	Dr. Buchhalter has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Epilepsy Foundation. Dr. Buchhalter has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Epilepsy Study Consortium. Dr. Buchhalter has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Buchhalter has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biocodex. Dr. Buchhalter has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Buchhalter has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biocodex. Dr. Buchhalter has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neurona.
Erica S. Westphal	The institution of Ms. Westphal has received personal compensation in the range of $500-$4,999 for serving as a Consultant for McKesson Coorporation. The institution of Ms. Westphal has received research support from Dent Neurologic Institute.
Sarah Z. Weingast	No disclosure on file
Sami Alkasab, MD	Dr. Alkasab has nothing to disclose.
John H. Sladky, MD, FAAN	Dr. Sladky has nothing to disclose.
Heinz Wiendl, MD, FAAN	Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Bristol Myers Squibb. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Immunovant. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Johnson&Johnson / Janssen. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB. Dr. Wiendl has received personal compensation in the range of $0-$499 for serving as a Consultant for Idorsia. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Argenx. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Immunic. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merck. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lundbeck. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for LTS. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Samsung. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sangamo. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Dianthus. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for INmune Bio_Syneos Health. Dr. Wiendl has received personal compensation in the range of $0-$499 for serving as a Consultant for Muna Therapeutics. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Myrobalan Therapeutics. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PSL Group. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Red Nucleus. Dr. Wiendl has received personal compensation in the range of $0-$499 for serving as a Consultant for Swiss Multiple Sclerosis Society. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Teladoc Health. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Toleranzia . Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Viatris. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck Serono. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol Myers Squibb. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sandoz. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sandoz-Hexal. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cellerys. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Uniqure. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biocryst. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Galapagos. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Idorsia. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biontech. The institution of Dr. Wiendl has received research support from Biogen. The institution of Dr. Wiendl has received research support from Roche. The institution of Dr. Wiendl has received research support from Deutsche Forschungsgemeinschaft. The institution of Dr. Wiendl has received research support from European Union. The institution of Dr. Wiendl has received research support from Argenx. The institution of Dr. Wiendl has received research support from CSL Behring. The institution of Dr. Wiendl has received research support from Merck. The institution of Dr. Wiendl has received research support from UCB. Dr. Wiendl has received research support from Alexion Syneos Health iVH UK Ltd.. The institution of Dr. Wiendl has received research support from Deutsche Myasthenie-Gesellschaft. The institution of Dr. Wiendl has received research support from Winicker Norimed GmbH. The institution of Dr. Wiendl has received research support from Novartis. Dr. Wiendl has received publishing royalties from a publication relating to health care. Dr. Wiendl has received publishing royalties from a publication relating to health care. Dr. Wiendl has received publishing royalties from a publication relating to health care.
Jonathan J. Halford, MD, FAAN	Dr. Halford has received personal compensation in the range of $500-$4,999 for serving as a Consultant for SK Life Sciences. Dr. Halford has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Takeda. Dr. Halford has received stock or an ownership interest from Corticare. The institution of Dr. Halford has received research support from Takeda. The institution of Dr. Halford has received research support from SK Life Sciences. The institution of Dr. Halford has received research support from Biogen.
Bradford B. Thompson, MD	Dr. Thompson has nothing to disclose.
Jennifer Simpson, MD	Dr. Simpson has nothing to disclose.
Paul M. Katz, MD	Dr. Katz has nothing to disclose.
Dharani Mudugal, MD	No disclosure on file
Murali K. Kolikonda, MD	No disclosure on file
Luke Chung	Luke Chung has received personal compensation for serving as an employee of Sanofi Genzyme. Luke Chung has received stock or an ownership interest from Sanofi Genzyme.
Sascha Gill, MSc	No disclosure on file
Siddharth Gupta, MD	No disclosure on file
Garrett E. Alexander, MD	No disclosure on file
Tyler P. Behymer	No disclosure on file
Jay Kinariwala, MD	Dr. Kinariwala has nothing to disclose.
Kishan Patel, MD	No disclosure on file
Christa S. Cooper, PA	No disclosure on file
Carly N. Ray, MD	No disclosure on file
Nisha Kapani	No disclosure on file
Jeff Wagner	No disclosure on file
Deepthi Vemuri	No disclosure on file
Margaret Spini	No disclosure on file
Bruce L. Miller, MD, FAAN	Dr. Miller has nothing to disclose.
Murray Grossman, MD, FAAN	Dr. Grossman has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology. The institution of Dr. Grossman has received research support from NIH.
Michael G. Dwyer III, MD, PhD	Dr. Dwyer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Myers Squibb. Dr. Dwyer has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Keystone Heart, Ltd. Dr. Dwyer has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. The institution of Dr. Dwyer has received research support from Novartis. The institution of Dr. Dwyer has received research support from Keystone Heart, Ltd. The institution of Dr. Dwyer has received research support from Bristol Myers Squibb. The institution of Dr. Dwyer has received research support from Roche.
Federica Agosta	Federica Agosta has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Philips. Federica Agosta has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier INC.
Adam L. Boxer, MD, PhD	An immediate family member of Dr. Boxer has received personal compensation for serving as an employee of Kaiser Permanente. Dr. Boxer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ono. Dr. Boxer has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Oscotec. Dr. Boxer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly. Dr. Boxer has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Arrowhead. Dr. Boxer has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neurocrine Biosciences. Dr. Boxer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Switch. Dr. Boxer has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Arvinas. Dr. Boxer has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Alector. Dr. Boxer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Boxer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Boxer has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Transposon. Dr. Boxer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen . Dr. Boxer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS. Dr. Boxer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Boxer has stock in Alector. Dr. Boxer has stock in Arvinas. Dr. Boxer has stock in Neurovanda. The institution of Dr. Boxer has received research support from Biogen. The institution of Dr. Boxer has received research support from Eisai. The institution of Dr. Boxer has received research support from Regeneron. The institution of Dr. Boxer has received research support from NIH. The institution of Dr. Boxer has received research support from Bluefield Project-5. Dr. Boxer has received research support from Rainwater Charitable Foundation. Dr. Boxer has received research support from GHR Foundation. Dr. Boxer has received intellectual property interests from a discovery or technology relating to health care.
Andrew D. Siderowf, MD	Dr. Siderowf has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Siderowf has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mitsubishi. Dr. Siderowf has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Boehringer-Ingelheim. Dr. Siderowf has received personal compensation in the range of $500-$4,999 for serving as a Consultant for askbio. Dr. Siderowf has received personal compensation in the range of $500-$4,999 for serving as a Consultant for capsida. Dr. Siderowf has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Parkinson Study Group. Dr. Siderowf has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Theravance. Dr. Siderowf has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurocrine. Dr. Siderowf has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Prilenia. Dr. Siderowf has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Wave. Dr. Siderowf has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neurogastrix. Dr. Siderowf has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Prevail. Dr. Siderowf has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alerity. Dr. Siderowf has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Clintrex. Dr. Siderowf has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Inhibikase. Dr. Siderowf has a non-compensated relationship as a Scientific Advisory Board with NeuroPacs that is relevant to AAN interests or activities.
Basil Sharrack, MD, PhD, FAAN	Dr. Sharrack has nothing to disclose.
Ashis H. Tayal, MD	Dr. Tayal has nothing to disclose.
Sanjay P. Singh, MD, FAAN	Dr. Singh has nothing to disclose.
Guillermo Izquierdo Ayuso, MD	Dr. Izquierdo Ayuso has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bayer, Biogen Idec, Novartis, Sanofi, Merck Serono, Roche, Actelion and Celgene. Dr. Izquierdo Ayuso has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genzyme, Novartis, Sanofi Aventis, Alexion.
Natalie Kukulka, MD	Dr. Kukulka has nothing to disclose.
Aaron Desai, MD, MBBS	Dr. Desai has nothing to disclose.
Keiko Lo	No disclosure on file
Sachin M. Kokane	No disclosure on file
Michelle Han, MD	No disclosure on file
Johnathan L. McKay, PhD	The institution of Dr. McKay has received research support from NIH. The institution of Dr. McKay has received research support from the McCamish Foundation.
Grace Kim	Mr. Kim has nothing to disclose.
Darshan Mehta	Darshan Mehta has received personal compensation for serving as an employee of Sunovion Pharmaceuticals Inc. .
Salma Suhana, MD	No disclosure on file
Jeffrey C. Wagner, MD	Dr. Wagner has nothing to disclose.
Christopher Skidmore, MD	Dr. Skidmore has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for SALTZ MONGELUZZI BENDESKY LLC. The institution of Dr. Skidmore has received research support from Neuropace. The institution of Dr. Skidmore has received research support from Jazz Pharmaceuticals. The institution of Dr. Skidmore has received research support from Rapport Therapeutics.
Shawna M. Cutting, MD, FAAN	The institution of Dr. Cutting has received research support from Genentech.
Antonio Gil-Nagel, MD	Dr. Gil-Nagel has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biocodex. Dr. Gil-Nagel has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EISAI . Dr. Gil-Nagel has received personal compensation in the range of $0-$499 for serving as a Consultant for GW Pharma. Dr. Gil-Nagel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Angelini Pharma. Dr. Gil-Nagel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EISAI. Dr. Gil-Nagel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for GW Pharma. Dr. Gil-Nagel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for PTC Therapeutics . Dr. Gil-Nagel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Stoke . Dr. Gil-Nagel has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Zogenix . Dr. Gil-Nagel has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Angelini Pharma. Dr. Gil-Nagel has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for BIAL . Dr. Gil-Nagel has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for EISAI . Dr. Gil-Nagel has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for GW Pharma. Dr. Gil-Nagel has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Jazz Pharma. Dr. Gil-Nagel has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for PTC Therapeutics . Dr. Gil-Nagel has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB Pharma. Dr. Gil-Nagel has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Zogenix . The institution of Dr. Gil-Nagel has received research support from Jazz Pharmaceuticals. The institution of Dr. Gil-Nagel has received research support from PTC Therapeutics. The institution of Dr. Gil-Nagel has received research support from Zogenix. The institution of Dr. Gil-Nagel has received research support from Agencia Estatal Innovacion.
Melissa M. Cortez, DO	The institution of Dr. Cortez has received research support from NIH NINDS. The institution of Dr. Cortez has received research support from Dysautonomia International. Dr. Cortez has received personal compensation in the range of $500-$4,999 for serving as a Content Expert, Reviewer, DSMB with NIH RECOVER project.
Thyagarajan Subramanian, MD, MBBS, FAAN	Dr. Subramanian has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Neurocrine. Dr. Subramanian has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Supernus. Dr. Subramanian has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Teva. The institution of Dr. Subramanian has received research support from National Institutes of Health. The institution of Dr. Subramanian has received research support from Ann and Phillip Gladfetler III Foundation. The institution of Dr. Subramanian has received research support from Department of Defense . Dr. Subramanian has received publishing royalties from a publication relating to health care. Dr. Subramanian has received personal compensation in the range of $500-$4,999 for serving as a Grant Reviewer with National Institutes of Health.
Amanda Tinsley, MD	No disclosure on file
Belgin Kocer	No disclosure on file
Bhavika Kakadia, DO	Dr. Kakadia has nothing to disclose.
Katelyn McCormack, NP	No disclosure on file
Arathi Nandyala, MD	Dr. Nandyala has nothing to disclose.
Lakshmi P. Digala, MD	Dr. Digala has nothing to disclose.
Flavia Ferrandina	No disclosure on file
Soo-Kyoung Kim	No disclosure on file
Manuela Vaneckova	Manuela Vaneckova has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis . Manuela Vaneckova has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Manuela Vaneckova has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Manuela Vaneckova has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. The institution of Manuela Vaneckova has received research support from Czech Ministry of Health project—grants NU 22-04-00193 . Manuela Vaneckova has received research support from Czech Ministry of Health project - RVO VFN 64165 . Manuela Vaneckova has received personal compensation in the range of $500-$4,999 for serving as a principal investigator with Czech Ministry of Health project—grants NU 22-04-00193 .
Staley A. Brod, MD	Dr. Brod has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Brod has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Sanofi.
Dana Horakova	Dana Horakova has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dana Horakova has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dana Horakova has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dana Horakova has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck.
Yuri Bronstein, MD	Dr. Bronstein has nothing to disclose.
Shahla Moghbel, MD	No disclosure on file
James C. Tanner, MD	No disclosure on file
Mohammad Shahidullah, MD, MBBS	No disclosure on file
Orly Moshe-Lilie, MD	No disclosure on file
Robert Riggio, MD	No disclosure on file
Zachary B. Jordan, MD	Dr. Jordan has nothing to disclose.
Nancy Baker, MD	Dr. Baker has nothing to disclose.
Alexander J. Moszczynski, MD, PhD	No disclosure on file
Ahmed Abd Elazim, MD	Dr. Abd Elazim has nothing to disclose.
Jordan Amar, MD	No disclosure on file
Elyse Gadra	Ms. Gadra has nothing to disclose.
Jeryl Ritzi yu	No disclosure on file
Virginia A. Devonshire, MD	Dr. Devonshire has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck- Serono. Dr. Devonshire has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis . Dr. Devonshire has received personal compensation in the range of $500-$4,999 for serving as a Consultant for biogen . Dr. Devonshire has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for novartis. Dr. Devonshire has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for roche. Dr. Devonshire has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for biogen .
Samuel F. Hunter, MD, PhD	The institution of Dr. Hunter has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Abbview. The institution of Dr. Hunter has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for EMDSerono. The institution of Dr. Hunter has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech. The institution of Dr. Hunter has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. The institution of Dr. Hunter has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Osmotica. Dr. Hunter has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Janssen. Dr. Hunter has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. Dr. Hunter has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for EMDSerono. Dr. Hunter has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Genentech. Dr. Hunter has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Novartis. Dr. Hunter has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Sanofi. The institution of Dr. Hunter has received research support from Biogen. The institution of Dr. Hunter has received research support from Abbvie. The institution of Dr. Hunter has received research support from Genentech/Roche. The institution of Dr. Hunter has received research support from Janssen. The institution of Dr. Hunter has received research support from Novartis. The institution of Dr. Hunter has received research support from Osmotica. The institution of Dr. Hunter has received research support from Sanofi. Dr. Hunter has received intellectual property interests from a discovery or technology relating to health care. Dr. Hunter has received personal compensation in the range of $5,000-$9,999 for serving as a Speaker with MS Views and News. Dr. Hunter has a non-compensated relationship as a CEO - Volunteer with NeuroNexes/Novel Pharmaceutics Institute that is relevant to AAN interests or activities. Dr. Hunter has a non-compensated relationship as a Writing support with Novartis Pharmaceuticals that is relevant to AAN interests or activities. Dr. Hunter has a non-compensated relationship as a Writing Support with Osmotica that is relevant to AAN interests or activities. Dr. Hunter has a non-compensated relationship as a Writing support with Mallinckrodt that is relevant to AAN interests or activities. Dr. Hunter has a non-compensated relationship as a Writing Support with Sanofi that is relevant to AAN interests or activities.
Opeolu Adeoye	No disclosure on file
Kristen M. Krysko, MD	Dr. Krysko has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Krysko has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Krysko has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for EMD Serono. Dr. Krysko has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Krysko has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Krysko has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. The institution of Dr. Krysko has received research support from MS Society of Canda. The institution of Dr. Krysko has received research support from Roche.
Shannon Kolind, PhD, MSc, BSc	Dr. Kolind has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Kolind has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Kolind has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Kolind has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. The institution of Dr. Kolind has received research support from Sanofi Genzyme. The institution of Dr. Kolind has received research support from Roche. The institution of Dr. Kolind has received research support from Biogen.
Matthew H. Wong, MD	No disclosure on file
Ariana M. Frontario, DO	Dr. Frontario has nothing to disclose.
Aldanica Olano	Aldanica Olano has nothing to disclose.
Michelle D. DeJesus Brazitis, MD	Dr. DeJesus Brazitis has nothing to disclose.
Jordan A. Combs, MD	Dr. Combs has nothing to disclose.
Tanu Garg, MD	Dr. Garg has nothing to disclose.
Monica Scarsella, MD	Dr. Scarsella has nothing to disclose.
Shuvro Roy, MD	Dr. Roy has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. Dr. Roy has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Roy has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Roy has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. The institution of Dr. Roy has received research support from The Siegel Rare Neuroimmune Association.
Vlatka Vukojevic, MD	No disclosure on file
Murat Sari, MD	The institution of Dr. Sari has received research support from NIH/NINDS.
Douglas Bernhard	No disclosure on file
Parul Agarwal	Parul Agarwal has nothing to disclose.
Howard Feldman, MD, FAAN	The institution of Dr. Feldman has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novo Nordisk. The institution of Dr. Feldman has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen Research & Development LLC. The institution of Dr. Feldman has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Tau Consortium. The institution of Dr. Feldman has received research support from US National Institute of Health NIH/NIA. The institution of Dr. Feldman has received research support from Vivoryon Therapeutics. The institution of Dr. Feldman has received research support from US National Institute of Health NIH/NIA. The institution of Dr. Feldman has received research support from US National Institute of Health NIH/NIA. The institution of Dr. Feldman has received research support from US National Institute of Health NIH/NIA. The institution of Dr. Feldman has received research support from US National Institute of Health NIH/NIA. The institution of Dr. Feldman has received research support from US National Institute of Health NIH/NIA. The institution of Dr. Feldman has received research support from Allyx Pharmaceuticals. The institution of Dr. Feldman has received research support from Canadian Institutes of Health Research . Dr. Feldman has received intellectual property interests from a discovery or technology relating to health care. Dr. Feldman has a non-compensated relationship as a Medical Advisory Council with Association for Frontotemporal Degeneration (AFTD) that is relevant to AAN interests or activities. Dr. Feldman has a non-compensated relationship as a International Scientific Advisory Board with Translating Research in Elder Care (TREC) that is relevant to AAN interests or activities. Dr. Feldman has a non-compensated relationship as a Conference, Presenter with Royal Society of Canada that is relevant to AAN interests or activities. Dr. Feldman has a non-compensated relationship as a Conference, Presenter with Banner Health that is relevant to AAN interests or activities. Dr. Feldman has a non-compensated relationship as a Conference, Presenter, Manuscript Author with University of British Columbia that is relevant to AAN interests or activities.
Kejal Kantarci, MD	The institution of Dr. Kantarci has received research support from Eli Lilly. The institution of Dr. Kantarci has received research support from NIH. The institution of Dr. Kantarci has received research support from ADDF. The institution of Dr. Kantarci has received research support from Eisai. The institution of Dr. Kantarci has received research support from BioArctic.
Neal S. Hermanowicz, MD, FAAN	No disclosure on file
Michael J. Strong, MD, FAAN	No disclosure on file
John Kornak	No disclosure on file
Kimiko Domoto-Reilly, MD	Dr. Domoto-Reilly has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for MedBridge. The institution of Dr. Domoto-Reilly has received research support from Lawson Health Research Institute. The institution of Dr. Domoto-Reilly has received research support from NIH. The institution of Dr. Domoto-Reilly has received research support from Biogen. The institution of Dr. Domoto-Reilly has received research support from Lewy Body Dementia Association. The institution of Dr. Domoto-Reilly has received research support from Garvey Institute for Brain Health Solutions. The institution of Dr. Domoto-Reilly has received research support from Cognition Therapeutics. The institution of Dr. Domoto-Reilly has received research support from Takayama Family.
Ellen Carl, MS	No disclosure on file
Louise D. McCullough, MD, PhD	The institution of Dr. McCullough has received research support from NIH. The institution of Dr. McCullough has received research support from American Heart Association.
Till Sprenger	No disclosure on file
Chiadi U. Onyike, MD	Dr. Onyike has received personal compensation for serving as an employee of Rainwater Foundation. Dr. Onyike has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Acadia Pharmaceuticals . Dr. Onyike has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Reata Pharmaceuticals. Dr. Onyike has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Goodell, DeVries, Leech & Dann. The institution of Dr. Onyike has received research support from Alector.
Daniel Miller, MD	Dr. Miller has nothing to disclose.
Ali Ezzati, MD	The institution of Dr. Ezzati has received research support from NIA. The institution of Dr. Ezzati has received research support from Alzheimer's Association. The institution of Dr. Ezzati has received research support from Cure Alzheimer's Fund.
Federico J. Rodriguez-Porcel, MD, FAAN	Dr. Rodriguez-Porcel has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BioVie. Dr. Rodriguez-Porcel has received personal compensation in the range of $500-$4,999 for serving as a Consultant for WCG. Dr. Rodriguez-Porcel has received research support from NIH. Dr. Rodriguez-Porcel has received publishing royalties from a publication relating to health care.
Jennifer Meeks	No disclosure on file
Ali M. Antoine	No disclosure on file
Heather Yong, MD	Dr. Yong has nothing to disclose.
John Leever, MD	Dr. Leever has nothing to disclose.
Caroline M. Tanner, MD, PhD, FAAN	Dr. Tanner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Evidera. Dr. Tanner has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neurocrine. Dr. Tanner has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Jazz Pharmaceuticals/Cavion. Dr. Tanner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bial . Dr. Tanner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Supernus. Dr. Tanner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche Genentech. The institution of Dr. Tanner has received research support from Gateway LLC. The institution of Dr. Tanner has received research support from Roche\Genentech. The institution of Dr. Tanner has received research support from Michael J Fox Foundation . The institution of Dr. Tanner has received research support from National Institute of Health . The institution of Dr. Tanner has received research support from Department of Defense. Dr. Tanner has received personal compensation in the range of $500-$4,999 for serving as a Faculty, CME presentation with Medscape /WebND.
Ralph H. Benedict, PhD	Dr. Benedict has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Dr. Benedict has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Benedict has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Bristol Meyers Squibb. Dr. Benedict has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Immunic Therapeutics. Dr. Benedict has received intellectual property interests from a discovery or technology relating to health care.
Mary M. Machulda, PhD	The institution of Dr. Machulda has received research support from NIH.
David G. Standaert, MD, PhD, FAAN	Dr. Standaert has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Abbvie, Inc. Dr. Standaert has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Curium. Dr. Standaert has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alnylam. Dr. Standaert has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biohaven. Dr. Standaert has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CVS/Pharmacy. Dr. Standaert has received personal compensation in the range of $500-$4,999 for serving as a Consultant for HanAll Biopharma. Dr. Standaert has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Eli Lilly. Dr. Standaert has received personal compensation in the range of $500-$4,999 for serving as a Consultant for F. Hoffman LaRoche. Dr. Standaert has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi-Aventis. Dr. Standaert has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Theravance, Inc. Dr. Standaert has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for International Parkinson and Movement Disorder Society. The institution of Dr. Standaert has received research support from Abbvie, Inc. The institution of Dr. Standaert has received research support from American Parkinson Disease Association. The institution of Dr. Standaert has received research support from National Institutes of Health. The institution of Dr. Standaert has received research support from F. Hoffman LaRoche. Dr. Standaert has received publishing royalties from a publication relating to health care. Dr. Standaert has received personal compensation in the range of $500-$4,999 for serving as a Reviewer with National Institutes of Health. Dr. Standaert has a non-compensated relationship as a Chair, Scientific Advisory Board with American Parkinson Disease Association that is relevant to AAN interests or activities.
Jacqueline Rick	No disclosure on file
Nara Michaelson, MD	The institution of Dr. Michaelson has received research support from Biogen. The institution of Dr. Michaelson has received research support from the National Multiple Sclerosis Society (NMSS). Dr. Michaelson has received research support from Sanofi.
Shuja Sheikh, MD	No disclosure on file
David Rahimian, MD	No disclosure on file
Jenna Kanter, MD	No disclosure on file
Lynette Masters, MBBS	No disclosure on file
Anirudha S. Rathnam, MD	Dr. Rathnam has nothing to disclose.
Nevin Shalaby	Nevin Shalaby has nothing to disclose.
Kathy Foris, MD	No disclosure on file
Huy Q. Nguyen, MD	No disclosure on file
Harathi Bandaru, MD	Dr. Bandaru has nothing to disclose.
Stephen Downs	Stephen Downs has stock in Digital Health Solutions. The institution of Stephen Downs has received research support from Child Neurology Foundation.
Marcela Pavon	No disclosure on file
Benjamin Atchie	No disclosure on file
Wendy M. King, PT	Ms. King has nothing to disclose.
Lauren A. Beslow, MD	Dr. Beslow has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Various . The institution of Dr. Beslow has received research support from NIH. Dr. Beslow has received publishing royalties from a publication relating to health care.
Guangwei Du, MD, PhD	No disclosure on file
Clarisse Carra-Dalliere	No disclosure on file
Philip Van Damme	The institution of Dr. Van Damme has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for QurAlis. The institution of Dr. Van Damme has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. The institution of Dr. Van Damme has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for VectorY. The institution of Dr. Van Damme has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for NRG Therapeutics. The institution of Dr. Van Damme has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. The institution of Dr. Van Damme has received research support from CSL Behring.
Ashhar Ali, DO, FAAN	Dr. Ali has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer. Dr. Ali has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Ebsco.
Amanda C. Guidon, MD, MPH	An immediate family member of Dr. Guidon has received personal compensation for serving as an employee of GE Healthcare. Dr. Guidon has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Guidon has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Guidon has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Regeneron. Dr. Guidon has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. Dr. Guidon has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AAN - Continuum. The institution of Dr. Guidon has received research support from NINDS. Dr. Guidon has received publishing royalties from a publication relating to health care. Dr. Guidon has a non-compensated relationship as a Committee Member with Myasthenia Gravis Foundation of America that is relevant to AAN interests or activities. Dr. Guidon has a non-compensated relationship as a Executive Committee Member with Neuromuscular Study Group that is relevant to AAN interests or activities.
Gayane R. Melikyan, MD, FAAN	Dr. Melikyan has nothing to disclose.
Deepa Dash, MD, DM	Dr. Dash has nothing to disclose.
Peter Kosa, PhD	Dr. Kosa has nothing to disclose.
Babak Razavi, MD, PhD	Dr. Razavi has stock in CortexXus. The institution of Dr. Razavi has received research support from Neuropace.
Robert J. Marquardt, DO	Dr. Marquardt has nothing to disclose.
Tracey H. Fan, DO	Dr. Fan has nothing to disclose.
M. S. Perry, MD	Dr. Perry has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for stoke therapeutics. Dr. Perry has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurelis. Dr. Perry has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Marinus. Dr. Perry has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for jazz pharmaceuticals. Dr. Perry has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for UCB. Dr. Perry has received personal compensation in the range of $500-$4,999 for serving as a Consultant for pyros. Dr. Perry has received personal compensation in the range of $500-$4,999 for serving as a Consultant for azurity. Dr. Perry has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biocodex. Dr. Perry has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Stoke Therapeutics. Dr. Perry has stock in Praxis Precision Medicine. Dr. Perry has stock in Biohaven. Dr. Perry has stock in Rapport. Dr. Perry has stock in Alto Neurosciences. Dr. Perry has a non-compensated relationship as a president with child neurology foundation that is relevant to AAN interests or activities. Dr. Perry has a non-compensated relationship as a President with Pediatric Epilepsy Research Consortium that is relevant to AAN interests or activities.
Shweta Varade, MD	Dr. Varade has nothing to disclose.
Andrew Lee	No disclosure on file
Rogelio Dominguez-Moreno, MD	Dr. Dominguez-Moreno has nothing to disclose.
Jordan Seliger	Jordan Seliger has nothing to disclose.
Rohit Bhatia, MD, MBBS, DM	Dr. Bhatia has nothing to disclose.
Wendy G. Mitchell, MD	Dr. Mitchell has nothing to disclose.
Kumar Rajamani, MD, FAAN	Dr. Rajamani has nothing to disclose.
Augusto A. Miravalle, MD, FAAN	Dr. Miravalle has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech. Dr. Miravalle has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for EMD Serono. Dr. Miravalle has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Miravalle has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for TG. Dr. Miravalle has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Amgen. Dr. Miravalle has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Miravalle has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Miravalle has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Miravalle has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for BMS. Dr. Miravalle has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for EMD Serono. Dr. Miravalle has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for TG therapeutics. Dr. Miravalle has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Amgen. The institution of Dr. Miravalle has received research support from Genzyme. The institution of Dr. Miravalle has received research support from EMD Serono. The institution of Dr. Miravalle has received research support from Alexion.
Sabrina Sacconi, MD	Dr. Sacconi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for LUPIN. Dr. Sacconi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for SANOFI. Dr. Sacconi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BIOGEN. Dr. Sacconi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AMICUS. Dr. Sacconi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB Pharma. Dr. Sacconi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ALEXION. Dr. Sacconi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for FULCRUM THERAPEUTICS. Dr. Sacconi has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for AXELYS. Dr. Sacconi has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for OLOGY. The institution of Dr. Sacconi has received research support from Solve FSHD.
Amy Tsou, MD	Dr. Tsou has nothing to disclose.
Marko Petrovic, MD	Dr. Petrovic has nothing to disclose.
Omar M. Al-Janabi, MD, PhD, MSc	Dr. Al-Janabi has nothing to disclose.
Alejandro J. De La Torre Ribadeneira, MD	No disclosure on file
Rachel Aubert, DO	Dr. Aubert has nothing to disclose.
Sonia Gill, MD	No disclosure on file
Paul M. Miller	No disclosure on file
Lisa Sun, MD	Dr. Sun has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for multiple law firms. The institution of Dr. Sun has received research support from American Heart Association. The institution of Dr. Sun has received research support from Thrasher Research Fund. The institution of Dr. Sun has received research support from Laney Jaymes Foundation for Pediatric Stroke.
Karthik Bodhinathan, PhD	Dr. Bodhinathan has received personal compensation for serving as an employee of TG Therapeutics. Dr. Bodhinathan has stock in TG Therapeutics.
Jens Witsch, MD	Dr. Witsch has a non-compensated relationship as a editorial team member with Neurology Reisdent & Fellow section that is relevant to AAN interests or activities.
Abinayaa Purushothaman Ravichandran, MBBS	Dr. Purushothaman Ravichandran has nothing to disclose.
Fang Yu, Jr., MD	No disclosure on file
Kimberly Taing	No disclosure on file
Kelly Rich, MS, CGC	Ms. Rich has nothing to disclose.
Richard J. Barohn, MD, FAAN	Dr. Barohn has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for NuFactor. The institution of Dr. Barohn has received research support from FDA OPD R01. Dr. Barohn has received intellectual property interests from a discovery or technology relating to health care.
Massimo Filippi, MD, FAAN	Dr. Filippi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion, Almirall, Biogen, Merck, Novartis, Roche, Sanofi. Dr. Filippi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion, Biogen, Bristol-Myers Squibb, Merck, Novartis, Roche, Sanofi, Sanofi-Aventis, Sanofi-Genzyme, Takeda. Dr. Filippi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bayer, Biogen, Celgene, Chiesi Italia SpA, Eli Lilly, Genzyme, Janssen, Merck-Serono, Neopharmed Gentili, Novartis, Novo Nordisk, Roche, Sanofi, Takeda, and TEVA. Dr. Filippi has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer Nature. The institution of Dr. Filippi has received research support from Biogen Idec, Merck-Serono, Novartis, Roche, the Italian Ministry of Health, the Italian Ministry of University and Research, and Fondazione Italiana Sclerosi Multipla.
Corrado Angelini, MD, FAAN	Dr. Angelini has nothing to disclose.
Maria Laura Stromillo, PhD	Maria Laura Stromillo, PhD has nothing to disclose.
Rohit Bakshi, MD, FAAN	Dr. Bakshi has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for EMD Serono. Dr. Bakshi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. The institution of Dr. Bakshi has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Journal of Neuroimaging. The institution of Dr. Bakshi has received research support from Bristol Myers Squibb. The institution of Dr. Bakshi has received research support from EMD Serono. The institution of Dr. Bakshi has received research support from Novartis.
Shafeeq Ladha, MD	Dr. Ladha has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Ladha has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi. Dr. Ladha has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amylyx. Dr. Ladha has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech. Dr. Ladha has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Annexon. Dr. Ladha has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amicus. Dr. Ladha has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neurosense. Dr. Ladha has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Rapa Therapeutics. Dr. Ladha has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen. Dr. Ladha has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Sanofi. Dr. Ladha has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Genentech. The institution of Dr. Ladha has received research support from Biogen. The institution of Dr. Ladha has received research support from Sanofi. Dr. Ladha has received publishing royalties from a publication relating to health care.
Fernando Cendes, MD, PhD, FAAN	Dr. Cendes has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB Pharma. Dr. Cendes has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB Biopharma. Dr. Cendes has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for United Medical – Brazil. Dr. Cendes has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Zodiac Pharma . Dr. Cendes has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Eurofarma – Brazil . Dr. Cendes has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Epilepsia. Dr. Cendes has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Frontiers in Neurology - Epilepsy. The institution of Dr. Cendes has received research support from São Paulo Research Foundation - FAPESP. The institution of Dr. Cendes has received research support from Conselho Nacional de Desenvolvimento Científico e Tecnológico - Brazil . The institution of Dr. Cendes has received research support from NIH.
Nicola De Stefano, MD	Dr. De Stefano has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck Healthcare KGaA. Dr. De Stefano has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Immunic AG. Dr. De Stefano has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis Pharma AG. Dr. De Stefano has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck Serono S.p.A. Dr. De Stefano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi Genzyme. Dr. De Stefano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche S.p.A.. The institution of Dr. De Stefano has received research support from Italian MS Society. The institution of Dr. De Stefano has received research support from Merck Healthcare KGaA.
Hsien Lee Lau, MD	No disclosure on file
Chintan K. Rupareliya, MD	Dr. Rupareliya has nothing to disclose.
Megha Subramanian	No disclosure on file
Mohammad Abbas, MD	No disclosure on file
Leticia Franceschet Ribeiro	No disclosure on file
Enrique C. Leira, MD, MS, FAAN	Dr. Leira has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AHA. The institution of Dr. Leira has received research support from NIH-NINDS.
Alessandro Padovani, MD	No disclosure on file
Jeffrey A. Wilken, PhD	No disclosure on file
Ludwig Kappos, MD, FAAN	Dr. Kappos has nothing to disclose.
Maria Alejandra Gonzalez Duarte, MD, FAAN	Dr. Gonzalez Duarte has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alnylam. Dr. Gonzalez Duarte has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astra Zeneca. Dr. Gonzalez Duarte has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alnylam . The institution of Dr. Gonzalez Duarte has received research support from Pfizer.
Marinos C. Dalakas, MD, FAAN	Dr. Dalakas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Grifols, . Dr. Dalakas has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Dysimmune Diseases Foundation. Dr. Dalakas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Octapharma. Dr. Dalakas has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ARGENX. Dr. Dalakas has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AAN. Dr. Dalakas has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Therapeutic Advances in Neurology (TAND). Dr. Dalakas has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Medlink.
Sven Schippling	No disclosure on file
Alexander P. Auchus, MD, FAAN	Dr. Auchus has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for various law firms. Dr. Auchus has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Various law firms.
Duha M. Al-Shorafat, MD	Dr. Al-Shorafat has nothing to disclose.
Neelam Goyal, MD, FAAN	Dr. Goyal has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Argenx. Dr. Goyal has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB. Dr. Goyal has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Janssen. Dr. Goyal has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. The institution of Dr. Goyal has received research support from Argenx.
Courtney M. Hrdlicka, MD	Dr. Hrdlicka has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Genomadix.
Brian J. Villafuerte Trisolini, MD	Dr. Villafuerte Trisolini has nothing to disclose.
Cynthia L. Sullivan, PhD	No disclosure on file
Charles Matouk	Charles Matouk has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Silk Road Medical. Charles Matouk has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Microvention. Charles Matouk has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Navigantis.
Vineeta Singh, MD, FAAN	Dr. Singh has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for genae Americas, Inc. .
Marie C. Eugene, DO, MSHPE, FAAN	Dr. Eugene has nothing to disclose.
Amgad Shebl, MD, MBBS, FAAN	No disclosure on file
Matthew Bokhari, MD	No disclosure on file
Daniel A. Crespo, MD	Dr. Crespo has nothing to disclose.
Sheyar Amin, MD	Dr. Amin has nothing to disclose.
Andrea Gardoni	No disclosure on file
Larisa Reyderman	Larisa Reyderman has nothing to disclose.
David Skoloudik, MD, PhD	No disclosure on file
Val J. Lowe, MD	Dr. Lowe has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for AVID Radiopharmaceutical. Dr. Lowe has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai Inc. The institution of Dr. Lowe has received research support from AVID Radiopharmaceuticals.
Timothy E. Lotze, MD, FAAN	Dr. Lotze has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Department of Justice VICP. The institution of Dr. Lotze has received research support from NIH. The institution of Dr. Lotze has received research support from National MS Society. The institution of Dr. Lotze has received research support from Sarepta Therapeutics. The institution of Dr. Lotze has received research support from PTC THERAPEUTICS. The institution of Dr. Lotze has received research support from Avexis. Dr. Lotze has received publishing royalties from a publication relating to health care. Dr. Lotze has received publishing royalties from a publication relating to health care.
Mark Agostini, MD	Dr. Agostini has nothing to disclose.
Klaus Schmierer, MD, PhD	Dr. Schmierer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AXDEV. Dr. Schmierer has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for MedScape. Dr. Schmierer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NeuroDiem. Dr. Schmierer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurology Academy. Dr. Schmierer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck KGaA. Dr. Schmierer has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Merck KGaA. Dr. Schmierer has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for F. Hoffmann-La Roche AG. Dr. Schmierer has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Novartis. Dr. Schmierer has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Teva.
Jeremy Moeller, MD, FAAN	Dr. Moeller has received publishing royalties from a publication relating to health care.
Richard J. Nowak, MD	Dr. Nowak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion . Dr. Nowak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for argenx. Dr. Nowak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Nowak has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Immunovant . Dr. Nowak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cabaletta Bio . Dr. Nowak has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amgen. Dr. Nowak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cour Pharma. Dr. Nowak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Nowak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janseen . The institution of Dr. Nowak has received research support from UCB. The institution of Dr. Nowak has received research support from Alexion . The institution of Dr. Nowak has received research support from Janseen. The institution of Dr. Nowak has received research support from Immunovant . The institution of Dr. Nowak has received research support from argenx. The institution of Dr. Nowak has received research support from Amgen. Dr. Nowak has a non-compensated relationship as a Member of the Board of Directors with Myasthenia Gravis Foundation of America (MGFA) that is relevant to AAN interests or activities.
Kan Ding, MD	The institution of Dr. Ding has received research support from National Institute of Aging. The institution of Dr. Ding has received research support from NINDS.
Christine Till, PhD	No disclosure on file
Jiwon Oh, MD, FAAN	Dr. Oh has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche. The institution of Dr. Oh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen-Idec. Dr. Oh has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for EMD-Serono. Dr. Oh has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi-Genzyme. Dr. Oh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Oh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. Dr. Oh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS. Dr. Oh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astra Zeneca. Dr. Oh has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Oh has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen-Idec. Dr. Oh has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi-Genzyme. The institution of Dr. Oh has received research support from Biogen-Idec. The institution of Dr. Oh has received research support from Roche.
Margaret E. Burnett, MD	Dr. Burnett has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Prism. Dr. Burnett has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD serono. Dr. Burnett has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for EMD Serono. Dr. Burnett has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. The institution of Dr. Burnett has received research support from Genentech.
Angeliki Tsapanou, PhD	Dr. Tsapanou has nothing to disclose.
Jennifer J. Majersik, MD, FAAN	Dr. Majersik has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Stroke. The institution of Dr. Majersik has received research support from NIH/NINDS. The institution of Dr. Majersik has received research support from NIH/NCATS.
Maria A. Rocca	Maria Assunta Rocca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen, Bristol Myers Squibb, Eli Lilly, Janssen, Roche. Maria Assunta Rocca has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for AstraZaneca, Biogen, Bristol Myers Squibb, Bromatech, Celgene, Genzyme, Horizon Therapeutics Italy, Merck Serono SpA, Novartis, Roche, Sanofi and Teva. The institution of Maria Assunta Rocca has received research support from MS Society of Canada, the Italian Ministry of Health, the Italian Ministry of University and Research, and Fondazione Italiana Sclerosi Multipla.
Kourosh Rezania, MD, FAAN	Dr. Rezania has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Akcea. Dr. Rezania has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alnylam.
Antonio Giorgio, MD	Dr. Giorgio has nothing to disclose.
Muhammad Hamdan	No disclosure on file
Lincoln Darla, MD	Dr. Darla has nothing to disclose.
Oussama Landolsi	No disclosure on file
Gianna Carla Riccitelli	No disclosure on file
Simona Bonavita	No disclosure on file
Uma Menon, MD, MBA, FAAN, FAAN	Dr. Menon has nothing to disclose.
Mikael Cohen	Mikael Cohen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen, Roche, Merck, Ad scientiam, Novartis, Alexion, BMS.
Charles Maitland	No disclosure on file
Pascal Maisonobe	Pascal Maisonobe has received personal compensation for serving as an employee of ipsen pharma. Pascal Maisonobe has received personal compensation for serving as an employee of Ipsen.
Yolanda Blanco Morgado, MD	Dr. Blanco Morgado has nothing to disclose.
Hina N. Dave, MD	Dr. Dave has nothing to disclose.
Navnika Gupta, MBBS	Dr. Gupta has nothing to disclose.
Yash K. Pandya	No disclosure on file
Leslie J. Higuita, MD	Dr. Higuita has nothing to disclose.
Gloria V. Lopez Cardenas, MD	No disclosure on file
Lauren B. Krupp, MD, FAAN	Dr. krupp has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Myers Squibb. Dr. krupp has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Celgene. Dr. krupp has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medscape. Dr. krupp has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EBIX. Dr. krupp has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. krupp has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Hoffman LaRoche. Dr. krupp has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for MMMK. Dr. krupp has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Patrick, Dolan, and Kaufman. Dr. krupp has received intellectual property interests from a discovery or technology relating to health care.
Bradford B. Worrall, MD, MSc, FAAN	The institution of Dr. Worrall has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AAN. The institution of Dr. Worrall has received research support from NIH. The institution of Dr. Worrall has received research support from AHA/ASA.
Paisith Piriyawat, MD	Dr. Piriyawat has nothing to disclose.
Mauricio F. Farez, MD	Dr. Farez has received personal compensation for serving as an employee of Entelai. Dr. Farez has stock in Entelai. The institution of Dr. Farez has received research support from Fundación Sadosky.
Kathryn Nichol, PhD	Dr. Nichol has received personal compensation for serving as an employee of Greenwich Biosciences.
Luiz De Souza, MD	No disclosure on file
Jessie Jacobson, DO	Dr. Jacobson has nothing to disclose.
Tori Riccelli	No disclosure on file
Frank Dicken	No disclosure on file
Min Young Chun, MD	Dr. Chun has nothing to disclose.
Yasemin Akinci, MD	Dr. Akinci has nothing to disclose.
Lindsey R. Kuohn, MD	Dr. Kuohn has nothing to disclose.
Giuseppe Magnani	Giuseppe Magnani has nothing to disclose.
Brian C. Healy	The institution of Mr. Healy has received research support from Analysis Group. The institution of Mr. Healy has received research support from Bristol-Myers Squibb. The institution of Mr. Healy has received research support from Verily Life Sciences. The institution of Mr. Healy has received research support from Novartis. The institution of Mr. Healy has received research support from Merck Serono. The institution of Mr. Healy has received research support from Genzyme.
Luigi Ferini-Strambi, MD	Dr. Ferini-Strambi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bioprojet. Dr. Ferini-Strambi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for lundbeck. Dr. Ferini-Strambi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for idorsia. Dr. Ferini-Strambi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Italfarmaco. Dr. Ferini-Strambi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Dr. Ferini-Strambi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bruno Farmaceutici. Dr. Ferini-Strambi has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier Sleep Medicine.
Martin K. Nicholas, MD	No disclosure on file
Aliya Sarwar, MD	Dr. Sarwar has received personal compensation in the range of $500-$4,999 for serving as a Amneal Fellowship Director Advisory Board Member with Amneal -Rytary.
Jorge Zamudio, MD, MBA	Dr. Zamudio has received personal compensation for serving as an employee of Abbvie. Dr. Zamudio has received personal compensation for serving as an employee of Abbvie. Dr. Zamudio has received stock or an ownership interest from Abbvie .
Faisal A. Ibrahim, MD	Dr. Ibrahim has nothing to disclose.
George R. Jackson, MD, PhD	Dr. Jackson has nothing to disclose.
Koray Onuk	Koray Onuk has nothing to disclose.
David Do, MD	Dr. Do has nothing to disclose.
Jared Srinivasan	No disclosure on file
Changrui Xiao, MD	Dr. Xiao has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for WIley. The institution of Dr. Xiao has received research support from NIH.
Yasser Tajali, MD	No disclosure on file
Maryam H. Hosseini, MD	Dr. Hosseini has nothing to disclose.
Sally I. Othman	No disclosure on file
Diana E. Slawski, MD	No disclosure on file
Alex Kim, MD	Dr. Kim has nothing to disclose.
Erin Zahradnik, MD	No disclosure on file
Camilla Cividini, MSc	Ms. Cividini has nothing to disclose.
Russell E. Bartt, MD, FAAN	Dr. Bartt has nothing to disclose.
Sandra Vanotti, MD	No disclosure on file
Bum Joon Kim	Dr. Kim has nothing to disclose.
Ken Ikeda, MD, PhD	No disclosure on file
Paul G. Mathew, MD, DNBPAS, FAHS, FACSM, FAAN	Dr. Mathew has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbvie/Allergan. Dr. Mathew has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lilly. Dr. Mathew has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. Dr. Mathew has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biohaven/Pfizer. Dr. Mathew has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Theranica. Dr. Mathew has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Impel. Dr. Mathew has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Upsher Smith. Dr. Mathew has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Linpharma. Dr. Mathew has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie.
Marijean Buhse	Marijean Buhse has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen.
Ryan Hebert	Ryan Hebert has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cerenovus .
Mark Siegler, MD	No disclosure on file
Jana Dusankova, MD	No disclosure on file
Shadi Milani, DO	Dr. Milani has nothing to disclose.
Asher Junger	No disclosure on file
Fariha Jamal	No disclosure on file
Robert Ruchinskas, PhD	No disclosure on file
Jonathan Phillips	Jonathan Phillips has nothing to disclose.
Maria Dimitriadou	No disclosure on file
Antje Tockhorn-Heidenreich	Antje Tockhorn-Heidenreich has received personal compensation for serving as an employee of Eli Lilly and Company. An immediate family member of Antje Tockhorn-Heidenreich has received personal compensation for serving as an employee of Evidera. Antje Tockhorn-Heidenreich has received stock or an ownership interest from Eli Lilly and Company . An immediate family member of Antje Tockhorn-Heidenreich has received stock or an ownership interest from PPD.
Patricia E. Penovich, MD, FAAN	Dr. Penovich has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Engage therapeutics. Dr. Penovich has received personal compensation in the range of $0-$499 for serving as a Consultant for LVIS. Dr. Penovich has received personal compensation in the range of $0-$499 for serving as a Consultant for Monteris. Dr. Penovich has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for SK Therapeutics. Dr. Penovich has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neurelis. Dr. Penovich has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Greenwich. Dr. Penovich has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for SK Biosciences. Dr. Penovich has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Neurelis. Dr. Penovich has a non-compensated relationship as a Comittee Member with American Epilepsy Society that is relevant to AAN interests or activities.
Sen Sheng, MD	Dr. Sheng has nothing to disclose.
Lucienne Costa Frossard Franc	No disclosure on file
May Christine Malicdan	No disclosure on file
Vanessa Cooper, MD	Dr. Cooper has nothing to disclose.
Adeeb M. Narangoli, MD	Mr. Narangoli has nothing to disclose.
Ahmet Tanritanir, MD	No disclosure on file
Alan Pestronk, MD, FAAN	The institution of Dr. Pestronk has received research support from Jain. The institution of Dr. Pestronk has received research support from Fulcrum. The institution of Dr. Pestronk has received research support from Argenyx. The institution of Dr. Pestronk has received research support from NeuroNext.
Charles W. Brock, MD	No disclosure on file
Salah G. Keyrouz, MD	No disclosure on file
Clifford R. Jack, Jr., MD	The institution of Dr. Jack has received research support from NIH. The institution of Dr. Jack has received research support from Alexander Family Alzheimer's Disease Research Professorship of the Mayo Clinic.
Joseph H. Friedman, MD, FAAN	No disclosure on file
Elisabetta Pagani	Elisabetta Pagani has nothing to disclose.
Jeffery Gunter	The institution of Jeffery Gunter has received research support from NIH. Jeffery Gunter has received intellectual property interests from a discovery or technology relating to health care.
Katherine D. Holland, MD, PhD	No disclosure on file
Vladimir S. Kostic, MD, PhD	Dr. Kostic has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Roche. An immediate family member of Dr. Kostic has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Alkaloid. The institution of Dr. Kostic has received research support from Ministry of ��ɫ��, Science and Technological Development of Serbia.
Florian Eichler, MD	An immediate family member of Dr. Eichler has received personal compensation for serving as an employee of UpToDate. Dr. Eichler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Atlas Venture. Dr. Eichler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Acadia Pharmaceuticals. Dr. Eichler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Leal Therapeutics. Dr. Eichler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Orchard Tx. Dr. Eichler has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ionis Therapeutics. The institution of Dr. Eichler has received research support from ASPA Therapeutics. The institution of Dr. Eichler has received research support from Abbvie. The institution of Dr. Eichler has received research support from Ionis Pharmaceuticals.
Constantine Farmakidis, MD, FAAN	Dr. Farmakidis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Farmakidis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for J&J. Dr. Farmakidis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Muscular Dystrophy Association.
Elisa Canu	The institution of Elisa Canu has received research support from Italian Ministry of Health .
Iris Katharina Penner, PhD	The institution of Dr. Penner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. The institution of Dr. Penner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. The institution of Dr. Penner has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Janssen. The institution of Dr. Penner has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genzyme. The institution of Dr. Penner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. The institution of Dr. Penner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TEVA. The institution of Dr. Penner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Celgene. The institution of Dr. Penner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bayer. The institution of Dr. Penner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS. The institution of Dr. Penner has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Penner has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen. Dr. Penner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Penner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Celgene . Dr. Penner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Penner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Penner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. The institution of Dr. Penner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck.
Janice M. Redmond, MD	Dr. Redmond has nothing to disclose.
Jens Wuerfel, MD	Dr. Wuerfel has received personal compensation for serving as an employee of MIAC AG. The institution of Dr. Wuerfel has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Actelion. The institution of Dr. Wuerfel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. The institution of Dr. Wuerfel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche.
Pavel Hok, MD	Dr. Hok has nothing to disclose.
Duaa Jabari, MD	Dr. Jabari has nothing to disclose.
Stephen L. Hauser, MD	Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NGM Bio. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Moderna. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BD. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pheno Therapeutics. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Nurix Therapeutics. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Gilead. Dr. Hauser has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Accure. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alector. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Hinge Therapeutics. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Neurona. Dr. Hauser has a non-compensated relationship as a Clinical Trial/Primary Investigator with Roche that is relevant to AAN interests or activities. Dr. Hauser has a non-compensated relationship as a Clinical Trial/Primary Investigator with Novartis that is relevant to AAN interests or activities.
Travis E. Losey, MD	No disclosure on file
Howard J. Rosen, MD	Dr. Rosen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly . Dr. Rosen has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alector. The institution of Dr. Rosen has received research support from NIH. The institution of Dr. Rosen has received research support from State of CA. Dr. Rosen has a non-compensated relationship as a Consultant with Prevail Therapeutics that is relevant to AAN interests or activities. Dr. Rosen has a non-compensated relationship as a consultant with Alchemab that is relevant to AAN interests or activities.
Raed Alroughani, MD, FAAN	Dr. Alroughani has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen, AstraZeneca, Novartis, Merck, Roche, Sanofi. Dr. Alroughani has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for AstraZeneca, Biogen, Novartis, Merck, Roche, Sanofi.
James W. Wheless, MD, FAAP, FACP, FAAN, FAES, FCNS, FAAN	Dr. Wheless has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Jazz. Dr. Wheless has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurelis. Dr. Wheless has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Azurity. Dr. Wheless has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Wheless has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biocodex. Dr. Wheless has received personal compensation in the range of $500-$4,999 for serving as a Consultant for LivaNova. Dr. Wheless has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Stoke. Dr. Wheless has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for LivaNova. Dr. Wheless has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Jazz. Dr. Wheless has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB. Dr. Wheless has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB. Dr. Wheless has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Neurelius.
Pietro Maggi, MD, PhD	No disclosure on file
Murat Kurtuncu, MD	Dr. Kurtuncu has nothing to disclose.
Vanessa Wiggermann	No disclosure on file
Dirk T. Deleu, MD, PhD, FRCP, FAAN	Dr. Deleu has nothing to disclose.
Bonnie Glanz	The institution of Ms. Glanz has received research support from CMSC. The institution of Ms. Glanz has received research support from NIH.
John T. Kissel, MD, FAAN	Dr. Kissel has nothing to disclose.
Paola Valsasina	Paola Valsasina has nothing to disclose.
Haitham Hussein, MD, FAAN	Dr. Hussein has nothing to disclose.
Naim I. Haddad, MD, FAAN	Dr. Haddad has nothing to disclose.
Bradley Lega, MD	The institution of Bradley Lega has received research support from NIH.
Nazeem Arsalan, MD	No disclosure on file
Amandeep Dolla, MBBS	Dr. Dolla has nothing to disclose.
Jeremy D. Wells, MD	No disclosure on file
Anvita Potluri, MD	Dr. Potluri has nothing to disclose.
Harrison Lang	No disclosure on file
Pavan Patel, DO	Dr. Patel has nothing to disclose.
Nicole K. Le	No disclosure on file
Junaid Aslam, MD, MBA	No disclosure on file
Ravi S. Menon, MD	No disclosure on file
Christopher Langston, MD	No disclosure on file
Jorge Maurino	Jorge Maurino has received personal compensation for serving as an employee of Roche Pharma Spain, Medical Department.
Roshan Dhanapalaratnam, MBBS	Dr. Dhanapalaratnam has received research support from Australian Government.
Syed Rahman	No disclosure on file
Hannah N. Rinehardt	No disclosure on file
Heloise Joly	No disclosure on file
Mamatha Pasnoor, MD, FAAN	Dr. Pasnoor has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Argenx BVBA. Dr. Pasnoor has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen Pharmaceutical. Dr. Pasnoor has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Immunovant. Dr. Pasnoor has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Pasnoor has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Annexon. Dr. Pasnoor has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Grifols. Dr. Pasnoor has received personal compensation in the range of $500-$4,999 for serving as a Consultant for amgen.
Alberto Ascherio, MD, PhD	Dr. Ascherio has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Pfizer. Dr. Ascherio has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck. Dr. Ascherio has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. The institution of Dr. Ascherio has received research support from NIH and US Department of Defense .
Hans-Peter Hartung, MD, FAAN	Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS Celgene. Dr. Hartung has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Geneuro. Dr. Hartung has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Hartung has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bayer. Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Frontiers Neurology.
Bianca Weinstock-Guttman, MD	Dr. Weinstock-Guttman has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. Dr. Weinstock-Guttman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech. Dr. Weinstock-Guttman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis . Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genzyme &Sanofi. Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen . Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bayer. Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Horizon. Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Weinstock-Guttman has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Weinstock-Guttman has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen. Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Janssen. Dr. Weinstock-Guttman has received personal compensation in the range of $0-$499 for serving as a Reviewer with NIH.
Bernhard Hemmer, MD	No disclosure on file
Eva-Maria Wicklein, MD	Dr. Wicklein has received personal compensation for serving as an employee of Bayer AG.
Laura Airas, MD, PhD	Dr. Airas has nothing to disclose.
Michael Carrithers, MD, PhD	The institution of Dr. Carrithers has received research support from Biogen.
Tigran Kesayan, MD	Dr. Kesayan has nothing to disclose.
Channa Kolb, MD	No disclosure on file
Elka Stefanova	No disclosure on file
Iva Stankovic	Iva Stankovic has nothing to disclose.
Lindsay N. Alfano, PT	Ms. Alfano has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for ATOM International, Ltd (Amicus Therapeutics, Catabasis, Genethon, Italfarmaco, NS Pharma, Pfizer, PTC Therapeutics). Ms. Alfano has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sarepta Therapeutics. The institution of Ms. Alfano has received research support from Novartis Gene Therapies. The institution of Ms. Alfano has received research support from Sarepta Therapeutics. The institution of Ms. Alfano has received research support from Audentes Therapeutics/Astellas Gene Therapies. Ms. Alfano has received intellectual property interests from a discovery or technology relating to health care.
Charles D. Schutt, MD	Dr. Schutt has nothing to disclose.
Rachel Salazar, PT	No disclosure on file
Brian Edlow, MD	Dr. Edlow has received research support from NIH.
Swetha Renati, MD	Dr. Renati has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bayer. Dr. Renati has received personal compensation in the range of $500-$4,999 for serving as a NeuroSAE with ��ɫ�� .
Vinita J. Acharya, MD, FAAN	Dr. Acharya has nothing to disclose.
Steven Tversky, DO	No disclosure on file
Philippe Picaut	No disclosure on file
Harald Kropshofer	Harald Kropshofer has nothing to disclose.
Fanny O'Brien	No disclosure on file
Jane Khalife, MD	Dr. Khalife has nothing to disclose.
Vaibhav Goswami, MD	Dr. Goswami has nothing to disclose.
David D. Kim, MD	No disclosure on file
Diego Santos Garcia	Diego Santos Garcia has nothing to disclose.
Dasa Viszlayova	No disclosure on file
Jamison Hofer, MD	No disclosure on file
Joely A. Mass	No disclosure on file
Thomas F. Scott, MD	Dr. Scott has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genzyme-Sanofi. Dr. Scott has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Serono. Dr. Scott has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. Dr. Scott has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Genentech. Dr. Scott has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Genzyme.
Lisa Silbert, MD, FAAN	The institution of Dr. Silbert has received research support from the NIH. Dr. Silbert has received personal compensation in the range of $0-$499 for serving as a Peer Reviewer, study section with NIH.
Vera Bril, MD	Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CSL. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alnylam. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Grifols. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Takeda. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Octapharma. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Powell Mansfield. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Akcea. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ionis. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Immunovant. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Momenta (now J&J). Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NovoNordisk. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Takeda. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Immunovant. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Bril has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Akcea. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alnylam. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for CSL. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. The institution of Dr. Bril has received research support from UCB. The institution of Dr. Bril has received research support from Argenx. The institution of Dr. Bril has received research support from Momenta (now J&J). The institution of Dr. Bril has received research support from Immunovant. The institution of Dr. Bril has received research support from Alexion. The institution of Dr. Bril has received research support from Takeda. The institution of Dr. Bril has received research support from Grifols. The institution of Dr. Bril has received research support from CSL. The institution of Dr. Bril has received research support from Octapharma. The institution of Dr. Bril has received research support from Akcea. The institution of Dr. Bril has received research support from Ionis. The institution of Dr. Bril has received research support from Viela Bio (now Horizon). Dr. Bril has received intellectual property interests from a discovery or technology relating to health care.
Edward Huey	No disclosure on file
Christopher Streib, MD	Dr. Streib has nothing to disclose.
Shadi Yaghi, MD	Dr. Yaghi has nothing to disclose.
Muhib Khan, MD, FAAN	The institution of Dr. Khan has received research support from Mayo Clinic ��ɫ�� Grant . The institution of Dr. Khan has received research support from Mayo Clinic Small Grants .
James E. Siegler III, MD	Dr. Siegler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Siegler has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Bayer. Dr. Siegler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Serb. Dr. Siegler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ceribell. Dr. Siegler has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Wallaby Phenox. Dr. Siegler has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Stroke: Vascular and Interventional Neurology. Dr. Siegler has received personal compensation in the range of $50,000-$99,999 for serving as an Expert Witness for Precision Medicine, LLC. The institution of Dr. Siegler has received research support from Philips. The institution of Dr. Siegler has received research support from Medtronic.
Davorka Tomic	Davorka Tomic has stock in Meck KGaA.
Karlo J. Lizarraga, MD, MS, FAAN	Dr. Lizarraga has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for FHC. The institution of Dr. Lizarraga has received research support from BlueRock. The institution of Dr. Lizarraga has received research support from Roche. The institution of Dr. Lizarraga has received research support from NIH/NINDS. Dr. Lizarraga has received personal compensation in the range of $500-$4,999 for serving as a Speaker with International Parkinson and Movement Disorders Society. Dr. Lizarraga has received personal compensation in the range of $0-$499 for serving as a Reviewer with National Institutes of Health. Dr. Lizarraga has a non-compensated relationship as a Editorial Board Member for Brain & Life with ��ɫ�� that is relevant to AAN interests or activities.
Tuncay Gunduz, MD	The institution of Dr. Gunduz has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis Pharmaceuticals. Dr. Gunduz has received research support from Turkish Neuroimmunology Society.
Gerhard Winkler	No disclosure on file
Weizhe Li, MD, PhD	No disclosure on file
Rajinder K. Dhamija, MD, FRACP	Prof. Dhamija has nothing to disclose.
Huanwen Chen, MD	Dr. Chen has nothing to disclose.
Emma Ciafaloni, MD, FAAN	Dr. Ciafaloni has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Argenx, Alexion, Sarepta, UCB, Hoffman-LaRoche, Biogen. Dr. Ciafaloni has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis, AnnJi Pharmaceutical, ML-BIO, Avidity. The institution of Dr. Ciafaloni has received research support from CDC, CureSMA, FDA, Orphazyme, Sarepta, PCORI, Neurogene. Dr. Ciafaloni has received publishing royalties from a publication relating to health care.
Sachin Kedar, MD, FAAN	Dr. Kedar has nothing to disclose.
Clyde E. Markowitz, MD	No disclosure on file
Rohit Das, MD, FAAN	Dr. Das has received personal compensation for serving as an employee of Oregon Health Science University. Dr. Das has received personal compensation in the range of $10,000-$49,999 for serving as a Physician Advisor with Concentra .
Albert Saiz	Albert Saiz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Albert Saiz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon Therapeutics. Albert Saiz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Albert Saiz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janseen. Albert Saiz has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Albert Saiz has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for novartis. Albert Saiz has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen.
Cristina M. Ramo, MD	Dr. Ramo has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ALMIRALL . Dr. Ramo has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for SANDOZ. Dr. Ramo has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Ramo has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Almirall. Dr. Ramo has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for BIOGEN. Dr. Ramo has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen . Dr. Ramo has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. The institution of Dr. Ramo has received research support from HORIZON-2020. The institution of Dr. Ramo has received research support from fis (SPANISH GOVERNMENT). The institution of Dr. Ramo has received research support from BIOGEN. The institution of Dr. Ramo has received research support from MERCK. The institution of Dr. Ramo has received research support from ALMIRALL. The institution of Dr. Ramo has received research support from NOVARTIS. The institution of Dr. Ramo has received research support from RICORS (Spanish Government). The institution of Dr. Ramo has received research support from ROCHE. Dr. Ramo has received publishing royalties from a publication relating to health care.
Maria-Jose Catalan, MD, PhD	No disclosure on file
Prachi Mehndiratta, MD	Dr. Mehndiratta has nothing to disclose.
Hussein Alshammari, MD	Dr. Alshammari has nothing to disclose.
Maria Corrada, PhD	The institution of Dr. Corrada has received research support from NIH.
Corey McMillan, PhD	Dr. McMillan has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. The institution of Dr. McMillan has received research support from Biogen. The institution of Dr. McMillan has received research support from NIH.
Anne D. Yacoub, MD	Dr. Yacoub has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AbbVie.
Tatjana Rundek, MD, PhD	The institution of Dr. Rundek has received research support from NIH.
Jaclyn Duvall, MD	Dr. Duvall has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie/Allergan. Dr. Duvall has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Abbive/Alllergan. Dr. Duvall has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Teva. Dr. Duvall has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Eli Lilly. Dr. Duvall has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Lundbeck. Dr. Duvall has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biohaven.
Janina Krell-Roesch, PhD	Dr. Krell-Roesch has nothing to disclose.
Anson Wang, MD	Dr. Wang has nothing to disclose.
Hrissanthi Ikonomidou, MD, PhD	An immediate family member of Dr. Ikonomidou has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for RNN Journal. An immediate family member of Dr. Ikonomidou has stock in Solvay. Dr. Ikonomidou has received personal compensation in the range of $500-$4,999 for serving as a Reviewer with NIH, FDA.
Tejinder Singh, MD	Dr. Singh has nothing to disclose.
Sreeja Kodali	Ms. Kodali has nothing to disclose.
Jeffrey A. Cohen, MD	Dr. Cohen has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Convelo. Dr. Cohen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astoria. Dr. Cohen has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Bristol Myers Squibb. Dr. Cohen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Viatris. Dr. Cohen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PSI. Dr. Cohen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Shionogi. Dr. Cohen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Celltrion.
Steven J. Kittner, MD, MPH	The institution of Dr. Kittner has received research support from NINDS.
Jonathan Rosand, MD	Dr. Rosand has received personal compensation for serving as an employee of Massachusetts General Hospital. Dr. Rosand has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly and Co. Dr. Rosand has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. The institution of Dr. Rosand has received research support from NIH. The institution of Dr. Rosand has received research support from American Heart Association. Dr. Rosand has received personal compensation in the range of $0-$499 for serving as a Peer reviewer with National Institutes of Health. Dr. Rosand has a non-compensated relationship as a Trustee with Columbia University that is relevant to AAN interests or activities.
Marc Malkoff, MD, FAAN	Dr. Malkoff has nothing to disclose.
Fernando D. Testai, MD, PhD, FAAN	Dr. Testai has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. Dr. Testai has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Livingston, Barger, Brandt & Schroeder, L.L.P.. Dr. Testai has received publishing royalties from a publication relating to health care.
Manish Modi	No disclosure on file
Manish Modi, MD	Dr. Modi has nothing to disclose.
Manuela Matta	No disclosure on file
Christopher D. Anderson, MD, PhD, FAAN	The institution of Dr. Anderson has received research support from Bayer AG. The institution of Dr. Anderson has received research support from American Heart Association. The institution of Dr. Anderson has received research support from National Institutes of Health. An immediate family member of Dr. Anderson has received publishing royalties from a publication relating to health care.
Navid Seraji-Bozorgzad, MD	No disclosure on file
Steven J. Cavalier, MD, FAAN	No disclosure on file
Bhaskar Roy, MD, FAAN	Dr. Roy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for argenx. Dr. Roy has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Roy has stock in Cabaletta bio. . Dr. Roy has stock in Pfizer. Dr. Roy has stock in CAVA. The institution of Dr. Roy has received research support from Abcuro Pharmaceuticals. The institution of Dr. Roy has received research support from Immunovant. The institution of Dr. Roy has received research support from argenx.
Nicolas Saikali, MD	Dr. Saikali has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for AbbVie. Dr. Saikali has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Lilly. Dr. Saikali has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Teva. Dr. Saikali has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Upsher-Smith. Dr. Saikali has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Axsome. The institution of Dr. Saikali has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Lundbeck.
David M. Ermak, DO	Dr. Ermak has nothing to disclose.
Scott M. Belliston, DO	Dr. Belliston has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech.
Laura Scholtz, MD	Dr. Scholtz has nothing to disclose.
Daniella Miller, MD	Dr. Miller has nothing to disclose.
David A. Shirilla, DO	No disclosure on file
Erin Smith, MD	Dr. Smith has nothing to disclose.
Haoming Pang, MD	Dr. Pang has nothing to disclose.
Emily Anderson	No disclosure on file
Paul Sanmartin, MD	No disclosure on file
Matthew Purbaugh, MD	Dr. Purbaugh has nothing to disclose.
William F. Taber	No disclosure on file
Anthony Traboulsee, MD	Dr. Traboulsee has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Traboulsee has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Traboulsee has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Traboulsee has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Traboulsee has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Traboulsee has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for EMD Serono. Dr. Traboulsee has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Roche. The institution of Dr. Traboulsee has received research support from Roche. The institution of Dr. Traboulsee has received research support from Consortium of MS Centers. The institution of Dr. Traboulsee has received research support from MS Canada. Dr. Traboulsee has received personal compensation in the range of $500-$4,999 for serving as a Workshop Chair with Consortium of MS Centers.
Douglas R. Jeffery, MD, PhD	No disclosure on file
Julio A. Chalela, MD	Dr. Chalela has nothing to disclose.
Thomas F. Tropea, DO	Dr. Tropea has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bial. The institution of Dr. Tropea has received research support from NINDS. The institution of Dr. Tropea has received research support from Parkinson Foundation. The institution of Dr. Tropea has received research support from Michael J Fox Foundation.
Pavel Klein, MD, FAAN	The institution of Dr. Klein has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Aquestive. The institution of Dr. Klein has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Neurelis. The institution of Dr. Klein has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for UCB Pharma. The institution of Dr. Klein has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for SK Life Sience. The institution of Dr. Klein has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Eisai. The institution of Dr. Klein has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. The institution of Dr. Klein has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Alliance. The institution of Dr. Klein has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Arvelle Therapeutics. Dr. Klein has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Aquestive. Dr. Klein has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Eisai. Dr. Klein has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for UCB Pharma. Dr. Klein has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for SK Life Sciences. Dr. Klein has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Sunovion. Dr. Klein has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for PrevEp. Dr. Klein has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Fenwick . Dr. Klein has received research support from DOD/CURE.
Ho Jin Kim, MD	Dr. Kim has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Altos Biologics, AstraZeneca, Biogen, Daewoong Pharmaceutical, Kaigene, Kolon Life Science, MDimune, Roche, and Sanofi. Dr. Kim has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion, AstraZeneca, Eisai, GC Pharma, Merck, Mitsubishi Tanabe Pharma, and Roche. Dr. Kim has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Multiple Sclerosis Journal, Journal of Clinical Neurology.
Alice Chen-Plotkin, MD	Dr. Chen-Plotkin has received intellectual property interests from a discovery or technology relating to health care.
Giulia Longoni, MD	Dr. Longoni has nothing to disclose.
John J. Volpi, MD	Dr. Volpi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NovaSignal. Dr. Volpi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for W.L. Gore. Dr. Volpi has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Diamedica. Dr. Volpi has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Janssen. Dr. Volpi has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Amgen. Dr. Volpi has received intellectual property interests from a discovery or technology relating to health care.
Radoslaw Kazmierski, MD, PhD	Dr. Kazmierski has nothing to disclose.
Roger Tam, PhD	The institution of Dr. Tam has received research support from Natural Sciences and Engineering Research Council. The institution of Dr. Tam has received research support from Praxis Spinal Cord Institute.
André Luiz Guimarães de Queiroz	André Luiz Guimarães de Queiroz has nothing to disclose.
Dong-Hui Ao	No disclosure on file
Douglas J. Mayson, MD	Dr. Mayson has nothing to disclose.
Benjamin Jiang, MD	Dr. Jiang has nothing to disclose.
Alexandra L. Da Silva	No disclosure on file
Sebastian Koch, MD	Dr. Koch has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Multiple Legal Matters. Dr. Koch has received stock or an ownership interest from Cerepeutics. Dr. Koch has received intellectual property interests from a discovery or technology relating to health care. Dr. Koch has received intellectual property interests from a discovery or technology relating to health care.
Kassandra L. Munger	Ms. Munger has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. The institution of Ms. Munger has received research support from Department of Defense.
Margherita Milone, MD, FAAN	Dr. Milone has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cartesian Therapeutics. Dr. Milone has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology Genetics, AAN. The institution of Dr. Milone has received research support from Mayo Clinic, CCaTS-CBD. The institution of Dr. Milone has received research support from Mayo Clinic, SGP Award. The institution of Dr. Milone has received research support from MDA for Care Center grant. The institution of Dr. Milone has received research support from Regenerative medicine Minnesota.
Mario Zappia, MD	No disclosure on file
Connie C. Marras, MD	Dr. Marras has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurocrine Biosciences. The institution of Dr. Marras has received research support from Theravance Inc. The institution of Dr. Marras has received research support from Centogene.
Simona Pontecorvo	No disclosure on file
Leigh E. Charvet, PhD	Dr. Charvet has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Johnson & Johnson. Dr. Charvet has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Springer Healthcare. Dr. Charvet has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for YBrain. Dr. Charvet has stock in Johnson&Johnson.
Ilena George, MD	The institution of Dr. George has received research support from Biogen.
Giacomo Boffa	Mr. Boffa has nothing to disclose.
Nathalie Jette, MD, MSc, FRCPC, FAAN	Dr. Jette has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for ILAE Epilepsia. The institution of Dr. Jette has received research support from NIH. The institution of Dr. Jette has received research support from AES.
Nizar Souayah, MD, FAAN	Dr. Souayah has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Takeda. Dr. Souayah has received publishing royalties from a publication relating to health care.
Ralitza H. Gavrilova, MD	Dr. Gavrilova has nothing to disclose.
Ingemar S. Merkies, MD	No disclosure on file
Anna Karydas	No disclosure on file
Gen Sobue, MD	Dr. Sobue has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Mistubishi Tanabe Pharma Corporation. Dr. Sobue has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Nippon Chemiphar Co., Ltd.. Dr. Sobue has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Mistubishi Tanabe Pharma Corporation. Dr. Sobue has received personal compensation in the range of $0-$499 for serving as an Expert Witness for Takeda Pharmaceutical Company Limited..
Maria Pia Sormani	Maria Pia Sormani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Maria Pia Sormani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Maria Pia Sormani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Maria Pia Sormani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Maria Pia Sormani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol meyer. Maria Pia Sormani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Maria Pia Sormani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Immunic. Maria Pia Sormani has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis, Roche. Maria Pia Sormani has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Maria Pia Sormani has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche.
Xiangyi Meng, PhD	Dr. Meng has nothing to disclose.
David A. Stamler, MD	Dr. Stamler has received personal compensation for serving as an employee of Alterity Therapeutics. Dr. Stamler has stock in Alterity Therapeutics.
Maria Vassilaki, MD, PhD	Dr. Vassilaki has stock in Abbott Laboratories. Dr. Vassilaki has stock in Johnson and Johnson. Dr. Vassilaki has stock in Medtronic. Dr. Vassilaki has stock in Amgen. Dr. Vassilaki has stock in AbbVie. Dr. Vassilaki has stock in Merck. The institution of Dr. Vassilaki has received research support from NIH. The institution of Dr. Vassilaki has received research support from European Union/ St. Anne's University Hospital Brno, Czech Republic. The institution of an immediate family member of Dr. Vassilaki has received research support from Avobis Bio, LLC.
Silvia Presas	Silvia Presas has nothing to disclose.
Muhammad Nagy, MBBCh, MSc	Dr. Nagy has nothing to disclose.
Elaine J. Skalabrin, MD	No disclosure on file
Yaakov Stern, PhD	Dr. Stern has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai. Dr. Stern has received intellectual property interests from a discovery or technology relating to health care. Dr. Stern has received publishing royalties from a publication relating to health care.
Alaleh Raji, MD	No disclosure on file
Sudeepta Dandapat, MD	Dr. Dandapat has nothing to disclose.
Said R. Beydoun, MD, FAAN	Dr. Beydoun has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. Dr. Beydoun has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion. Dr. Beydoun has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Janssen. Dr. Beydoun has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for CSL. Dr. Beydoun has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for AstraZeneca. Dr. Beydoun has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Argenx. Dr. Beydoun has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB. Dr. Beydoun has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer. Dr. Beydoun has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Takeda. Dr. Beydoun has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Alnylam. Dr. Beydoun has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alexion. Dr. Beydoun has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for CSL. Dr. Beydoun has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for UCB. Dr. Beydoun has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Takeda. Dr. Beydoun has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for AstraZeneca. Dr. Beydoun has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Argenx. Dr. Beydoun has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Janssen. The institution of Dr. Beydoun has received research support from Abcuro. The institution of Dr. Beydoun has received research support from Sean Healy & AMG Center for ALS. The institution of Dr. Beydoun has received research support from Regeneron. The institution of Dr. Beydoun has received research support from RemeGen. The institution of Dr. Beydoun has received research support from Sanofi. The institution of Dr. Beydoun has received research support from Novartis.
Alvino Bisecco	Alvino Bisecco has nothing to disclose.
Andreas Lysandropoulos	Andreas Lysandropoulos has nothing to disclose.
Imama A. Naqvi, MD	Dr. Naqvi has nothing to disclose.
Ralf Linker	Dr. Linker has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Linker has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer. The institution of Dr. Linker has received research support from Novartis. The institution of Dr. Linker has received research support from Biogen.
Pooja Khatri, MD, FAAN	The institution of Dr. Khatri has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lumosa. Dr. Khatri has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Bayer. The institution of Dr. Khatri has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Diamedica. Dr. Khatri has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Basking Biosciences. Dr. Khatri has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Heart Association. The institution of Dr. Khatri has received research support from Cerenovus. Dr. Khatri has received publishing royalties from a publication relating to health care.
Tjalf Ziemssen, MD, FAAN	Dr. Ziemssen has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche. Dr. Ziemssen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Ziemssen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS . Dr. Ziemssen has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merck. Dr. Ziemssen has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Roche. Dr. Ziemssen has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Ziemssen has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck. Dr. Ziemssen has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Sanofi. Dr. Ziemssen has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for TEVA. Dr. Ziemssen has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for Dresden Internation University. The institution of Dr. Ziemssen has received research support from Novartis. The institution of Dr. Ziemssen has received research support from Merck. The institution of Dr. Ziemssen has received research support from Sanofi. The institution of Dr. Ziemssen has received research support from BMS. The institution of Dr. Ziemssen has received research support from Roche.
Joel Kramer, PhD	The institution of Dr. Kramer has received research support from tau consortium. Dr. Kramer has received publishing royalties from a publication relating to health care.
Zbigniew K. Wszolek, MD, FAAN	Dr. Wszolek has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Polish Neurological Society/Via Medica. Dr. Wszolek has received intellectual property interests from a discovery or technology relating to health care.
Diana Dimitrova, PhD	No disclosure on file
Xue Ming, MD	Dr. Ming has nothing to disclose.
Cyrus P. Zabetian, MD	The institution of Dr. Zabetian has received research support from American Parkinson Disease Association. The institution of Dr. Zabetian has received research support from Department of Veterans Affairs. The institution of Dr. Zabetian has received research support from NIH. Dr. Zabetian has a non-compensated relationship as a Member, Scientific Advisory Council with Lewy Body Dementia Association that is relevant to AAN interests or activities.
Shin Nabatame	No disclosure on file
Colleen Marino, PhD	No disclosure on file
Rossitza Chichkova, MD	Dr. Chichkova has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Argenx. Dr. Chichkova has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Grifols. Dr. Chichkova has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB.
James R. Couch, Jr., MD, PhD, FAAN	No disclosure on file
Jeffrey Statland, MD	Dr. Statland has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Arrowhead. Dr. Statland has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ML Bio. Dr. Statland has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Epic Bio. Dr. Statland has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Armatus . Dr. Statland has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Kate Therapeutics. Dr. Statland has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Vita Therapeutics. Dr. Statland has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Dyne Therapeutics. Dr. Statland has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Avidity . Dr. Statland has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Fulcrum Therapeutics. Dr. Statland has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Statland has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Vertex . The institution of Dr. Statland has received research support from NIH. The institution of Dr. Statland has received research support from FSHD Society. The institution of Dr. Statland has received research support from Friends of FSH Research. The institution of Dr. Statland has received research support from FSHD Canada. The institution of Dr. Statland has received research support from MDA.
Mathula Thangarajh, MD, PhD, FAAN	Dr. Thangarajh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sarepta. Dr. Thangarajh has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for NS Pharma.
Albi J. Chalissery, MD	No disclosure on file
Thienhuu Nguyen	No disclosure on file
Mohammed Alhaidar, MD	Dr. Alhaidar has nothing to disclose.
Taylor R. Anderson, MD	Dr. Anderson has nothing to disclose.
Katie Alex	No disclosure on file
James C. Grotta, MD, FAAN	Dr. Grotta has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Frazer Ltd. Dr. Grotta has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Haemonetics. Dr. Grotta has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Acticor. Dr. Grotta has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Prolong Pharma. Dr. Grotta has received publishing royalties from a publication relating to health care. Dr. Grotta has received publishing royalties from a publication relating to health care.
Marc Verin	Mr. Verin has nothing to disclose.
Mohamed Shehab-Eldin, MD, MB, BCh, MSc	No disclosure on file
Philipp Albrecht, PhD	Dr. Albrecht has received personal compensation for serving as an employee of Abbvie. Dr. Albrecht has received personal compensation for serving as an employee of Biogen. Dr. Albrecht has received personal compensation for serving as an employee of Bristol Myers Squibb. Dr. Albrecht has received personal compensation for serving as an employee of Ipsen. Dr. Albrecht has received personal compensation for serving as an employee of Merck. Dr. Albrecht has received personal compensation for serving as an employee of Merz. Dr. Albrecht has received personal compensation for serving as an employee of Novartis. Dr. Albrecht has received personal compensation for serving as an employee of Roche. Dr. Albrecht has received personal compensation for serving as an employee of Sanofi. Dr. Albrecht has received personal compensation for serving as an employee of Lilly.
Ziad Hussein	No disclosure on file
Jayant N. Acharya, MD, DM, FAAN	Dr. Acharya has nothing to disclose.
Matteo De Marco, PhD	No disclosure on file
David R. Cornblath, MD	Dr. Cornblath has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Octapharma. Dr. Cornblath has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Annexon. Dr. Cornblath has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Pfizer. Dr. Cornblath has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Grifols. Dr. Cornblath has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cigna. Dr. Cornblath has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alnylam. Dr. Cornblath has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Anavex. Dr. Cornblath has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Hansa. Dr. Cornblath has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for MPTP. Dr. Cornblath has received intellectual property interests from a discovery or technology relating to health care.
Giovanni Coppola, MD	Dr. Coppola has received personal compensation for serving as an employee of Regeneron. Dr. Coppola has received stock or an ownership interest from Regeneron.
Megan Quimby	Ms. Quimby has nothing to disclose.
Sara Razmjou-Schwarz, MD	No disclosure on file
Angelo Antonini, MD	Dr. Antonini has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BIAL. Dr. Antonini has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ABBVIE. Dr. Antonini has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Antonini has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for THERAVANCE. Dr. Antonini has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ROCHE. Dr. Antonini has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for ABBVIE. Dr. Antonini has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for ZAMBON. Dr. Antonini has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for BOEHRINGER.
Maromi Nei, MD	No disclosure on file
Jong W. Lee, MD, PhD	The institution of Dr. Lee has received research support from NIH. The institution of Dr. Lee has received research support from NIH. The institution of Dr. Lee has received research support from UCB. Dr. Lee has received personal compensation in the range of $10,000-$49,999 for serving as a Contract work with Teladoc.
Laxman Bahroo, DO, FAAN	Dr. Bahroo has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbvie. Dr. Bahroo has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Acorda. Dr. Bahroo has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Neurocrine. Dr. Bahroo has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Supernus. Dr. Bahroo has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Teva. Dr. Bahroo has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Ipsen. Dr. Bahroo has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Amneal. Dr. Bahroo has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Acadia. Dr. Bahroo has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Revance. Dr. Bahroo has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merz. Dr. Bahroo has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Abbvie. Dr. Bahroo has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Acorda. Dr. Bahroo has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Amneal. Dr. Bahroo has received personal compensation in the range of $100,000-$499,999 for serving on a Speakers Bureau for Supernus. Dr. Bahroo has received personal compensation in the range of $100,000-$499,999 for serving on a Speakers Bureau for Neurocrine. Dr. Bahroo has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Sunovion. Dr. Bahroo has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Kyowa Kirin. Dr. Bahroo has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Lundbeck. Dr. Bahroo has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Merz.
Raffaella Migliaccio	Raffaella Migliaccio has nothing to disclose.
Theodore Wein, MD	No disclosure on file
Emilia M. Gatto, MD, FAAN	Dr. Gatto has received personal compensation in the range of $0-$499 for serving as a Consultant for UCB. Dr. Gatto has received personal compensation in the range of $0-$499 for serving as a Consultant for Bago Argentina. Dr. Gatto has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bago. Dr. Gatto has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB. Dr. Gatto has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Janssen. Dr. Gatto has received research support from Roche. The institution of Dr. Gatto has received research support from CHDI.
Scott McGinnis, MD	Dr. McGinnis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai.
Wei Liu, MD	Dr. Liu has nothing to disclose.
Rosa Rademakers, PhD	Rosa Rademakers, PhD has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Mayo Clinic. Rosa Rademakers, PhD has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Arkuda Therapeutics. Rosa Rademakers, PhD has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Alzheimer Fondation. Rosa Rademakers, PhD has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Kisick Family Foundation (FTD grant program). The institution of Rosa Rademakers, PhD has received research support from NIH. The institution of Rosa Rademakers, PhD has received research support from DOD. The institution of Rosa Rademakers, PhD has received research support from Flanders Institute for Biotechnology (VIB). The institution of Rosa Rademakers, PhD has received research support from Flanders Funds for Scientific Research.
Lesley Schofield	No disclosure on file
Dieter Haering	Dieter Haering has received personal compensation for serving as an employee of Novartis.
Jillian Chan, MD	No disclosure on file
Dianalee McKnight, PhD	Dr. McKnight has nothing to disclose.
Xuemei Huang, MD, PhD	Dr. Huang has received personal compensation for serving as an employee of NIH. Dr. Huang has received personal compensation for serving as an employee of DoD. The institution of Dr. Huang has received research support from NIH.
Vladimiro Sinay, MD	No disclosure on file
Shawn C. Aylward, MD	Dr. Aylward has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Pediatric Neurology. The institution of Dr. Aylward has received research support from Pfizer. Dr. Aylward has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant with Vaccine injury counsel.
Chokri A. Mhiri, MD	Prof. Mhiri has received personal compensation for serving as an employee of Hikma. Prof. Mhiri has received personal compensation for serving as an employee of Sanofi Genzyme. Prof. Mhiri has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Prof. Mhiri has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche.
Myassar Zarif	Myassar Zarif has nothing to disclose.
Daniel J. Licht, MD	No disclosure on file
Steve Chung, MD, FAAN	The institution of Dr. Chung has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for ucb pharma. Dr. Chung has received personal compensation in the range of $500-$4,999 for serving as a Consultant for SK Life sciences. Dr. Chung has received personal compensation in the range of $500-$4,999 for serving as a Consultant for eisai. Dr. Chung has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for eisai. Dr. Chung has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for ucb. Dr. Chung has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for SK Life sciences. Dr. Chung has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for sunovion.
Yasuo Iwasaki, MD	No disclosure on file
Subhashie Wijemanne, MD	No disclosure on file
David S. Kushner, MD, FAAN	Dr. Kushner has nothing to disclose.
Ricardo Alonso	Ricardo Alonso has nothing to disclose.
Lucia Rivera Lara, MD	Dr. Rivera Lara has received personal compensation in the range of $5,000-$9,999 for serving as a expert witness with Legal firms.
Per Odin	Per Odin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AbbVie. Per Odin has received personal compensation in the range of $0-$499 for serving as a Consultant for Britannia. Per Odin has received personal compensation in the range of $0-$499 for serving as a Consultant for Convatec. Per Odin has received personal compensation in the range of $0-$499 for serving as a Consultant for UCB.
Jee H. Jeong, MD	Dr. Jeong has nothing to disclose.
Eng Lo, MD	Eng Lo, MD has nothing to disclose.
Betty C. Soliven, MD	Dr. Soliven has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CVS Pharmacy. The institution of Dr. Soliven has received research support from NIH. The institution of Dr. Soliven has received research support from NIH. The institution of Dr. Soliven has received research support from Alexion. The institution of Dr. Soliven has received research support from Roche/Genentech.
Sandro Iannaccone	No disclosure on file
Scheherazade Le, MD	Dr. Le has nothing to disclose.
Alessandro Meani	Alessandro Meani has nothing to disclose.
Tomas Uher	Tomas Uher has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Tomas Uher has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol myers. Tomas Uher has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Tomas Uher has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. The institution of Tomas Uher has received research support from Novartis.
Sofia Akrivou	No disclosure on file
Alessandro Orlando, MPH	No disclosure on file
Loredana Storelli	Loredana Storelli has nothing to disclose.
Denise F. Chen	Ms. Chen has nothing to disclose.
Saeed Ansari, MD	Dr. Ansari has nothing to disclose.
Marie Wencel, CCRP	Ms. Wencel has nothing to disclose.
Mohammad Anadani, MD	Dr. Anadani has nothing to disclose.
Amit S. Singh, MD	Dr. Singh has nothing to disclose.
Jeenendra P. Singhvi, MD, FAAN	Dr. Singhvi has nothing to disclose.
Ericka S. Wong, MD	Dr. Wong has nothing to disclose.
Alan Wilman, PhD	No disclosure on file
Anisa Kelley, MD	Dr. Kelley has nothing to disclose.
Pauline Hwang, NP	Ms. Hwang has nothing to disclose.
Amputch Karukote, MD	Dr. Karukote has nothing to disclose.
Assunta Bianco	Assunta Bianco has nothing to disclose.
Andrew Heim	Andrew Heim has nothing to disclose.
Marie Theaudin, MD	No disclosure on file
Carlo S. Tornatore, MD	Dr. Tornatore has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Serono. Dr. Tornatore has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Tornatore has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Tornatore has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen.
Katya Rascovsky	No disclosure on file
Nadia Tenenbaum, MD	Dr. Tenenbaum has received personal compensation for serving as an employee of EMS Serono. Dr. Tenenbaum has stock in EMS Serono.
Amanda S. Lindy, PhD	Dr. Lindy has received personal compensation for serving as an employee of GeneDx.
David K. Li, MD	Dr. Li has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Li has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Biogen. Dr. Li has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Academy of Health Care Learning. Dr. Li has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Sanofi-Genzyme. Dr. Li has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Consortium of MS Centers.
Samir Belal, MD	No disclosure on file
Bart Van Wijmeersch, MD, PhD	Prof. Van Wijmeersch has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Prof. Van Wijmeersch has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Prof. Van Wijmeersch has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Prof. Van Wijmeersch has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Prof. Van Wijmeersch has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Celgene/Bristol Myers Group. Prof. Van Wijmeersch has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Prof. Van Wijmeersch has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen Pharmaceutics. Prof. Van Wijmeersch has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Prof. Van Wijmeersch has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck. Prof. Van Wijmeersch has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. Prof. Van Wijmeersch has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Prof. Van Wijmeersch has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. The institution of Prof. Van Wijmeersch has received research support from Merck. The institution of Prof. Van Wijmeersch has received research support from Roche.
Barbara Bumstead, NP	Ms. Bumstead has nothing to disclose.
Mel Feany, MD, PhD	No disclosure on file
Agustin Ibanez, PhD	Dr. Ibanez has nothing to disclose.
Berenice Silva	SIlva Berenice has nothing to disclose.
Jennifer A. Roggenbuck, MS, CGC	The institution of Ms. Roggenbuck has received research support from Packard Foundation.
Richard R. Murphy, MBChB, FAAN	Dr. Murphy has nothing to disclose.
Daniel Golan, MD	No disclosure on file
Scott Mintzer, MD	No disclosure on file
Clarissa L. Yasuda, MD, PhD	Prof. Yasuda has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for LIBBS. Prof. Yasuda has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ABBOTT. Prof. Yasuda has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for LIBBS.
Adam B. Cohen, MD	Dr. Cohen has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Thirty Madison. Dr. Cohen has received stock or an ownership interest from Thirty Madison.
Osamu Kano, MD, PhD	Dr. Kano has nothing to disclose.
Leon A. Weinstock, MD	Dr. Weinstock has nothing to disclose.
Mauro Comola	No disclosure on file
Aarushi Suneja, MD	Dr. Suneja has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie. Dr. Suneja has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Abbvie.
Loren D. Pena	No disclosure on file
Mary J. Holmay, RN, BSN	No disclosure on file
Chinwe Nwadiogbu	No disclosure on file
Lucas Bonamico	No disclosure on file
Xavier Ayrignac	Xavier Ayrignac has nothing to disclose.
Harry Alexopoulos	No disclosure on file
Kaustubh S. Limaye, MD	Dr. Limaye has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Scientia Vascular.
Daniel P. Kurz, MD	An immediate family member of Dr. Kurz has received personal compensation for serving as an employee of Grainger. Dr. Kurz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Foundation for Sarcoidosis Research. An immediate family member of Dr. Kurz has or had stock in Grainger. The institution of Dr. Kurz has received research support from Biogen.
Nora Roesch	No disclosure on file
Jessica Rice, MD	Dr. Rice has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Greenwich Pharmaceuticals.
Karlla Danielle Ferreira Lima	Karlla Danielle Ferreira Lima has nothing to disclose.
Rachel J. Saban, MD	Dr. Saban has nothing to disclose.
Fabio Buttari	No disclosure on file
Sumita M. Strander	Ms. Strander has nothing to disclose.
Lingling Ding	No disclosure on file
Alexander Pantelyat, MD, FAAN	Dr. Pantelyat has received personal compensation for serving as an employee of MedRhythms, Inc.. Dr. Pantelyat has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for MedRhythms, Inc.. Dr. Pantelyat has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Kelly & Ignoffo Law Group. The institution of Dr. Pantelyat has received research support from NIH/NIA.
Aimee Szewka, MD, FAAN	Dr. Szewka has nothing to disclose.
Allison Wright Willis, MD	Dr. Wright Willis has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Pharmacoepidemiology and Drug Safety. Dr. Wright Willis has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for JAMA Neurology. The institution of Dr. Wright Willis has received research support from NIH. The institution of Dr. Wright Willis has received research support from NIA. The institution of Dr. Wright Willis has received research support from Biogen. The institution of Dr. Wright Willis has received research support from Parkinson Foundation. The institution of Dr. Wright Willis has received research support from Arcadia.
Danielle Harvey, PA-C	No disclosure on file
Omar M. Hussein, MD	No disclosure on file
Alice J. Schabas, MD	Dr. Schabas has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Schabas has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Schabas has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for EMD Serono. Dr. Schabas has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amgen.
Heidi N. Beadnall, MD	Dr. Beadnall has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Beadnall has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Beadnall has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. The institution of Dr. Beadnall has received research support from MSBase Foundation.
Devashish D. Ruikar, MD	Dr. Ruikar has nothing to disclose.
Elie Naddaf, MD	Dr. Naddaf has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Expert Connect. Dr. Naddaf has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Klick, Inc. Dr. Naddaf has received personal compensation in the range of $500-$4,999 for serving as a Consultant for WebMD. Dr. Naddaf has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Johnson and Johnson. Dr. Naddaf has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Arcellx. The institution of Dr. Naddaf has received research support from NIAMS. The institution of Dr. Naddaf has received research support from Fulcrum therapeutics. The institution of Dr. Naddaf has received research support from Abcuro. The institution of Dr. Naddaf has received research support from Cabaletta . The institution of Dr. Naddaf has received research support from Arcellx.
Kiyokazu Kawabe, MD	No disclosure on file
Nazely Ashikian, MD	Dr. Ashikian has nothing to disclose.
Atul T. Patel	Atul T. Patel has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Revance. Atul T. Patel has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for IPSEN. Atul T. Patel has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie. Atul T. Patel has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Allergan/Abbvie. Atul T. Patel has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for IPSEN. The institution of Atul T. Patel has received research support from Abbvie. The institution of Atul T. Patel has received research support from IPSEN.
MingMing Ning, MD	No disclosure on file
Edoardo Malfatti, MD	Dr. Malfatti has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Spark therapeutics. Dr. Malfatti has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sarepta. The institution of Dr. Malfatti has received research support from AFM. The institution of Dr. Malfatti has received research support from Spark Therapeutics. The institution of Dr. Malfatti has received research support from AFM. The institution of Dr. Malfatti has received research support from ANR.
Maria Goicochea	No disclosure on file
Priya Kishnani, MD	Priya Kishnani, MD has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi/Genzyme. Priya Kishnani, MD has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Amicus Therapeutics. Priya Kishnani, MD has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Maze Therapeutics. Priya Kishnani, MD has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for JCR Pharmaceutical. Priya Kishnani, MD has received personal compensation in the range of $500,000-$999,999 for serving as a Consultant for Asklepios Biopharmaceutical Inc. (AskBio). Priya Kishnani, MD has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi/Genzyme. Priya Kishnani, MD has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Amicus Therapeutics. Priya Kishnani, MD has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Baebies, Inc.. The institution of Priya Kishnani, MD has received research support from Sanofi/Genzyme. Priya Kishnani, MD has received research support from Amicus Therapeutics. Priya Kishnani, MD has received intellectual property interests from a discovery or technology relating to health care. Priya Kishnani, MD has received intellectual property interests from a discovery or technology relating to health care.
Tamara Miller, MD	Dr. Miller has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics Therapeutics, Abbvie, Genentech. Dr. Miller has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for EMD Serono, TG Therapeutics, Biogen, Abbvie, Genentech, Lundbeck. The institution of Dr. Miller has received research support from Abbvie, Ipsen, Alexion, Pfizer, BMS, Genentech, ThermoFisher Scientific.
Thomas L. Winder, PhD, FACMG	Dr. Winder has nothing to disclose.
Alejandra D. Martinez, MD	No disclosure on file
Benedikt Schoser	Benedikt Schoser has received personal compensation for serving as an employee of Alexion. Benedikt Schoser has received personal compensation for serving as an employee of Argenx. Benedikt Schoser has received personal compensation for serving as an employee of Amicus. Benedikt Schoser has received personal compensation for serving as an employee of Astellas. Benedikt Schoser has received personal compensation for serving as an employee of Denali. Benedikt Schoser has received personal compensation for serving as an employee of Avidity . Benedikt Schoser has received personal compensation for serving as an employee of Sanofi. Benedikt Schoser has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Taysha. Benedikt Schoser has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Astellas. Benedikt Schoser has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Encoded. Benedikt Schoser has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Kedrion.
Diego Silva, MD, PhD	No disclosure on file
David Bar-Or	David Bar-Or has received intellectual property interests from a discovery or technology relating to health care.
Zheng-Yu Jin	No disclosure on file
Dong Wook KIM	No disclosure on file
Manoj Goyal	No disclosure on file
Angelica Guareschi	No disclosure on file
Varalakshmi Ballur Narayana Reddy, MD	No disclosure on file
Saima Usmani, MD	Dr. Usmani has nothing to disclose.
Shashika Rodrigo, MD	Dr. Rodrigo has nothing to disclose.
Karla Washington	No disclosure on file
Ibrahim Laleka	No disclosure on file
James A. Giles, MD	Dr. Giles has received personal compensation for serving as an employee of Yale University. The institution of Dr. Giles has received research support from NIH/NINDS.
Christopher Green, MD	No disclosure on file
Thais Secchi	No disclosure on file
Petr Kanovsky, PhD	Dr. Kanovsky has nothing to disclose.
Claire Riley, MD, FAAN	Dr. Riley has received personal compensation for serving as an employee of AstraZeneca. Dr. Riley has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Riley has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Riley has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Riley has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. Dr. Riley has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Riley has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. Dr. Riley has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Immunic AG. Dr. Riley has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cabaletta Bio. Dr. Riley has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol Myers Squibb. Dr. Riley has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Riley has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics.
Claudio Gasperini, MD	Dr. Gasperini has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche, Merck, Genzyme, Novartis,Bayer, Teva, Almirall.
Kolar N. Murthy, MD, FAAN	Dr. Murthy has nothing to disclose.
Guy Nagels, MD	No disclosure on file
Balaji Krishnaiah, MD, FAAN	Dr. Krishnaiah has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for ACP. Dr. Krishnaiah has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Merck Manual. Dr. Krishnaiah has received publishing royalties from a publication relating to health care.
Bichun Ouyang	Bichum Ouyang has nothing to disclose.
Sameer Ansari	Sameer Ansari has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Hyperfine. Sameer Ansari has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Boston Scientific. Sameer Ansari has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medtronic. Sameer Ansari has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for MIcrovention. Sameer Ansari has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Imperative Care. Sameer Ansari has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Oculus Imaging. Sameer Ansari has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Perfuze. Sameer Ansari has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Rapid Medical. Sameer Ansari has or had stock in Clearvoya LLC. An immediate family member of Sameer Ansari has or had stock in Hyperfine. The institution of Sameer Ansari has received research support from NIH. Sameer Ansari has received intellectual property interests from a discovery or technology relating to health care.
Arshdeep Singh, Jr., MBBS	No disclosure on file
Michael R. Frankel, MD	The institution of Dr. Frankel has received research support from Nico Corporation, Inc.
Anelyssa Cysne Frota D' Abreu, MD, PhD, MPH, FAAN	The institution of Dr. Cysne Frota D' Abreu has received research support from U.S. NIH Institute on Aging. The institution of Dr. Cysne Frota D' Abreu has received research support from Biogen. The institution of Dr. Cysne Frota D' Abreu has received research support from American College Of Radiology. The institution of Dr. Cysne Frota D' Abreu has received research support from COGNITION THERAPEUTICS, INC.. The institution of Dr. Cysne Frota D' Abreu has received research support from Eli Lilly. The institution of Dr. Cysne Frota D' Abreu has received research support from Jansen. Dr. Cysne Frota D' Abreu has received personal compensation in the range of $10,000-$49,999 for serving as a Lecturer with Pri_med.
Emanuele D'Amico	Emanuele D'Amico has nothing to disclose.
Madeline C. Fields, MD	Dr. Fields has nothing to disclose.
Meredith Wicklund, MD, FAAN	The institution of Dr. Wicklund has received research support from Arizona Alzheimer's Consortium. The institution of Dr. Wicklund has received research support from NIH.
Waleed Brinjikji, MD	Waleed Brinjikji, MD has nothing to disclose.
Omar Jawdat, MD	Dr. Jawdat has nothing to disclose.
Ashley Petrone	No disclosure on file
Corey C. Ford, MD, PhD, FAAN	No disclosure on file
Sarita Said-Said, MD, FAAN	Dr. Said-Said has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Gritman Medical Center.
Erika Silverman	Ms. Silverman has nothing to disclose.
Bruce M. Coull, MD	Dr. Coull has nothing to disclose.
Joseph L. Schindler, MD	Dr. Schindler has received personal compensation for serving as an employee of Aeromics. Dr. Schindler has received personal compensation in the range of $50,000-$99,999 for serving as an officer or member of the Board of Directors for Aeromics. Dr. Schindler has received stock or an ownership interest from Aeromics. Dr. Schindler has received publishing royalties from a publication relating to health care.
Andrei V. Alexandrov, MD	The institution of Dr. Alexandrov has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NovaSignal. Dr. Alexandrov has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NovoNordisc. Dr. Alexandrov has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for AstraZeneca. Dr. Alexandrov has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for American Society of Neuroimaging. Dr. Alexandrov has received publishing royalties from a publication relating to health care.
Peter Bede, MD, PhD	Dr. Bede has nothing to disclose.
Hacer Durmus, MD	Dr. Durmus has nothing to disclose.
Piraye Serdaroglu, MD	No disclosure on file
Maria Luisa Martinez Gines, MD	Dr. Martinez Gines has nothing to disclose.
Edoardo G. Spinelli, MD	Dr. Spinelli has nothing to disclose.

��ɫ����

��ɫ����

��ɫ��

��ɫ��